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1. INTRODUCTION 
Polycystic ovarian syndrome (PCOS) is one of the most common reproductive 
endocrinological disorders with a broad spectrum of clinical manifestations affecting 
about 6.8% of women of reproductive years
[1]
. A polycystic ovary is an abnormally 
large numbers of developing egg seen to the ovarian periphery, looking like a “String 
of pearls”. PCOS was previously called Stein-Leventhal syndrome after the 
physicians who first characterized it in 1930’s[2]. It is associated with 
oligomenorrhoea, anovulation (causing endocrine disorder such as thyroid disease, 
adrenal disease and pituitary tumors)
[3]
, infertility, hirsutism and obesity in young 
women having bilaterally enlarged cystic ovaries. It is a condition in which women 
have high levels of male hormones (Androgen) and anovulation are known to interact 
with insulin resistance in the pathophysiology of PCOS. Hyperinsulinaemia appears 
to interfere with ovarian steroidogenic defects as well as anovulatory mechanisms. 
Child and adolescent overweight and obesity were associated with 
significantly increased risk of later polycystic ovary syndrome symptoms 
[4]
. 
Failure of ovulation results in prolonged, excessive endometrial stimulation by 
estrogens. Under these circumstances, endometrial glands undergo mild architectural 
changes, including cystic dilation (persistent proliferative endometrium). Thus 
hyperplasia occurs in most commonly around menopause or in association with 
persistent anovulation in younger women. Conditions leading to hyperplasia include 
polycystic ovarian disease including Stein Leventhal Syndrome
[3a]
. 
Globally, prevalence estimates of PCOS are highly variable, ranging from 
2.2% to as high as 26%. WHO estimates that it affected 116 million women are 
affected Worldwide in 2012(3.4% of women). 
In India the prevalence is gradually increasing. It is due to the lifestyle that 
people have adopted. Almost all foods are packed with chemicals that lead to 
hormonal imbalance. The cause of PCOS remains unclear. 
The prevalence of PCOS among them was 22.5% by Rotterdam and 10.7% by 
Androgen Excess Society Criteria. Non-obese women comprised 71.8% of PCOS 
diagnosed by Rotterdam Criteria. Mild PCOS [oligomenorrhoea and polycystic 
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ovaries on USG] was the most common phenotype (52.6%). Hyperinsulinemia was 
presenting among 19.2% of diagnosed PCOS causes 
[5]
. 
There is an intriguing pathophysiological frame work to support the 
therapeutic advantages of insulin sensitizers in the management of PCOS, including 
metabolic aspects, ovulatory functions and hyperandrogenemia. Metformin and 
thiazolineodiones are the two more widely used insulin sensitizers
[6]
. 
Obesity is clearly associated with adverse pregnancy outcomes in the lager 
population, and it likely increases the risk of adverse pregnancy complications with 
PCOS. One meta-analysis that looked at pregnancy in women with PCOS and 
adjusted for differences in obesity in women with PCOS did note increased rates of 
gestational diabetes, preterm labour and infant mortality among women with PCOS. 
Medicine as everyone knows is not merely a science but an art as well. Siddha 
science is very ancient in origin, as old as the earliest civilization of the southern 
peninsula of India. Siddha system of medicine was expounded by a class of more 
intelligent people called Siddhars. Siddhars were the great scientists in the ancient 
period and they are the original creator of the Siddha system of medicine 
[7]
. 
The term 'Siddha' has been derived from 'Siddhi' which means an object to be 
attained or achievement or perfection of heavenly bliss. Siddhars were the men who 
achieved supreme knowledge in the fields of medicine, yoga and meditation 
[8]
. 
This system represents a well-established, codified and organized medical 
system that had been utilized and refined in India over hundreds of generations with 
sophisticated theoretical foundations and philosophical explanations, expressed in 
thousands of Tamil manuscripts dealing with curative, preventive, preservative 
aspects and longevity of life in the simplest way. 
The Siddha system is effective in treating various diseases of the liver, 
gastrointestinal tract, skin diseases, allergic disorders, general fevers, chronic 
diseases, gynaecological disorders. Many Siddhars were more concentrated in treating 
various gynaecological disorders including Karpavayu.  
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The signs and symptoms of Karpavayu i.e., diseases which prevents 
pregnancy characterized by multiple ovarian cysts is called Sinaippai neerkatigal, 
Soolaga neerkattigal, Karpapai neerkattigal correlated with the Poly Cystic Ovarian 
Syndrome (PCOS) in which poly means many, cystic means water filled sac-like 
structure and when many are formed in the ovary called PCOS which is mentioned in 
the following verses, 
“ப ொருமி இரத்தத் தனைமரித்துப் ப ொதவுதொம் வலிஉண்டொய் 
குருதியழியில் வலிதீருங் கூடுங் பெர்ப் ந் தனையழிக்கும் 
வருடியிடுப்புக் குனடந்துனையு மல்த்னத மிெவுமிருக்ெி நிறகும் 
ப ருெப்  னைக்குங் குவிமுனலயொய்! ப சங் பெர்ப் வொயுவிபத” 
-தன்வந்திரி னவத்தியம்  ொெம் 1 
The symptoms of Karpavayu includes diminished menstrual flow with 
abdominal pain, when the flow increases the pain is relieved.  Prevents conception 
and there is low back pain and constipation 
[9]
.  
It is natural to be afflicted by disease and necessarily medicine administered. It 
is said that cure is effected only for those who have good sound body and those with 
bad constitution will not be identified. 
PCOS has become a common health problem which affects women’s 
menstrual cycle, hormone imbalance, ability to bear children, appearance, mental state 
and is also the main cause for infertilty.  In Siddha the clinical features of PCOS are 
described in  “Yugi Muni Vaithya Kaaviyam”, “Thirumoolar Karukidai Vaithyam” 
and in “Gnanavettiyan – 1500”  by Thiruvalluva Nayanaar discussed in detail about 
female reproductive problems such as PCOS, infertility, fibroids, etc.,. Prevention and 
cure are the basic aims of all systems of medicine whereas the Siddha system has in 
addition the transcedental motivation of what might called the immortality of the 
body.The basic emphasis of Siddha system is on positive health viz.to prevent 
diseases by carefull dieting. 
Numerous single drug and compound drug formulations documented in 
classical Siddha literatures are highly efficacious and devoid of side effect or adverse 
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effects and are useful to the mankind. Today we are only exploring their efficacy and 
usefulness through advanced scientific research tools and modern techniques. 
Hence, current research looked into ancient Siddha system of medicine in 
search of an effective alternative and number of herbs that could act at the level of 
hypothalamic-pituitary-axis. Various herbs are reported in Siddha system of medicine 
which aid in bleeding and clotting mechanisms along with potentially corrects the 
lipid and carbohydrate metabolism. Several herbal formulation have been developed 
which helps to improve PCO phenotype via directly acts on hypothalamo-pituitary-
ovary-uterine axis and thereby regularize the menstrual cycles 
[10]
. 
Siddha System approaches have become common for the management of 
such metabolic syndromes. According to Siddha, many formulations have been 
reported which help to restore the ovulation and minimize the PCO phenotypes. One 
of such effective formulation mentioned in this system is “Ashuwathi Chooranam” 
for treating ‘Karpa Vayu’ (PCOS) successfully [11]. Some principal herbal ingredients 
of this formulation which include Withania somnifera, Zingiber officinale, Piper 
nigrum, Piper longum, Myristica fragrans, Glycyrizzha glabra, Syzygiumar 
omaticum, Picrorrizha Scrophularia, are known to possess various beneficial 
activities. Hyoscymus niger has a stimulatory effect on the ovarian tissue, which may 
produce an estrogen-like activity that enhances repair of the endometrium and stops 
bleeding 
[12]
. It is found to be effective in menorrhagia and dysmenorrhea. Even 
though it is mentioned in Siddha system of medicine for treating PCOS, no 
scientific data available to confirm its effectiveness in treating various 
gynaecological disorder especially PCOS.  
This Siddha drug “Ashuwathi Chooranam” is yet remained unexplored for its 
exact chemical, -pharmacological values in terms of scientific research. To fill these 
scientific lacunae, the present work was undertaken to standardize Ashuwathi 
chooranam to validate through physicochemical analysis, phytochemical analysis, 
instrumental analysis, toxicological studies and pharmacological screening in animal 
model. 
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2. AIM AND OBJECTIVES 
AIM 
Polycystic  ovarian  syndrome  (PCOS)  is  a  heterogeneous  collection  of  
signs  and symptoms which together form a spectrum of the disorder with 
mild/severe disturbance in reproduction, endocrine and metabolic functions. The 
pathophysiology of PCOS appears  to  be  multifactorial  and  polygenic, which  is  
contributed  by  intra  and  extra ovarian factors. Women with PCOS demonstrate 
decreased sensitivity to the feedback effects of gonadal steroids on GnRH 
secretion
[13]
. 
This causes an accelerated frequency of LH secretion from anterior 
pituitary
[14]
 resulting into abnormal steroid synthesis contributed majorly by ovarian 
theca cells
[15]
.  Intrinsic anomaly of steroidogenesis reflects itself in causing follicular  
arrest which is evident  by  the  presence  of  peripheral  cysts  in  ovary. Biochemical 
alterations of ovarian function render its effect on metabolically active organs by 
causing insulin resistance, leading to metabolic syndrome. 
With emphasis to above, current available mode of treatment for PCOS is 
by use of insulin sensitizers like metformin and ovulatory agent like clomiphene 
citrate
[16]
. But, these drugs have been reported for their side effects upon prolonged 
usage
[17]
. There by, in current decade, research is directed towards the ancient Siddha 
system of medicine to manage mainly hypoglycemia and PCOS related disorders. 
As stated in Siddha classical literature, Ashuwathi Chooranam helps to 
improve menstrual irregularities in reproductive age. However, scientific evaluation 
of Ashuwathi Chooranam for treatment of female infertility has not been attempted 
till date. In this regard, it would be interesting to examine the role of Ashuwathi 
Chooranam in management of Polycystic Ovarian Syndrome (PCOS) and its 
associated complications.  
Thereby, the present investigation was aimed to validate the safety and 
efficacy of the Siddha poly-herbal formulation “ASHUWATHI CHOORANAM” for 
Ovulation Inducing Activity in Female Wistar Albino Rats. 
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OBJECTIVES 
The objectives of this work were done through the following steps. 
 Collection of relevant literature from classical Siddha texts as well as Modern 
sciences that supported this study. 
 Description of pharmacognostic features of the plant in this formulation 
including the taxonomic identification, collection, purification of plants etc. 
 Preparation of the drug according to the procedure described in Siddha 
literature. 
 Standardisation of the trial drug by means of physico-chemical analysis, phyto 
chemical analysis. 
 Revealing the anions and cations present in the drugs through proximate 
chemical analysis. 
 Elucidation of the chemical structure, microscopical structure of the drugs by 
means of instrumental analysis. 
 Interpreting the results of acute and repeated 28 days oral dose toxicity of 
“ASHUWATHI CHOORANAM” according to OECD guidelines 423 and 407. 
Detailing the study of pharmacological activities like  
 Effect of Ashuwathi Chooranam in letrozole induced PCOS rat model. 
a) Development  of  PCOS  rat  model  with  the  help  of  Letrozole  (non-
steroidal aromatase inhibitor). 
b) Estimation of FSH, LH, Estradiol and Progesterone levels 
 Anti-oxidant activity of the trial drug “ASHUWATHI CHOORANAM” in 
female Wistar rats. 
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3. REVIEW OF LITERATURE 
3.1. DRUG REVIEW 
3.1.1. SIDDHA ASPECT OF THE DRUG: 
அசு஬ா஡ிச் சூ஧஠ம் 
“அநி஬ானநி஬ா ஦க஬ா஡ சூ஧஠ந்஡ன் னண஦னந஦க் ககள் 
திநி஬ாய் ஬ந்஡ தனக஧ாகம் கதாகும்தடிக்கு அப௃க்கிநாக஬ர் 
குநி஦ா஦ிடித்து ஬டிகட்டி கூட்டு ஥பேந்து ஡ிரிகடுகு 
ந஢நி஦ாய்ஞ்ச் சா஡ிக்காய் தத்஡ிரி ஢ீ஡ ஥து஧ங் கி஧ாம்தாக஥” 
 
 “ஆக஥ கடுகுக஧ாக஠ி ஦ஞ்ச஥ தாகங் குநசாணி 
ஆக஥ ஬னகக்கு ப௃க்க஫ஞ்சி ஦ணினில் ந஬துப்தி தூபாக்கி 
ஆக஥ ஦ிபேதத்ன஡ங் க஫ஞ்சு ஥஡ிக சணீி஦ின஬ ந஦ாக்க 
ஆக஥ ந஧ட்டி ஦ப௃க்கிநாக஬ர்ப் நதாடிப௅ஞ் சூ஧஠஥ாச்கச”. 
க஬று 
“சூ஧஠ ஥ாச்ச஡ணில் ந஬பேகடி஡ான் ந஢ய்஦ில்  
   தூடர்ந்து ஦ிபேகதாது ஥ண்டனந்஡ானுண்஠ 
கா஧஠஥ாய் ஬஧ண்டு ஬ற்நி஦ிபேந்஡ க஡கம் 
    கணத்஡ வுடல் பூரித்துப் தபேக்கு஥ப்தா 
பூ஧஠஥ாய் தூனித்துப் பூரித் க஡ார்க்கு 
    பூட்டடா க஡ணிகன ம்ண்டனந்஡ான் ஬ற்றும் 
஬ா஧஠஥ாய் தித்த்ந஥ாடு தாண்டு ஡஧ீ 
           ஬ாழ்க஥ன஡ புபி஦ா஡ க஥ாரிலூட்கட”  
 
“ஊட்டடா ந஦னிகடிக்கும் தசுவு ஢ீரி 
     நனாடுங்கா஡ சித்து ஬ி஭ந் க஡ட்கு க஬ப்நதண்ன஠ 
பூட்டடா ஬ிபக்நகண்ன஠ க஥லும் பூசு 
   நதால்னா஡ ஦ீனபந஦ாடு கசானக ஡஧ீ 
ப௄ட்டடா ந஬ள்பாட்டு ஢ீரிகன஡ான்  
     ஥ிகுந்஡ நதபேம்தாட்டுக்கு ந஦ள்நபண்ன஠ ந஬ல்னம் 
஢ீட்டடா஬ிரி஦னுக்கு ந஬ந்஢ீலூட்டி 
     ஢ிக஫க஬ பூசி஬ிட ஢ின்றுகதாக஥” 
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“஢ின்றுகதாம் ஡னன஦ினபத் ஡ிபேந்஡ானப்தா 
     க஢஧ா஬ின் தானிகன பெட்டுவூட்கட 
஢ின்றுகதாம் ஭ட்குன்஥ம் ஬ாய்வு ஥க஧ாசிக்கு 
     ஢ீட்டடா கச்சல் த஫ச்சாற்நிகன ஡ான் 
஢ின்றுகதாஞ் சூனனகல௃க்குப௃ரி஦ிகன பெட்டு 
     ஢ில்னா஡ கசானக கா஥ானன கதாக 
஢ின்றுகதாம் ஢ிம்தத்஡ின் சாற்நிலுண்஠ 
     ஢ினனநகட்டுப் திள்னப஦ினா ஡஬ர்க்குக் கககப” 
 
“திள்னப஦ில்னா ஡஬ர்க்கு஥தா தி஧஥ி஦ினனச் சாற்நில் 
     திசகா஥ல் ஢ல்நனண்ன஠ தாகனினனச் சாறும் 
஡ள்பா஡ ஥ினகுடகண கூட்டிப௅ண்஠ 
     சந்஡஡ி஡ா னுண்டாகுந் ஡ாட்சி஦ில்னன 
கள்பப௃ள்ப னக஥சக்குக் காய் ந஬ண்ன஠ ஡ன்ணில் 
     கணகந஥ழு ககாடபேந்து கணிவுண்டாகும் 
ந஡ள்பி஦ ஢ற்கா஦ ந஥ாடு ஡ிப்தினிச் சாற்நினபேந்஡ 
   ந஡ரின஬஦ர்க்கு ஥ா஡஬ினட சிநக்குந்஡ாகண”. 
-அகத்஡ி஦ர் ன஬த்஡ி஦ கா஬ி஦ம் 1500 
Ingredients 
Amukkura - Withania somnifera  
Chukku  - Zingiber officinale (dried ginger) 
Milagu  - Piper nigram 
Thippili  - Piper longum 
Jaadhikaai  - Myristica fragrans 
Jaadhipathiri - Myristica fragrans          
Adhimadhuram- Glycirriza glabra 
Krambu - Syzygium aromaticum 
Kadugurohini - Picrorhiza scrophulariiflora 
Krosaniomam  - Hyoscymus niger 
Amukkara - Withania somnifera 
The herb grows in India and Balochistan. The plant is ash in colour. Its fruit 
resembles tomato. When the fruit ripens it is red in colour. 
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Synonyms: 
Amukkuri 
Amukkuravi 
Asuvam  
Ashuvagantham 
Erulichevi 
Kidichevi 
Varagakarni 
Vernacular names: 
English  - Winter cherry 
Telugu  - Penneru-gadda 
Malayalam - Amukkuram 
Kanada  - Sogade-beru 
Sanskrit  - Aswagandha 
Arab  - Luban 
Persian  - Habdul Kaknaje 
Hindhi  - Habdul Kaknaje 
Urdu  - Asgandh 
Part used  :  Root, leaf, seed. 
Taste  :  Bitter 
Character:  Heat 
REVIEW OF LITERATURE 
 
OVULATION INDUCING ACTIVITY OF ASHUWATHI CHOORANAM                                          8  
 
Division  :  Pungent 
Actions  : 
Aphrodisiac 
Tonic  
Diuretic 
Febrifuge  
Alterative 
De-obstruent 
Soporific 
Sedative. 
General Properties: 
 
“நகாஞ்சந் து஬ர்ப்தாங் நகாடிக஦ம் சூனன஦ரி 
             ஥ிஞ்சுக஧ப் தான்தாண்டு ந஬ப்த஡ப்பு-஬ிஞ்சி 
                         ப௃சுவுறு க஡ாப௃ம்கதா ந஥ாகம்அண 
                 ஢குட ந஬பேண்டுறு஬ாழ் ஢ாள்”. 
      -அகத்஡ி஦ர் கு஠஬ாகடம் 
Indications: 
It is used for strength, stamina, beauty, longevity. 
Therapeutic uses 
It is effective in kayam, vadha diseases, eczema, fever and swelling. 
External application 
 The root tuber was ground with cow’s urine and the paste was boiled. 
This was applied externally for tumours, swellings and for pain. 
 The above paste along with chukku was ground in hot water, applied for 
swellings. 
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 The root tuber or leaf was ground and applied for tumours and wound. 
Decoction  
It is given for fever. 
Amukkara podi 
The root tuber was boiled in milk, washed, dried and powdered.  
Dose: 2 to 4 gms. 
Adjuvant   : honey 
Indications: Vali iyam, swelling, anorexia, obesity
 [18]
 
Siddha formulations 
Amukkara chooranam, amukkura legium. 
Chukku – Zingiber officinale 
Synonyms: 
Arukkan 
Artharagam  
Upakullam 
Ularntha inji 
Kadupathiram 
Chukku 
Chundi 
Chondi 
Soupannam 
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Souvarnam 
Navasuru 
Vernacular names: 
Tamil  - Chukku 
English - Dried ginger 
Telugu  - Sonti 
Malayalum - Chukku 
Kannadam - ona shunti or sunti 
Sanskrit - Nagaram 
Hindi  - Sonth 
Arab & Per     - Znagebilarataba 
Part used :      Root (dried) 
Taste        :      Acrid 
Character:    Heat 
Division   :      Acrid 
Action     :   
Stimulant 
Stomachic 
 Carminative. 
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General characters 
 
“சூனன஥ந்஡ம் ந஢ஞ்நசரிப்பு க஡ாடக஥ப் தம்஥஫னன 
ப௄னம் இன஧ப்திபே஥ல் ப௄க்கு஢ீர் -஬ானகத  
க஡ாட஥஡ி சார்ந் ந஡ாடர்஬ா஡ குன்஥஢ீர்த் 
க஡ாடம்ஆ ஥ம்கதாக்குஇஞ் சுக்கு”. 
-அகத்஡ி஦ர் கு஠஬ாகடம். 
Indications: 
Indigestion, heart burn, belching, cough, asthma, sinusitis, haemorrhoids, 
gastric ulcer, bloating, anaemia, fever. 
Therapeutic uses 
Decoction: 
The decoction prepared from it is administered for fevers. 
Chukku karpam: 
The chukku powder along with sugarcane juice can be given in morning for 
gastritis. 
Siddha formulations 
Sowbakiya chundi, panchadepagini chooranam, panchadepagini legium 
[18a]
 . 
Kirambu - Cloves 
Synonyms: 
Lavangam 
Anjukam 
Tiraili 
Varangam 
Chosam 
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Vernacular names: 
 
Tamil  - Kirampu 
English - Cloves, Clove tree 
Telugu  - Lavangalu 
Malayalum - Karampu 
Kannadam - Lavanga 
Sanskrit - Lavangam 
Hindi  - Long 
Part used :   Dried flower buds, fruit and oil. 
Taste        :  Acrid    
Character:  Heat    
Division   :  Acrid  
Action      : 
Carminative 
Antispasmodic 
 Appetizer 
General characters 
“தித்஡஥஦க்கம்கத஡ிந஦ாடு஬ாந்஡ிப௅ம்கதாம் 
சுத்஡஬ி஧த்஡க்கடுப்புந்க஡ான்றுக஥ா-ந஥த்஡ 
இன஬ங்கங்நகாண்ட஬பேக்ககற்சுக஥ாகும்  
஥ன஥ங்கககட்டுந஥ண஬ாழ்த்து 
சுக்கின஢ட்டங்கர்஠சூர்஬ி஦ங்கனாஞ்சணந்஡ாட் 
சிக்கல்஬ிடாச்சர்஬ாசி஦ப்தி஠ிப௅- ஥க்கிக்குட் 
டங்கப்பூக஬ாடு஡ரிதடபேந்க஡ான்நினில் 
஬ங்கப்பூக஬ாடுன஧த்து஬ா” 
-அகத்஡ி஦ர் கு஠஬ாகடம் 
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Indications   
It cures giddiness, diarrhoea, dysentery, vomiting, anal fissure and cataract. 
Therapeutic uses: 
It is used in medicine and culinary preparation.  
To extract oil, it must be fresh and oily.  
Decoction  
It is used for arresting vomiting and curing digestive disorders like indigestion, 
colic, flatulence, dyspepsia etc. 
It is specially recommended for pregnant women in case of vomiting and 
rumbling noise of the stomach. 
The oil distilled from this forms and esteemed remedy for tooth-ache. 
Siddha formulations 
Kumkumapoo maathira, Kirambu thylam,  kapadamathirai 
[18b]
. 
Jathikaai -myristica fragrans 
Synonyms: 
Kullakai 
sathikkai 
Vernacular names: 
Eng  -   Nut meg 
San  - Jatipatri 
Mal  - Jatipattriri 
Tel  - Jakikaya 
Kan  - Jajikayi 
Arab  - Jojubuva 
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 Pers  - Jaurzoboyah 
 Hindi  - Jae-phal 
 Duk  - Japhal 
Part used :      Fruit 
Taste        :      Astringent, acrid 
Character:     Heat 
Division   :      Acrid 
Action      :   
 Stimulant  
 Stomachic 
 Carminative 
 Narcotic 
 Aromatic 
 Aphrodisiac  
 Tonic 
General properties: 
"஡ாது ஢ட்டம் கத஡ி சபே஬ாசி ஦ஞ்சி஧ க஢ாய் 
ஓதுசு஬ா சங்காசம் உட்கி஧ா஠ி - க஬க஡ா  
டினக்காய் ஬பேம்தி஠ிகதாம் ஌ற்ந஥஦ல் தி஡த்ங் 
குனக்காய் ஦பேந்து஬ர்க் கூறு ".  
    -அகத்஡ி஦ர் கு஠஬ாகம். 
 
Indications: 
Oligospermia, diarrhoea, headache, cough, asthma, stomach pain, bloating. 
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Therapeutic uses: 
Sathikakai oil: The oil obtained by distillation process can be given up to 1-5 
drops for tooth ache. 
Sathikkai powder: It is used to cure cough, stomach pain, migraine, and 
menorrhagia. 
Decoction: It is given in the dehydration after vomiting and diarrhoea.  
Sathikkai was ground and applied around the eyes to increase the power of 
vision 
[18c]
. 
Jathipathiri - Myristica fragrans(Arill) 
Synonyms: 
Jathipathiri 
Vasuvasi 
Vernacular names 
Eng                          -  Arillus of the nut 
Tel                           -  Japtri 
Mal   -  Jatipattriri 
Kan                          -  Japatri 
Sans                         - Jatipatri 
Arab                         -  Bisbasah 
Pers                          -  Bazbaz 
Hind                         -  Javatri 
Duk                           -  Joutri 
Part used :   Arill of the fruit 
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Taste        :             Acrid 
Character:       Heat 
Division   :            Acrid 
Actions 
Aphrodisiac 
Carminative 
Stimulant 
Hypnotic 
General properties 
"சா஡ி஡பேம் தத்஡ிரிக்குத் ஡ாதச் சு஧ந்஡஠ிப௅ம் 
ஓதுகின்ந தித்஡ம் உ஦பேங்காண் - ஡ாது஬ிர்த்஡ி  
ப௅ண்டாங் கி஧க஠ிக஦ா கடா஡க் க஫ிச்சலுறும் 
தண்டாங் குனநக஦ தகர் ".  
     -அகத்஡ி஦ர் கு஠஬ாகடம் 
  
Indications: 
It is used in fever, steatorrhea, and diarrhoea. It strengthens the body. 
Therapeutic uses 
It is given in the dehydration after vomiting and diarrhoea.  
Sathipathiri was ground and applied around the eyes to increase the power of 
vision
[18d]
. 
Milagu -  Piper nigrum 
Synonyms 
Kalinai 
Kari 
Kayam 
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Kolagam 
Thirangal 
Miriyal 
Sarumabantham 
Valisam 
Maasam 
Vernacular names: 
Eng  -    Black pepper  
Hin  -    Kali-mirch  
Kan  -    Menasu  
Mal  -    Kurumulaku   
San  -    Maricha 
Tel  -    Miriyalu  
Sans  -    Maricha 
Habitat: 
It is a climber. The plant is cultivated in South Indian parts of India Such as 
Kerala, Cochi, Kudagu Mysore. The fruit of this plant is called as Milagu. 
Part used : Seed, shoot. 
Taste    :  Bitter, acrid 
Character: Heat 
Division  : Acrid 
Actions  : 
Antidote 
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Carminative 
Antiperiodic 
Rubefacient 
Stimulant 
Resolvent 
Antivatha 
General properties: 
  “ச஡ீசு஧ம் தாண்டு சிகனத்஥ங்கி஧ா஠ிகுன்஥ம் 
஬ா஡ம் அபேசிதித்஡ம் ஥ாப௄னம் -ஓதுசன்ணி  
  ஦ாச஥தஸ் ஥ா஧ம் அடன்க஥கம் காச஥ின஬ 
஢ாசங் கநி஥ிபகிணால்  
  -க஡஧ன் கு஠஬ாகடம் 
 ககாணுகின்ந தக்க஬னி குய்஦வுக஧ா கம்஬ா஡ 
          கசா஠ி஡ங்க ழுத்஡ிற்குள் க஡ான்றுக஢ாய் -கா஠ி஦  
             காதுக஢ாய் ஥ா஡ர்குன்஥ங் கா஥ானன ஥ந்஡ந஥ன்நரீ் 
                                  ஌துக஢ாய் கா஦ிபேக்கில் ஈங்கு. 
   -அகத்஡ி஦ர் கு஠஬ாகடம். 
Indications: 
Fever, anaemia, diarrhoea, gastric ulcer, vatham, pitham, kapam diseases will be 
cured. 
One of the ingredients in Trikatuku 
Pills: 
The pill made of this given for prolapse of pile mass. 
External application: 
Milagu thailam: 
The oil extracted from can be given for vatha diseases, sinusitis, deaf. 
Paste: 
The paste made when is treated for alopecia, the hair starts to grow 
[18e]
. 
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Thippili - Piper nigrum  
Synonyms 
Aarkathi 
Unsaram 
Ulavainaasi 
Kaman 
Kudari 
Kolagam 
Koli 
Kozhaiyaruki 
Saram  
Vernacular names: 
Eng                  -    Long pepper 
Tel  -    Pippilu  
Mal  -    Thippili  
San  -     Pippali 
Duk  -     Pipliyan 
Kan  -     Hippili  
Pers  -     Daraife-fil 
Habitat: 
 Piper longum is a climber mainly cultivated in South India and West Bengal for 
the fruit. The acrid taste of it is higher than the pepper. 
Types: 
Arisi thippili and yanai thippili. 
Part used:  Fruit, rice 
Taste: Sweet 
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Character:     Heat 
Division: Sweet 
Actions: 
Stimulant  
Carminative 
General properties: 
   “கட்டி ந஦஡ிர்஢ின்று கடுக஢ா஦ல் னாம்த஠ிப௅ம் 
஡ிட்டி ஬ினண஦கலும் க஡கந஥த்஡ -புட்டி஦ாம்  
஥ா஥னுக்கு ஥ா஥நணண ஥ற்ந஬ர்க்கு ஥ற்ந஬ர்க்கு 
஥ற்ந஬ணாங் 
   கா஥ந஥னுந் ஡ிப்தினிக்கும் னக.  
                    -க஡஧ன்  .ந஬ண்தா   
 
Indications: 
Cough, anaemia, sinusitis, anorexia, gastric ulcer, asthma, diseases of ear and 
nose, tuberculosis 
Thippili is one of the ingredients in Trikatuku 
Therapeutic uses: 
Thippili five parts and thettran seed three parts are powdered well and 4gms of 
it given in kaluneer, three days in the morning gives a cure for white discharge 
and menorrhagia.  
Thippili karpam: 
 The powder of it along with honey can be given for tinea about one month. 
Thippili arisi:  
It cures bloating, fever, tuberculosis and increases the sperm count 
[`18f]
. 
Athimadhuram - Glycyrrhiza glabra 
Synonyms 
Athingam 
Atti 
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Madhugam 
Kundriver 
Vernacular names: 
Eng.  - Jequitity; Indian or Jamaica liquorice.  
Tel  - Ati-Madhuramu, Yashti-Madhukam 
Mal  - Ati-Madhuram, Iratti-madhuram  
San  - Yashti-Madhukam   
Arab  - Aslussus 
Pers  - Bikhe-Mahak 
Hindhi  - Jathi-Madh,Mulath 
Duk  - Mitthi-Lak 
Habitat: 
The plant grows in hilly areas like the Abrus precatorius it is also a root. It is 
small or big in size, yellow in colour and externally dirty white in colour. The 
seeds are in different colours of black, white and red. 
Part used : Root  
Taste        : Sweet, bitter 
Character: Heat 
Division    : Acrid 
Actions     : 
Emollient, Demulcent Mild, Expectorant, Laxative, Tonic. 
General properties: 
     “கத்஡ி஦ரி ப௃ப்த஠ி஦ால் ஬பேபுண்  
          கண்க஠ாய்உன் ஥ா஡ம்஬ிக்கல் ஬னிந஬ண் குட்டம் 
          தித்஡ந஥லும் புபேக்கி கிரிச்ச஧ம் ஆ஬ர்த்஡ 
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          தித்஡஥஡ ப௄ர்ச்னச ஬ிட தாகம் ந஬ப்ப்ந் 
          ஡த்஡ி஬பே ஬ா஡கசா ஠ி஡ங்கா ஥ானன 
          சபே஬஬ிடங் கா஥ி஦ங்க஢ாய் ஡ாது ஢ட்டங் 
          குத்஡ிபே஥ல் ஆசி஦ங்கம் இ஡ழ்க஢ாய் இந்து 
          கு஦ப்புணும்கதாம் ஥தூகந஥ணக் கூறுங் காகன”. 
- க஡஧ன் கு஠஬ாகடம். 
 
Therapeutic uses: 
The powder of Atimathuram, Milagu, Kattukai along with honey is given for 
cough. 
Atimathuram and Mutsangan was ground in lime juice and given for jaundice. 
Atimadhuram along with thiratchai uppu can be given for diarrhoea
 [18g]
. 
Kadugurohini -Picrorhiza scrophulariiflora 
Synonyms 
Kadugurohini 
Kadagarohini 
Vernacular names 
Eng  -    Picrorhiza 
Tel  -   Katki  
Mal  -   Katukurohini, Katurohini  
San  -   Katvi, Katurohini, Katuka 
Hin  -   Katuka, Kuru, Kutuki 
Kan  -    Katukarohini 
Habitat: 
The plant grows in Himalayas from Kashmir to Sikkim. The outer surface of the 
root is dirty white in colour and inner it is black in colour. It is also called Nattu 
kadugurohini.  
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Part used :    Root  
Taste        :           Bitter, acrid 
Character:    Heat 
Division   :    Acrid 
Actions    : 
Antiperiodic 
Cathartic 
Stomachic 
Anthelmintic 
General properties: 
“஥ாந்஡ஞ் சு஧ன஥஦ம் ஬ாப௅க஧ப் தாணா஥ஞ் 
கசர்ந்஡஥னல் கட்டு ஡ிரிக஡ாடம் - கதாந்஡நதாட்டுப்  
புண்஬஦ிறு க஢ா஦ின஬கதாம் நதாற்நகாடிக஦ -கத஡ிப௅ண்டாம்  
஡ிண்கடுகு க஧ாக஠ிக்குத் க஡ர்”. 
 
  -அகத்஡ி஦ர் கு஠஬ாகடம். 
Indications: 
Indigestion, fever, iyya peruku, eczema, dysentery, stomach pain, wounds. 
Therapeutic uses: 
Decoction: 
The decoction of the root is given for dropsy 
[18h]
. 
Kurosani omam – Hyoscyamus niger 
Synonyms 
Thippiyam 
Karasavai 
Karabi 
Karsavai 
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Vernacular names 
Eng  -    Henbaneseeds, Black henbane 
Tel  -   Kurasani oamamu   
Mal  -    Kurasani (omum)  
San  -     Parasikayavani 
Hin  -     Khorasani-Ajowan 
Kan  -     Kurasani voma, Kurasani Vadakki     
  
Habitat: 
In India it grows in Himalayas at a height of 8000 to 11,000 feet. The leaf is 
greenish yellow in colour, it has a characteristic odour. Flowers are light yellow 
in colour. 
Part used :    Seed 
Taste    :    Acrid, slightly bitter 
Character:    Heat 
Division  :       Acrid 
Actions: 
Hypnotic 
Sedative 
Anodyne 
Antispasmodic 
Mild diuretic 
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General properties: 
“ந஬குப௄த்஡ி஧ம்஬ா஡ம் ஬ரீி஦஢ட் டம்புண் 
உகுகத஡ி ப௅ட்கடுப்தி கணாகட - ஥ிகுக஧ப்தான்  
஡஧ீாக் கத஥ின஬கதாம் நசய்஦கு க஧ாசாணிந஦ன்நால் 
஬ா஧ா ஥஦க்கப௃று ஥ால்”. 
     -அகத்஡ி஦ர் கு஠஬கடம். 
Indications: 
Diseases of the teeth, Polycystic Ovarian Syndrome, bronchitis, glitch of 
memory, tremor, insomnia. 
Therapeutic uses: 
Decoction: 
The extract of Hyoscyamus can be given for insomnia, glitch of memory 
[18i]
. 
3.1.2. BOTANICAL ASPECT 
Withania somnifera 
Kingdom - Plantae 
Class  - Magnoliopsida 
Order  - Solanales  
Family  - Solanaceae  
Genus  - Withania  
Species - somnifera 
Occurrence and distribution: 
 Withania somnifera is an evergreen shrub growing to 1m height. It 
grows abundantly in India especially in Madhya Pradesh, Bangladesh, Srilanka 
and northern parts of Africa. 
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Description of the plant: 
 It is an upright shrub, star shaped branches covered with fine hairs, 
leaves alternate and ovate, up to 10cm long and up to 5cm wide, flowers yellow 
in colour, fruit red berries in papery protective covering. Root long fleshy 
tubers. 
Part used: 
Rhizome 
Actions: 
Diuretic 
Antipyretic 
Anthelmintic 
Alterative 
Aphrodisiac 
De-obstruent 
Chemical constituents: 
Steroid lactone, withanolides, withanolide A, withanoside IV. 
Uses: 
Used as a sedative or calming agent and for insomnia. 
Anti-inflammtory agent; it is used to treat rheumatic pain and arthritis. 
General tonic and adaptogen which helps the body to adapt stress and promote 
strength
 [19]
. 
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Glycyrrizha glabra 
Kingdom -Plantae  
Class  -Angiosperms  
Order  -Fabales  
Family  -Fabaceae  
Genus  -Glycyrrizha  
Species -glabra 
Occurrence and distribution: 
 A genus of perennial herbs and undershrub’s distributed in the sub-
tropical and warm temperate regions of the World, chiefly in the Mediterranean 
Countries and China. In India it grows in Himalayas and hilly districts of South 
India. 
Description of the plant: 
 It is a hardy herb or undershrub attaining a height up to 6ft; leaves 
multifoliolate, imparipinnate; flowers in axillary spikes, papilionaceous, 
lavender to violet in colour; pods compressed containing reniform seeds. The 
underground part in some varieties consists of a rootstock with a number of 
long, branched stems. The dried, peeled or unpeeled underground stems and 
roots constitute the drug, known in the trade as Liquorice. 
Part used: 
Root 
Actions: 
Tonic 
Expectorant 
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Demulcent 
Mildly laxative 
Haemolytic 
Chemical constituents: 
 The principle constituent of liquorice to which it owes its characteristic 
sweet taste is glycyrrhizin which is present in different varities. Other 
constituents present in liquorice are glucose, sucrose, mannite, starch, 
asparagine, bitter principles, resins, a volatile oil and colouring matter. The 
yellow colour is due to the anthoxanthin glycoside; isoliquiritin. A steroid 
estrogen, possibly estriol is also reported to be present in liquorice.  
Uses: 
Useful in irritable conditions of the mucous membrane of genitourinary tract. 
Liquorice extract is a constituent of cough syrups, throat lozenges and pastilles. 
The extract is reported to exert a healing effect on gastric ulcers. 
It is spasmolytic and stimulates hydrochloric acid secretion. 
It is used in the treatment of Addison’s disease [19a]. 
Piper longum 
Kingdom - Plantae 
Class  - Angiosperms 
Order  - Piperales  
Family  - Piperaceae  
Genus  - Piper   
Species - longum 
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Occurrence and distribution: 
 It is climbing plant cultivated on large scale in limestone soil 400-600 m 
below the Cherapunji region which receives very high rain fall. India imports a 
large quantity of long pepper from Malaysia and Singapore.  
Description of the plant: 
 Long pepper is cultivated mainly by layering of the mature branches or 
by suckers planted at the beginning of the rainy season. The stems have nodes 
where the fruitful branches and leaves born. It has adventitious roots. Leaves are 
numerous, stalked and cordate at the base with seven nerves. The inflorescence 
is pedunculated flower spike that comes out from the nodes of the main stem. 
The long pepper fruit is a drupe small, arranged in the flower spike forming 
compact fruiting, welded, reminiscent of black catkins and hard, between 2 and 
3(up to 5) cm long. 
Part used: 
Root 
Actions: 
Tonic 
Expectorant 
Demulcent 
Mildly laxative 
Haemolytic 
Chemical constituents: 
 The fruit of Piper longum has shown the presence of the alkaloids 
piperine (4-5%) and piplartine and two new liquid alkaloids, one of which is 
designated as alkaloid A. This is closely related to pellitorine. Sesamin, 
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dihydrostigmasterol and e new sterol, piplasterol are also present. The oil of the 
fruit contains terpinolene, n-octadecane, α-thujene, p-methoxy acetophenone. 
Uses: 
The fruits as well as the roots are attributed with numerous medicinal 
uses, and may be used for diseases of the respiratory tract viz. cough, asthma, 
bronchitis, tuberculosis, etc.; as counter irritant and analgesic, as snuff in coma 
and drowsiness and internally as carminative; as sedative in insomnia and 
epilepsy; as general tonic and haematinic; as cholagogue in obstruction of bile 
duct and gall bladder; as an emmenagogue and abortifacient 
[19b]
. 
Piper nigrum 
Kingdom -  Plantae 
Class  - Angiosperms 
Order  - Piperales  
Family  - Piperaceae  
Genus  - Piper   
Species - nigrum 
Occurrence and distribution: 
 A branching, climbing perennial shrub, mostly found cultivated in the 
hot and moist parts of India and other tropical countries. Pepper is one of the 
most ancient crops cultivated in India and ha probably originated in the hills of 
south-western parts of India. In India, pepper is grown mainly in Kerala, Madras 
and Mysore and to a very small extent in Assam. 
Description of the plant: 
 Branches stout, trailing and rooting at the nodes; leaves entire, very 
variable in breadth. Flowers minute in spikes, usually dioecious, fruits ovoid or 
globose, bright red when ripe; seeds usually globose, testa thin, albumin hard. 
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Part used: 
Fruit 
Actions: 
Stomachic 
Antiperiodic 
Alterative 
Carminative 
Chemical constituents: 
 The fruit of Piper nigrum retards the development of rancidity in oils 
and fats, frozen ground pork, beef and lard. This activity has been attributed to 
the presence of tocopherols in the oleoresin. Arginine, piperine, lysine, 
histidine, cystine, asparagine, serine, glutamic acid, threonine, β-alanine, γ-
aminobutyric acid and pipecolic acid. 
Uses: 
 The fruits have stimulant and carminative properties and are used in 
haemorrhoidal affection. They are used in tonics for languidness and after 
childbirth, also in digestive and other disorders. In modern Indian medicine, it is 
much employed as an aromatic stimulant in cholera, weakness following fevers 
and as an alterative in paraplegia and arthritic diseases 
[19c]
. 
Picrorhiza scrophularia 
Kingdom - Plantae 
Class  - Angiosperms 
Order  - Piperales  
Family  - Scrophulatriaceae  
Genus  - Picrorhiza 
REVIEW OF LITERATURE 
 
OVULATION INDUCING ACTIVITY OF ASHUWATHI CHOORANAM                                          32  
 
Species - scrophularia 
Occurrence and distribution: 
 A small genus of perennial herbs distributed in the alpine Himalayas 
from Kashmir to Sikkim at altitudes of 2,700 – 4,500 m.  
Description of the plant: 
 The leaves of the plant almost radical, spathulate sharply serrate; flowers 
white or pale blue-purple, in a dense terminal spicate raceme; fruit an ovoid 
capsule.  
Part used:  
Rhizome 
Actions: 
Antiperiodic 
Cholagogue 
Stomachic 
Laxative 
Chemical constituents: 
 The roots of the plant contain large proportion of bitter principles, 
mainly a glucoside named picrorhizin also contain glucosidal bitter principle 
kutkin, non-bitter product kurrin, D-mannitol, vanillic acid, kuti-sterol, 
sesquiterpene. 
Uses: 
It is used for bacterial infections 
[19d]
. 
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Myristica fragrans 
Kingdom - Plantae 
Class  - Angiosperms 
Order  - Magnoliales  
Family  - Myristicaceae  
Genus  - Myristica 
Species - fragrans 
Occurrence and distribution: 
 In India, it is grown in Madras, Nilgiris, Coimbatore, Salem, Tirunelveli, 
Madurai, Ramanathapuram districts; a few trees were found in various localities 
in Kerala, Assam and other States. 
Description of the plant: 
 A dioecious or occasionally monoecious evergreen, aromatic tree. 
Usually 9-12 m. high. Bark greyish black, longitudinally fissured in old trees; 
leaves elliptic or oblong-lanceolate, coriaceous; flowers in umbellate cymes, 
creamy yellow, fragrant; fruits yellow, broadly pyriform or globose, 6-9 cm 
long, glabrous, often drooping; pericarp fleshy, seed broadly ovoid, arillate, 
albuminous, with a shell like purplish brown testa. 
Part used: 
Fruit 
Actions: 
Stimulant 
Astringent 
Aphrodisiac 
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Carminative 
Tonic 
Chemical constituents: 
 Analysis of nutmeg contains protein, carbohydrates, fibre, minerals like 
calcium, phosphorous, iron, carotene. 
Uses: 
 It is a major constituent of preparations prescribed for dysentery, 
stomach ache, flatulence, nausea, vomiting, malaria, rheumatism, sciatica and 
early stages of leprosy 
[19e]
. 
Zingiber officinale 
Kingdom - Plantae 
Class  - Angiosperms 
Order  - Zingiberales  
Family  - Zingiberaceae  
Genus  - Zingiber 
Species - officinale 
Occurrence and distribution: 
 Ginger has been under cultivation in India from times immemorial; the 
plants on the West coast of India are said to bear flowers quite frequently in 
October. Kerala gives much higher yield of the ginger as compared to that of the 
local types. Jamaican ginger is considered to be the best quality ginger and the 
Indian ginger comes the second.  
Description of the plant: 
 Ginger is an herbaceous, rhizomatous perennial, reaching up to 90 cm. 
in height under cultivation. Rhizomes are aromatic, thick-lobed, pale yellowish, 
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differing in shape and size in the different cultivated types. The herb develops 
several lateral shoots in clumps which begin to dry when the plants matures. 
Leaves narrow, distichous, dark green, flowers in spikes. 
Part used: 
Rhizome 
Actions: 
Stimulant 
Antioxidant 
Carminative 
Rubefacient 
Anti-depressant 
Anti-narcotic 
Chemical constituents: 
 Analysis of nutmeg contains crude protein, crude fibre, caprylic acids, 
phenol, zingiberene, ar-curcumene, zingiberol, cumene, limonenephellandrene. 
Uses: 
 Ginger is valued in medicine as a carminative and stimulant to the 
gastrointestinal tract. It is much in vogue as a household remedy for flatulence 
and colic. Ginger contains an anti-histaminic factor 
[19f]
. 
Hyoscyamus niger 
Kingdom -Plantae 
Class  - Magnoliopsida 
Order  - Solanales  
Family  - Solanaceae  
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Genus  -Hyoscyamus 
Species -niger 
Occurrence and distribution: 
 Usually biennial, is an evergreen shrub growing to 1m height. It grows 
abundantly in India especially in Madhya Pradesh, Bangladesh, Srilanka and 
northern parts of Africa. 
Description of the plant: 
 It is an upright shrub, star shaped branches covered with fine hairs, 
leaves alternate and ovate, up to 10cm long, flowers yellow in colour, fruit red 
berries in papery protective covering. Root long fleshy tubers. 
Part used: 
Seeds 
Actions: 
Diuretic 
Antipyretic 
Anthelmintic 
Alterative 
Abortifacient 
Chemical constituents: 
Hyoscyamine- N-oxide isolated from roots, leaves and stems. Total alkaloids 
from the aerial parts contained hyoscyamine, hyoscine, skimmianine, 
apoatropine, tropine, etc. 
Uses: 
Used as a sedative or calming agent and for insomnia. 
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Anti-inflammatory agent; it is used to treat rheumatic pain and arthritis. 
General tonic as adaptogen helping the body to adapt stress and promote 
strength 
[19g]
. 
3.2. DISEASE REVIEW  
3.2.1. Siddha aspect of the disease 
Synonyms 
 Soothaga katti 
 Ruthuneer katti.  
 Soothaga katti 
 Soothaga thiratchi 
 Soothaga noi 
 Soothaga kolaru [20]  
Soothaga vayu& Pcos 
“சித்஡ாண கர்ப்தத்஡ில் கசர்ந்஡ிடும் இ஧த்஡ந்஡ான் 
஬த்஡ாம் வுபேண்டு ஬ாப௅கதால் ஓடிடும் 
஬ற்ந தசிகதாகும் உ஫ன்கந இன஧ந்஡ிடும் 
஬ற்நாக க஫ிச்சனாம் ஬ன்சூ஡க ஬ாப௅஬”. 
-஡ிபேப௄னர் கபேக்கினட ஬஦ித்஡஦ம் 600 
Soothaga vayu  refers to a condition of building up of or accumulation of vayu 
and blood in the uterine cavity. This runs around the womb and result in loss of 
appetite, flatulence, dysentery. 
“ககல௃க஥ சூ஡கத் ஡ினக்கிணி ஬ாய்வு 
நகடுத்து ஬ிடும்஥ா஡ ஬ிடாய்கட்டிகதாகும் 
ஆல௃க஥ கபேக்கு஫ிப௅ம் தூர்ந்து க஡கம் 
அப்தகண ப௅஡ி஧ ஥துஅடி ப௄னத்஡ில் 
஢ீல௃க஥ சூ஡கத்஡ில் ஬ாய்வு க஡ான்நி 
க஢஧ாண அடி஬஦ிறு ஬னிப்புக் காணும் 
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தால௃க஥ ஡னன஬னிக்கும் இடுப்பு னபச்சல் 
தக்கு஬஥ாய் ஥பேந்துண்஠த் ஡பீேந்஡ாகண 
-ஆ஬ி஦பிக்கும் அப௃஡ப௃னநச் சுபேக்கம் 
Soothaga vayu may be compared to Poly cystic ovarian syndrome, which is   
characterized by vayu accumulation in the uterus may lead to amenorrhoea, 
lower abdomen pain, headache, low back ache etc. 
“நதாபே஥ி இ஧த்஡த் ஡னண஥ரித்துப் கதா஡வு஡ாம் ஬னிஉண்டாய் 
குபே஡ி஦஫ி஦ில் ஬னி஡பீேங் கூடுங் நகர்ப்தந் ஡னண஦஫ிக்கும்  
஬பேடி஦ிடுப்புக் குனடந்துனபப௅ ஥ல்த்ன஡ ஥ிகவு஥ிபேக்கி ஢ிநகும் 
நதபேகப் தன஠க்குங் கு஬ிப௃னன஦ாய்! கதசங் நகர்ப்த஬ாப௅஬ிக஡” 
- அகத்஡ி஦ர் ஆப௅ள் க஬஡ம்  0011 
According to Siddha principles, the PCOS is a kind of vayu disorder called 
karppa vayu which is characterized by frequent miscarriages, abdominal pain, 
low back ache, severe constipation. 
“஢஬ின்நிடக஬ ஦ிடுப்பு ஬஦ிற்நதபேத்துக் காணும் 
஢ன஥ாண க஥ணி஦து வூ஡ிக் காணும் 
கு஬ின்நிடக஬ ப௃ம்஥டிப்பு ஬஦ிற்நில் க஡ான்றும் 
கு஠஬஡ி஦ாந் க஡஬஡ா நதண்஠ா ணாலும் 
஢஬ின்நிடக஬ சன்஥த்஡ின் ஥னகட ஦ாகும் 
ச஡ாகானங் கபேப்த஥து ஡ரி஦ா ந஡ன்று 
பு஬ின்நிடக஬ பெகிப௃ணி சிகிச்சா சா஧ம் 
புகன்நிட்டார் கனாகத்து ஥ாந்஡ற் காக஥." 
  - பெகின஬த்஡ி஦சிந்஡ா஥஠ி- 
Siddha Yugi muni in the above lines says that the symptoms of Nirandhara 
maladu are obesity, increased waist hip ratio, flabby abdomen with three folds 
of skin. He further says that females with these features may suffer from 
infertility. These symptoms can be correlated to PCOS in modern
[21]
. 
Aetiology 
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“சூ஡கக஢ாய்஬பேம்஬஫ி: 
...............................................................  
     ஡஧஠ி஦ில் நதண்கல௃க்கு நகற்த க஢ாய்கள் 
஢஦க்கக஬ ஬ந்து ந஡ன்ணந஬ன்நால் ன஥ந்஡ா 
     ஢ன்ன஥ப௅டன் பேது஬ாகும் ஢ாபிற்நாகண 
஥஦க்கக஬ ஥ாப் தாண்டம் தால்த஫த்஡ிணாகன 
     ஬ந்து஡டா சூ஡கத்஡ின் ஬ாப௅஡ாகண 
 
஡ாநணன்ந கபேக்கு஫ி஦ில் ஬ாய்வு ஡ங்கி 
     ஡பர்ந்஡ ந஡ாபே கசான஧஦ிணால் ஡னச஡ான்ப௄டி 
ஊநணன்ந க஡கந஥ல்னாம் ஥஡ர்த்து ஢ல்ன 
     உண்ன஥ப௅ள்ப அடி஬஦ிற்நில் ஬னி ப௅ண்டாச்சு 
தாநணன்ந கபேக்கு஫ி ஡ான் ஬ிபக்க ஥ன்நி 
     த஧஥ாண ஬ிந்து஬ங்கக அணுகான஡஦ா 
஌நணன்நால் ஆ஡ி஦ிகன ஬ாய்வு நகாண்டு 
     இபேந்஡஡ிணால் நகற்த஥து இல்னன ஡ாகண 
-அகத்஡ி஦ர் அப௃஡ கனனஞாணம் 
The above lines explain the aetiology of reproductive diseases according to 
Siddha science. It says consumption of high calorie diet like starchy foods, 
milk, fruits during menstruation results in accumulation of Vayuin the uterine 
cavity. This leads to reduced blood flow to the organ resulting in obesity, 
abdominal pain and finally failure of conception.     
“இனசந்஡ந஡ாபே நதண்஥னடு ஋ங்கு஥ில்னன 
ணாகன ஥னடாண கச஡ிககல௃ 
அனசந்஡ிபேக்கும் கத஦ாலும் தித்஡த்஡ாலும் 
      அடி஬஦ிறு ந஢ாந்து஬பேம் ஬ாப௅஬ாலும் 
தினசந்஡ கர்ப்தப்புழு஬ாலும் கி஧கத்஡ாலும் 
      தி஠ி஦ாலும் க஥கன஬ சூரி஦ாலும் 
துசங்நகட்டக் கன஬ி஦ிணால் பூந஬ாதுங்கித் 
      துனங்கா஥ற் திள்னப஦ில்னன நசால்னக்கககப 
-த஡ிநணண் சித்஡ர்கள் தாடி஦ ன஬த்஡ி஦ 
சில்னனநக் ககான஬- 
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Causes for infertility 
The causes for female infertility are increased Pitham, Vatham, worms in the 
womb, planetary positions, viral infections and increased frequency of sexual 
intercourse.  
“஢஬ின்நிடக஬ ஦ிடுப்பு஬஦ிற் நதபேத்துக்காணும் 
஢ன஥ாண க஥ணி஦து வூ஡ிக்காணும் 
கு஬ின்நிடக஬ ப௃ம்஥டிப்பு ஬஦ிற்நில்க஡ான்றும் 
கு஠஬஡ி஦ாந்க஡஬஡ா நதண்஠ாணாலும் 
஢஬ின்நிடக஬ சன்஥த்஡ின் ஥னகட஦ாகும் 
ச஡ாகானங் கபேப்த஥து ஡ரி஦ாந஡ன்று 
பு஬ின்நிடக஬ பெகிப௃ணி சிகிச்சாசா஧ம் 
புகன்நிட்டார்கனா கத்து ஥ாந்஡ற்காக஥. 
-பெகி ன஬த்஡ி஦ சிந்஡ா஥஠ி. 
஢ாடி ஢னட 
“஥ா஡ர் னக஥ிடித்஡ கதாது஬ந்஡ிடும் ஢ாடிப௄ன்றும் 
கச஡஥ா஦ிற்று ஢ின்று கச஧க஬ த஡ித்து஢ிற்கில் 
ஓதுக஥ சூ஡கத்஡ில் ஓங்கி஦ ஬ாய்வு஢ின்று 
கத஡஥ாய் ஬ான஡தண்஠ி தி஠ி஦ினண ஬ினபக்குந்஡ாகண” 
   -த஡ிநணன் சித்஡ர்கபின் ஢ாடி சாஸ்த்஡ி஧ம் 
    When the naadi is felt in women if all the 3 nadi’s are found diffused and 
then felt together  then those women is subjected to mensural troubles and those 
women has Soothga vaayu and has different types of physical, characteristic and 
mental changes and leads to problems.  
3.2.2 Modern aspect of the disease 
Polycystic ovarian syndrome (PCOS) 
Polycystic ovarian syndrome (PCOS) is a common hormonal disorder in 
the middle of women reproductive age. It is a complex, heterogenous disorder, 
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containing numerous small cysts located along the outer edge of each ovary 
(polycystic appearance).The cysts are not harm but it leads to hormonal 
imbalance especially androgen, they producing slightly more androgen, this will 
stops ovulation, get acne and growth of extra hairs. The cause of PCOS is 
unknown, but genetics may be a factor. PCOS can be passed down from either 
your mother's or father's side. 
History 
It was primarily described by American Gynecologists Irving F.Stein, 
Sr. and Michael L. Leventhal, in 1935 that is why otherwise called as Stein – 
Leventhal Syndrome. 
Other names 
 Poly cystic ovary disease 
 Functional ovarian hyper androgenism 
 Ovarian hyperthecosis 
  Sclerocystic ovary syndrome  
  Stein – Leventhal Syndrome. 
Epidemiology  
 8-25% - normal women having Pcos on ultra sonographic findings. 
14% women who taking oral contraceptives are found to have Pcos. 
Etiology 
 Exact cause is unknown but hormone imbalance in brain and ovaries 
may cause PCOS. 
 Excess insulin: Many women with pcos have too much insulin 
secretion, this excessive insulin may cause increased secretion of testosterone 
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this will leads to some symptoms like growth of excess body hair or irregular 
periods. 
 Heredity: It has an evidence of genetic involvement. Family history 
reveals monozygotic twins are more prone to this disease than dizygotic 
twins. 
Classification 
The WHO criteria for classification of anovulation include the 
determination of oligomenorrhea (menstrual cycle >35 days) or amenorrhea 
(menstrual cycle > 6 months) in combination with concentration of prolactin, 
follicle stimulating hormone (FSH) and estradiol. Almost 80% of anovulation 
patients have normal serum FSH and Estradiol levels and demonstrate very 
heterogeneous symptoms ranging from anovulation, obesity, biochemical or 
clinical hyperandrogenism and insulin resistance. 
PCOS is the most common cause of anovulation in women with normal 
serum FSH and Estradiol levels. Despite the heterogeneity in symptoms 
associated with PCOS, the essential feature is arrested follicular development at 
the stage when selection of the dominant follicle should normally occur.  
The small ovarian follicles are believed to be the result of disturbed 
ovarian function with failed ovulation, reflected by the infrequent or absent 
menstruation that is typical of the condition. In a normal menstrual cycle, one 
egg is released from a dominant follicle essentially a cyst that bursts to release 
the egg. After ovulation the follicle remnant is transformed into a progesterone-
producing corpus luteum, which shrinks and disappears after approximately 12–
14 days. In PCOS, there is a so-called "follicular arrest", i.e., several follicles 
develop to a size of 5–7 mm, but not further. No single follicle reaches the 
preovulatory size (16 mm or more). 
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Fig No. 1. Poly cystic ovaries 
Table No.1. Clinical signs and symptoms associated with PCOS 
 Clinical signs and symptoms associated with PCOS 
Symptom Frequency 
Oligomenorrhoea 29-52% 
Amenorrhoea 19-51% 
Hirsutism 64-69% 
Obesity 35-41% 
Acne 27-35% 
Alopecia 3-6% 
Acanthosis nigricans <1-3% 
Infertility 20-74% 
Elevated Serum LH 40-51% 
Elevated testosterone 29-50% 
 
Diagnostic Criteria 
Diagnostic criteria have been established by the modified consensus of the 
National Institutes of Health and Child Health and Human Development (1990) and by 
consensus criteria established during the ESHRE/Rotterdam Conference in 2003. 
NIH Criteria (both required) 
1. Chronic anovulation 
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2. Clinical or biochemical signs of hyperandrogenism 
Minor NIH Criteria 
1. Insulin resistance 
2. Perimenarchal onset of hirsutism and obesity 
3. Elevated LH/FSH ratio 
4. Intermittent anovulation associated with hyperandrogenemia 
5. Ultrasound evidence of polycystic ovaries 
Rotterdam Criteria-two of three required 
1. Oligo and /or anovulation 
2. Clinical or biochemical signs of hyperandrogenism 
3. Polycystic ovaries 
Patho Physiology 
Typically, the ovaries are enlarged. The capsules are thickened and 
pearly white in colour. On bisection, multiple follicular cysts measuring about 5 
mm in diameter are crowded around the cortex. 
Histologically, there is thickening of tunica albuginea. The cysts are 
follicles at varying stages of maturation and regression. It should be 
remembered that PCOS may be un associated with enlarged ovaries.  
The pathophysiology of primary PCOS is obscure. There is abnormal 
pulse frequency of GnRH simultaneous with increased pituitary sensitivity to 
GnRH. The LH secretion is tonically elevated due to persistant high level of 
oestrone or androgens or both. FSH secretion remains either normal or decrease 
due to negative feedback effect of oestrogens and inhibin. 
Hormonal inervation of PCOS 
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Because of relative low levels FSH, there is defective ovarian 
folliculogenesis due to lack of aromalisation. The net effect is diminished 
oestradiol and increased inhibin production.Due to elevated LH, there is 
hypertrophy of theca cells and more androgens are produced either from theca 
cells or stroma. 
 
 
 
 
 
 
Fig No. 2. Difference between normal ovaries with polycystic ovaries 
Clinical features 
 Menstrual disorders: oligomenorrhoea, ammenorrhoea, 
 Excessive androgen: Elevated levels of male hormones (androgens) may 
result in physical signs, such as excess facial and body hair (hirsutism), adult 
acne or severe adolescent acne, and male-pattern baldness (androgenic alopecia) 
 Polycystic ovaries. Enlarged ovaries containing numerous small cysts can 
be detected by ultrasound 
 Infertility 
 Central obesity associated with insulin resistance, (serum insulin, high level 
of homocysteine) 
 Low-grade inflammation: 
 Research has shown that women with PCOS have low-grade inflammation.  
Complication 
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 Type 2 diabetes 
 High blood pressure 
 Cholesterol and lipid abnormalities, such as elevated triglycerides or low 
high-density lipoprotein (HDL) cholesterol, the "good" cholesterol 
 Elevated levels of C-reactive protein, a cardiovascular disease marker 
 Metabolic syndrome, a cluster of signs and symptoms that indicate a 
significantly increased risk of cardiovascular disease 
 Nonalcoholic steatohepatitis, a severe liver inflammation caused by fat 
accumulation in the liver 
 Sleep apnea 
 Abnormal uterine bleeding 
 Cancer of the uterine lining (endometrial cancer), caused by exposure to 
continuous high levels of estrogen  
 Gestational diabetes or pregnancy-induced high blood pressure, if you do 
become pregnant 
Diagnosis 
 CT, MRI. 
Laboratory test 
 Serum values 
 
 LH level is elevated and/or the ratio LH:FSH is > 3:1 
 Reversible oestradiol: oestrone ratio (oestrone level is markedly 
elevated) 
 SHBG level is reduced. 
 Androstenedione is elevated. 
 Serum testosterone and DHEA-S may be marginally elevated. 
Radiologic Studies in PCOS 
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 Ultrasonographic examination of PCOS women reveals an increase in 
ovarian size and an increased number of immature follicles. The Rotterdam 
criteria include enlarged ovaries measuring >10 cm3 and more than 12 follicles 
measuring 2-9 mm in diameter. 
 PCOS is a disorder comprising multiple clinical variants and apparent 
genetic propensities grouped together into the “PCOS phenotype” [21]  
Differential diagnosis 
 CAH- congenital adrenal hyperplasia 
 Cushing syndrome. 
3.4.3 Drugs used in Pcos 
           The drug therapy of infertility due to ovulatory failure was till recently 
empirical and disappointing. 
Classification of ovulation inducing drugs 
 Synthetic GnRH 
 Human menopausal and chronic gonadotropins 
 Bromergocriptine 
 Antiestrogenic compound 
GnRH 
 The GnRH (then called LH-RH) was isolated by Schally in 1971 by 
extracting and processing one million pig hypothalami. The GnRH of 
sheep, pigs, cows and human origin are identical in structure. 
 
 GnRH is decapeptide. 
 It is synthesized in hypothalamus. 
 It is also found human placenta. 
 It also appears in high concentration in breast milk. 
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Therapeutic uses 
Assessment of the function of the pituitary gonadotropes. 
Induction of ovulation. 
Treatment of males and females with idiopathic, hypothalamic, 
hypogonadotropic hypogonadotropism (Kallman syndrome). 
Adverse reactions 
 Hot flushes. 
 Sweating. 
 Vaginal dryness. 
 Headache. 
 Occasionally diminished libido and depression. 
 Prolonged treatment causes Osteoporosis. 
Human menopausal urinary Gonadotropin (hMG, Menotropins, Pregonal) 
         This is prepared from the urine of the menopausal women and is available 
in ampoules containing 75 IU of FSH and LH each. 
Therapeutic uses 
 Induce ovulation in women with anovulation due to pituitary-hypothalamic 
disorders but with normal ovaries and poly cystic ovaries. 
Adverse reactions 
 Hyperstimulation syndrome due this the ovaries become very large and 
friable. 
 Abdomimal pain. 
 Nausea. 
 Ascities. 
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 Shock. 
Bromorgocriptines (Bromocriptine, Parlodel, Proctinal) 
        This semisynthetic ergot alkaloid is a selective D2 receptors. 
Therapeutic uses 
 It inhibits hyper prolactinemia and stops galactorrhea. 
 It lowers the serum prolactin levels and restores potency in males. 
Antiestrogenic compound 
Clomiphine citrate (Clomid, Fertyl) 
        This is triphenyllethylene compound, the available Clomiphene preparation 
contains “cis” as well as “trans” forms. It is the “cis” form which is related 
structurally to oestrogen and is more potent than the racemic form. 
Therapeutic uses 
 Ovulation induction. 
 In those with regular anovulatory cycles, it is started on the fifth day after 
onset of mensuration. 
 Generally, ovulation occurs 70% of women; of these lessthan 50% may 
conceive. 
Cyclofenil (ondomid) 
 This compound has a structure similar to clomiphine  and is used for Pcos. 
 It does not exert anti-estrogenic effect. 
 It is usually start on the third day of the menstrual bleeding, it can induce 
ovulation. 
Letrozole 
 This aromatase inhibitor has been used for ovulation induction in patients 
with PCOS. 
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 It acts by inhibiting aromatase and thus reducing the production of 
estrogen. 
 Excess estrogen over-suppresses FSH production. 
 Aromatase inhibitors promote the development of healthy ovarian follicle 
and ovulation.  
Metformin 
     Biguanide class of antidiabetic agents, which also includes the withdrawal 
of phenformin and buformin agents, comes from French lilac (Galega officinalis), 
a plant used in folk medicine for centuries.  
  Metformin was first described in the scientific literature in 1922 by Emil 
Werner and James Bell, as a product of the synthesis of N'''', N''''-
dimethylguanidine. Antidiabetic therapy has been proposed as a treatment for 
polycystic ovary syndrome (PCOS), a condition often associated with insulin 
resistance, since the late 1980s. 
 The use of metformin in PCOS was first reported in 1994 in a small study 
conducted at the University of the Andes. The UK National Institute for Health 
and Clinical Excellence recommended in 2004 that women with PCOS and a 
body mass index above 25 be given metformin for anovulation and infertility 
treatment when other has failed to produce results. 
 However, two large clinical studies in most returned negative results 
2006-2007, with metformin being no better than placebo and metformin-
clomifene combination no better than clomiphene alone.  
 It improves peripheral insulin effects, particularly on the muscle.  
 It decreases hepatic glucose production and reduced FA oxidation.  
 The insulin resistance is reduced by increasing the glucose consumption 
device, by a totally unknown muscle membrane effect.  
 In vitro, there is an increase in the translocation of glucose transporters 
(Glut1 & 4).  
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Effects on obese patients with PCOS: 
 We also note a resurgence of ovulatory cycles in 50% of cases and 
pregnancy Studies show after treatment for 2 months because of 3x 500 mg / day 
or 850 mg 2x / d:  
 BMI of diminution of 7 to 10%  
 decreased insulin secretion of + / - 35% during the OGTT;  
 increased SHBG of 20 to 25%  
  decrease in triglycerides  
 decreased androgen spontaneous. 
POLY CYSTIC OVARIAN SYNDROME 
The purpose of this chapter is to present a review of the current research 
on polycystic ovary syndrome (PCOS). PCOS is one of the most common 
endocrine disorders in women of reproductive age, affecting 5-10%of the 
population. Despite its prevalence, PCOS remains largely under unknown. 
This review has been mainly focused on the pathogenesis, related health 
consequences, diagnosis as well as the prevalence and incidence of the disease. 
It then delves into the pathogenesis with a focus on genetics, obesity, insulin 
resistance and birth weight. Lastly, the health consequences related to PCOS are 
discussed, with a focus on insulin resistance. The health outcomes reviewed 
include the metabolic syndrome, cardiovascular disease, and type II diabetes 
mellitus.  
Many of the symptoms of PCOS are solely through lifestyle 
modifications. Although many questions remain surrounding polycystic ovary 
syndrome, this chapter provides a summary of the current research. 
PCOS 
Polycystic Ovary Syndrome (PCOS) is a heterogeneous disorder.  As 
one of the leading causes of anovulatory infertility, it is believed that5-
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10%ofthe reproductive-aged female population is living with polycystic ovary 
syndrome 
[22]
. The first description of polycystic ovary syndrome (PCOS) was 
performed by Stein and Leventhal in the year 1935, in which they presented to 
a group of patients characterized by the clinical association of amenorrhea, 
hirsutism and obesity
 [23]
. The development of PCOS has been linked to 
hereditary and environmental factors including genetics, insulin resistance, 
obesity and birth weight. The presence of PCOS is associated with an increased 
prevalence of adverse health conditions such as the metabolic syndrome, 
cardiovascular disease and type II diabetes mellitus. Insulin resistance is 
believed to play a key role in the development of PCOS and in the development 
of related conditions 
[24]
. In the past few years, research has been done to better 
understand the mechanisms behind the development poly cystic ovary 
syndrome and the impact it has on the female body, particularly in relationship 
to insulin resistance. 
Diagnosis 
Poly cystic ovary syndrome is a largely under diagnosed disorder. It was 
described as a clustering of symptoms including enlarged ovaries, obesity, 
hirsutism, and chronic anovulation 
[23a]
. However, it took another fifty-five 
years before formal criterion were proposed for the diagnosis of PCOS 
[25]
. 
Polycystic ovary syndrome is now diagnosed based on the presence of the 
following criteria: clinical and biochemical hyperandrogenism, menstrual 
irregularities, and the presence of poly cystic ovaries. Common features of the 
disease which are not part of the diagnosis include insulin resistance, 
luteinizing hormone (LH)/follicle stimulating hormone (FSH) concentrations, 
and obesity 
[26]
. Thus, it was subsequently required for the diagnosis the plasma 
elevation of luteinizing hormone (LH) and the ratio of LH / FSH, being years 
later the visualization by ultrasound of multiple ovarian cysts (Fig.3&4). 
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Fig No. 3 and 4: macroscopic and ultrasonography image of polycystic 
ovary syndrome. 
However, these criteria have been reviewed and modified recently.  In 
the consensus held in Rotterdam in 2003, the main difference established and 
consisted of the inclusion of ovarian polycystosis again, defined by the presence 
of 12 or more follicles in each ovary between 2 and 9 mm in diameter and / or 
the existence of an increased ovarian volume (greater than 10 mL) as one of the 
criteria for diagnosis 
[27]
. At the end of 2006, the Androgen Excess Society 
(AES) has defined new criteria 
[28]
, according to which the diagnosis of PCOS.  
Existence of hyperandrogenism, defined by the presence of hirsutism 
and / or Hyperandrogenemia, together with ovulatory dysfunction, defined by 
the existence of oligoovulation and / or polycystic ovaries and the exclusion of 
secondary pathologies. (Table 1) 
 
 
 
 
 
 
 
Table  No. 2. Diagnostic Criteria for Polycystic Ovarian Syndrome. 
NICHD 
Criteria  
Criteria 
forRotterdam  
AES Criteria 
 
 
Oligoovulation 
  
 
 
Oligo and / or 
Anovulation 
Hyperandrogenism: 
Hirsutism and / or 
clinical 
Hyperandrogenemia 
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According to the NICHD and AES criteria, items 1 and 2 must be present for the 
diagnosis of SOP. The Rotterdam criteria require the presence of 2 of the 3 
individual points. In all Secondary etiologies should be ruled out. 
Clinical Hyperandrogenism 
Clinical hyperandrogenism is one of the more noticeable features of 
PCOS. Women are often diagnosed with PCOS when they seek treatment 
options from their health care provider for some of the negative cosmetic 
outcomes associated with PCOS. Clinical androgen excess in women with 
PCOS manifests in the form of acne, hirsutism, and/or alopecia.  Acne typically 
occurs on the face or the back. The presence of acne is correlated with an 
increase in DHEAS and it is often one of the first clinical signs of 
hyperandrogenismin women 
[29]
. Hirsutism is male-pattern excess hair growth. 
Common areas for hair growth include the side-burns, chin, naval area, and 
chest. Hirsutism is ranked according to the Ferriman-gallweyscale 
[30]
.A score 
of 6-8 is mild, 8-15 is serious, and greater than 15 are classified as overt 
hirsutism. A woman is considered hirsute with as core greater than eight 
[31]
. 
Alopecia, or hair loss, occurs in the form of male-pattern baldness. Alopecia is 
less common in women with PCOS than hirsutism and acne but it does still 
occur.  With each of these clinical symptoms, it is important to remember that 
there could be another cause responsible other than PCOS. It is important to rule 
out other possible aetiologies. 
Menstrual Irregularities 
 
Hyperandrogenism 
And / or 
biochemical clinical 
 
Hyperandrogenism And / or 
biochemical clinical 
 
Ovarian anomaly: Oligo-
anovulation and / or ) 
Ovaries 
- Polycystic ovaries 
--- Polycystic ovaries 
 
-- 
Exclusion of other pathologies such as hyperprolactinemia, adrenal hyperplasia 
Congenital and androgen secreting tumors 
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Menstrual irregularities including oligio-amenorrhea or chronic 
anovulation are common features of PCOS.  Women are often diagnosed with 
PCOS when they seek treatment for menstrual irregularities or when they have 
difficulty becoming pregnant. A woman with oligio-amenorrhea has infrequent 
or very light menstruation.  During the first two years post menarche, irregular 
cycles are common. After this time, cycles should normalize. At this time, 
oligiomenorrhea can be identified as less than 9 menstrual cycles per year. 
Amenorrhea is defined as cycles lasting more than 90 days 
[32]
. Some women 
with PCOS may have normal menstruation patterns but they may not ovulate. 
This means ovulation cannot be determined solely by the presence of 
menstruation.  Chronic anovulation is diagnosed based on progesterone levels 
on days 20-24 in the menstrual cycle 
[30]
. Menstrual irregularities are one of the 
main reasons women with PCOS have difficulty becoming pregnant. Often, it 
is not until a woman has difficulty becoming pregnant that she will seek 
guidance from a medical provider. 
Polycystic Ovaries 
As referenced by the name, PCOS can also be identified by the 
presence of polycystic ovaries. Poly cystic ovaries are identified by the 
presence of at least one ovary greater than 10cm
3
or the presence of 12or more 
follicles between 2-9 mm in diameter. Follicles are fluid-filled sacs which can 
grow on one or both of a woman’s ovaries.  The presence of polycystic ovaries 
is typically identified with a transvaginal ultrasound.  This produces better 
results than the transabdominal route. However, for virgin, adolescent girls, the 
transabdominal route is a suitable method for diagnosing the presence of 
polycystic ovaries 
[30]
. 
National Institute of Health Criteria 
From the time it was identified in 1935, until1990, there was no formal 
tool for diagnosing polycystic ovary syndrome. In 1990, a conference was held 
by the National Institute of Health (NIH) to finally establish minimal criteria. 
A questionnaire was sent out to 58 researchers who voted on the criteria. 
REVIEW OF LITERATURE 
 
OVULATION INDUCING ACTIVITY OF ASHUWATHI CHOORANAM                                          56  
 
Researchers agreed that PCOS would be defined as menstrual irregularity-
oligomenorrhoea or anovulation, clinical or biochemical signs of 
hyperandrogenism, and the exclusion of other causes of these two criteria such 
as androgen- secreting tumours or Cushing syndrome 
[33]
. This remained the 
main the diagnostic tool for PCOS until the Rotterdam conference was held 
in2003. (See Table1) 
Rotterdam Criteria 
In 2003, a conference was held by the American Society for 
Reproductive Medicine and the European Society of Human Reproduction and 
Embryologyin Rotterdam, Netherlands.  The purpose of this conference was to 
revisit the criteria for diagnosing PCOS. Experts in Europe believed that 
polycystic ovarian morphology detected by ultrasound should be considered as 
a diagnostic criterion. The decision made in Rotterdam for the diagnosis of 
PCOS was that women must meet two of the following three criteria: chronic 
oligo-ovulation or anovulation, clinical or biochemical androgen excess with 
the exclusion of other etiologies, and the presence polycystic ovaries based on 
an ultrasound. The Rotterdam definition provided a broader set of criteria than 
the NIH definition, allowing for increased diagnosis. Under the Rotterdam 
criteria, women without androgen excess or without menstrual irregularities 
could still be diagnosed with PCOS 
[34]
.These criteria remained the main 
diagnostic tool until 2006. (See Table 1) 
Adolescent girls and the better development of other diseases associated with 
PCOS which will be discussed later. 
Prevalence and Incidence 
Prevalence 
Based on the current criteria, the prevalence of PCOS is between 5-10% 
in reproductive aged women 
[35]
. It is difficult to determine the exact 
prevalence of PCOS for a variety of reasons.  One issue is that health care 
providers do not always use the same criteria to identify PCOS.  As mentioned 
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above, there are the National Institute of Health, Rotterdam, and Androgen 
Excess Society criteria which are all in use. 
A retrospective birth cohort study was done on 728 women born 
between the years of 1973-1975 to analyze the difference between these three 
criteria. The 728 women were interviewed when they were between the ages of 
27-34.  Based on the NIH criteria, 8.7+/-2% were diagnosed with PCOS.  
Based on the Rotterdam criteria, the prevalence was 11.9+/-2.4%. Lastly, under 
the AES recommendations, PCOS prevalence came in at10.2+/-2.4%.  
Although the same women were analyzed for all three criteria, results varied. 
A second problem with determining the prevalence of PCOS is that it 
remains a highly undiagnosed disease. In the study of the 728 women born in 
the US, 68-69% of the women suffering from PCOS had not been previously 
diagnosed 
[36]
. Also, adolescents are rarely screened for the disease in studies 
since parental consent must be obtained. Based on an Iranian study, the current 
estimate for adolescents with PCOS is around 3%. This was a random cross- 
sectional study done in Iranian high schools 
[37]
. One reason this value is much 
lower than among the adult population is that a specific set of criteria has not 
been identified for adolescents in diagnosing PCOS. 
Pathogenesis 
The cause of PCOS is currently unknown but the etiology appears to be 
heterogeneous. Links have been made between heritable and environmental 
factors.These factors include genetics, insulin resistance, obesity, and birth 
weightas related to the adipose tissue expandability hypothesis. 
Genetics 
Recent studies provide support for a genetic component of PCOS with 
evidence of the disorder occurring among women of the same family. A cross-
sectional study was done evaluating 29 families with a history of polycystic 
ovary syndrome against10 control families. There was found to be nearly a 
50% prevalence of PCOS among siblings 
[38]
. In a similar study, the first degree 
relatives of 14 women with PCOS were screened. Female relatives were 
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screened for the presence of polycystic ovaries and male relatives were 
screened for male pattern baldness. Again, the first degree relatives of women 
with PCO Shad a 51% chance of being affected.  The results of these two 
studies indicate a single gene effect or autosomal dominant inheritance 
[25]
. 
Further research needs to be done to further evaluate the genetic 
component of PCOS. Although it appears to be of autosomal dominant 
inheritance, there is not enough evidence at this time to prove this theory. With 
continuing research on the human genome, it may be possible to someday 
identify the gene responsible for the development of polycystic ovary 
syndrome. 
Insulin Resistance 
Insulin resistance (IR) is a defining characteristic of polycystic ovary 
syndrome, occurring. In 50-70% of the PCOS population 
[40]
. Insulin resistance 
is an impaired metabolic response which occurs when cells cease to respond to 
ordinary levels of insulin 
[41]
 .IR occurs in both lean and obese women with 
PCOS. In contrast, women without PCOS, insulin resistance occurs primarily 
in the obese. This suggests that IR is an intrinsic part of the disease. Some 
believe that insulin resistance may be present in all women with PCOS. 
However, there is a lack of consistency in measuring for IR and so some 
women remain undiagnosed 
[29]
. 
Research suggests that levels of insulin resistance do not remain 
stagnant for women with PCOS.  In a recent observational study, 1,212 women 
with PCOS were monitored for differences in hormonal, metabolic, and ultra 
sonographic features of PCOS between age groups.  The age groups were 
broken down to less than 20years old, 21-30years old, and 31-39years old.  The 
degree of insulin resistance worsened as age increased.  (Panidis) This is 
important to keep in mind given the relationship between insulin resistance and 
the development of other diseases. If the presence of polycystic ovary 
syndrome and insulin resistance can be identified early on, perhaps the level of 
insulin resistance can be maintained at lower levels before it is able to worsen 
the symptoms of PCOS. 
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Obesity 
Obesity is another component of PCOS which may contribute to the 
pathogenesis of the disorder. In patients suffering from PCOS, the incidence of 
obesity is somewhere between 50-75%, which is higher than in the general 
population 
[41]
. Not only is obesity more common among women with PCOS, 
research suggests that obesity may exacerbate many of the manifestations of 
PCOS including androgen levels and insulin resistance. 
With excess weight gain, women who were previously asymptomatic 
may begin to show symptoms of PCOS. There is an increased prevalence of 
symptoms among obese PCOS patients when compared to non-obese controls. 
Obese women suffering from PCOS generally have higher serum androgen 
concentrations and a reduced response to fertility treatments when compared to 
lean women with PCOS. Obese women with PCOS experience greater 
menstrual irregularity when compared to non-obese patients 
[42]
. There is also 
an increased presence of hirsutism at 73% compared to 56% for non-obese 
women 
[43]
. The same can be said for the presence of acanthosis nigricans 
[27]
. 
Birth Weight and the Adipose Tissue Expandability Hypothesis 
In the general population, there is a strong positive correlation between 
obesity and insulin resistance. In the PCOS population, this remains true.  
However, the degree of insulin resistance among normal-weight women is 
increased. These women are identified as metabolically obese, normal-weight 
(MONW). A study done comparing MONW and metabolically normal controls 
in body fat composition found an increase in total, visceral, and subcutaneous 
fat in the MONW group 
[44]
.  
The relationship between MONW and PCOS may be explained by birth 
weight and the adipose tissue expandability hypothesis.  According to this 
theory, each individual l can safely store a certain amount of excess adipose 
tissue (AT) before adverse metabolic effects are observed.  When this level is 
reached, called the metabolic set point, lipotoxicity occurs. Lipotoxicity causes 
an increase in free fatty acids, hyper triglyceridemia and lipid deposits in non-
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subcutaneous AT and in non-adipose organs. This can lead to insulin 
resistance. It is believed that women with PCOS have a lower metabolic set 
point than the general population. This explains why normal weight women 
with PCOS are insulin resistant 
[45]
. 
Birth weight is a key factor in determining an individual’s metabolic set 
point. The number of adipocytes of an adult is set early in life.  When prenatal 
growth is stunted, the development of AT is reduced and fewer adipocytes 
develop.  Most infants suffering from stunted pre-natal growth will experience 
spontaneous catch-up growth. However, this is observed as an increase in 
adipocyte size rather than an increase in the number of adipocytes. With fewer 
adipocytes, the body has a decreased ability to safely gain fat before adverse 
metabolic affects are observed.  When AT is properly expanded in fetal and 
early infant life, there seems to be increased protection against obesity related 
insulin resistance 
[46]
. 
Prenatal exposure to androgen excess may be one cause of stunted pre-
natal growth, resulting in low-birth weight. If a woman has PCOS, she would 
have increased androgen levels which could potentially affect her developing 
fetus. However, data is inconclusive on this subject. Most of the research has 
only been done on animals and no effect has been observed in human studies. 
In one study, when exposed to testosterone, neither maternal androgen a 
main or fetal androgenamia was seen to be elevated in girls who developed 
PCOS.  Also, the fetus is protected from exposure to maternal androgens by the 
placenta 
[46]
.  This means that increased maternal androgen levels should not 
impact the fetus. Based on this research, it seems unlikely that maternal 
androgen levels have much impact on birth weight. Other factors are likely 
responsible. 
Health Consequences 
Women with polycystic ovary syndrome are at increased risk for a 
variety of health conditions. These conditions include the metabolic syndrome, 
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cardiovascular disease (CVD) and type II diabetes mellitus (T2DM). Insulin 
resistance is a key feature in the development of each of these diseases. 
Metabolic Syndrome 
Women with PCOS are at increased risk for developing the metabolic 
syndrome when compared to the general population. The metabolic syndrome 
is a clustering of symptoms associated with insulin resistance.  Diagnosis is 
based on the presence of three of the following five criteria: elevated waist 
circumference (greater than 40 inches for men and 35 inches for women), 
elevated triglycerides (greater than ore qual to 150 mg/dl), reduced HDL 
cholesterol (less than 40 mg/dLin men and 50 mg/dLin women), elevated blood 
pressure (greater than or equal to 130/85 mm Hg), or elevated fasting glucose 
(greater than or equal to 10 mg/dl) 
[29]
. 
Cardiovascular Disease 
A cross-sectional study was done to help establish the link between 
PCOS and CVD.  Sixty-two women with PCOS were analyzed in comparison 
to forty-eight healthy controls. BMI, waist circumference, and blood pressure 
were taken as well as plasma concentrations of glucose, triglycerides, total 
cholesterol, and HDL. Women with PCOS showed a significantly higher 
TG/HDL ratio when compared to the control group. This indicates that women 
with PCOS are at increased risk for cardiovascular disease. The variable which 
had the most influence on Tg/HDL ratio was waist circumference. This 
indicates that abdominal obesity remains an important feature in the 
development of CVD, in PCOS women and the general population alike 
[47]
. 
Although PCOS is one of the most common endocrine disorders in 
women of reproductive age, there is currently no cure for polycystic ovary 
syndrome. For this reason, early diagnosis of the disease based on established 
criteria is important. With an early diagnosis, it is possible to manage the 
manifestations of PCOS.  With proper management, obesity and insulin 
resistance can be controlled for as well as the associated diseases.  The current 
forms of treatment for PCOS will be discussed in the next chapter. The main 
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focus is on drug therapy and lifestyle modifications. With the proper 
management of insulin resistance and obesity, it is possible to dramatically 
decrease the negative health outcomes associated with polycystic ovary 
syndrome. 
A Comparison of Drug Therapies and Lifestyle Modifications Used to 
Treat Polycystic Ovary Syndrome 
Introduction 
Polycystic ovary syndrome (PCOS) is the leading cause of anovulatory 
infertility in women of reproductive age 
[28]
. Affecting as many as 1 in 10 
women in the United States, 
[37]
 this common endocrine disorder remains 
largely undiagnosed.  Typically, it is not until a woman has difficult becoming 
pregnant that her health care provider will begin to notice the clustering of 
symptoms associated with PCOS including clinical and biochemical signs of 
hyperandrogenism, menstrual irregularities, and the presence of polycystic 
ovaries. 
The majority of women with PCOS suffer from insulin resistance. 
Insulin resistance and the resultant hyperinsulinaemia play a key role in the 
pathogenesis of PCOS. Although insulin resistance is exacerbated by weight 
gain, normal-weight women with PCOS are also insulin resistant. 
The pathogenesis of PCOS is not completely understood; there is not 
yet a cure for the disease. However, with the proper management of PCOS, it is 
possible to restore fertility, improve menstrual regularity and reduce androgen 
excess. This is achieved primarily through an improvement in insulin 
sensitivity. 
Drug Therapy 
Drug therapy is an effective form of treatment for polycystic ovary 
syndrome. Drug therapy can improve insulin resistance and hormonal 
metabolic profiles, restore menstrual regularity, and decrease the clinical 
symptoms associated with PCOS. Common forms of drug therapy include 
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combined oral contraceptives, insulin-sensitizing agents, and anti-androgens. 
However, there are adverse side-effects associated with each of these drugs. It 
is important to understand the possible risks connected with each. 
Combined Oral Contraceptives 
Hormonal oral contraceptives are the most common form of drug 
therapy used in the treatment of PCOS.  Oral contraceptives allow for a 
restoration in menstrual cycles, although ovulation does not occur. Regular 
menstrual cycles are associated with a decreased risk of developing 
endometrial cancer 
[48]
. Oral contraceptives are also used to treat clinical 
symptoms of PCOS including hirsutism and acne. They work by increasing 
levels of sex-hormone binding globulin (SHBG) 
[49]
. Increased levels of SHBG 
decrease circulating androgen levels and decrease their bioavailability 
[50]
.With 
an improvement in androgen levels, there is a subsequent improvement in the 
clinical symptoms associated with PCOS. 
Based on recent studies, the use of combined oral contraceptives is an 
effective form of drug therapy for the treatment of PCOS.  The end result is an 
improvement in many of the clinical and biochemical features of PCOS. 
Although their use is common among all women of child-bearing age, little 
research has been to evaluate the relationship between the use of oral 
contraceptives and the development of disease outcomes associated with 
PCOS. Some studies indicate that the use of oral contraceptives may decrease 
insulin sensitivity and glucose tolerance. This would increase the risk for 
T2DM which women with PCOS are already predisposed to develop 
[28]
. 
Insulin Sensitizing Agents 
Insulin Sensitizing agents are another form of drug therapy used in the 
treatment of PCOS. Common forms of insulin sensitizing drugs include 
metformin and rosiglitazone. These drugs are intended to be used in 
combination with diet and exercise.  They are commonly prescribed to people 
with type II diabetes mellitus. These drugs work primarily by inhibiting hepatic 
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glucose production and increasing insulin sensitivity in the peripheral tissues 
[24]
. 
However, fasting insulin levels only showed an improvement following 
the use of metformin 
[25]
. In another 6 month trial, similar results were observed 
with both drugs including a decrease in fasting insulin, postprandial insulin, 
HOMA-IR, LH, triglyceride, LDL, and testosterone levels. A decrease in BMI 
was only observed with the metformin group 
[51]
. 
To test its efficacy, atrial was done in India, investigating the impact of 
metformin when administered daily for three months. In this prospective study, 
there was an observed decrease in serum insulin and serum testosterone with a 
positive correlation between the two. This positive correlation reveals an 
etiological connection between insulin resistance and some of the clinical 
features of PCOS related to increased testosterone levels. With metformin 
therapy, the study subjects also experienced a fall in fasting plasma glucose to 
insulin ratio; a marker of insulin resistance 
[52]
. 
Anti-androgens 
Anti-androgens are used to improve the biochemical profiles of PCOS 
women.  This leads to an improvement in clinical symptoms such as hirsutism 
and acne. The improvements seen from anti-androgens are similar to those 
experienced with oral contraceptive use, but the improvements are greater. 
Anti-androgens work by attaching to androgen-binding receptors through 
competitive inhibition.  Anti-androgens can also decrease androgen production. 
Examples of anti-androgens prescribed include spironolactone, flutamide, and 
finasteride 
[24]
.  
Once again, there are risks associated with taking anti-androgens which 
should be carefully considered. They can cause fatigue, dizziness, headaches, 
nausea, breast tenderness, weight-gain, loss of libido, hypotension and 
hepatoxicity. Liverand renal function should be correlated and reveals an 
etiological connection between insulin resistance and some of the clinical 
features of PCOS related to increased testosterone levels. With metformin 
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therapy, the study subjects also experienced a fall in fasting plasma glucose to 
insulin ratio; a marker of insulin resistance 
[53]
. 
The benefits of metformin treatment are obvious.  However, similar to 
other forms of drug therapy, the risks of metformin should be carefully 
considered.  Common side-effects include nausea and diarrhoea. On rare 
occasion, lactic acidosis has occurred. This typically occurs in conjunction with 
renal or cardiovascular disease. It is unknown if metformin is safe to use during 
pregnancy.  Despite this, medical practitioners continue to prescribe it to help 
prevent the development of gestational diabetes 
[24]
. Before starting on 
metformin therapy, women with PCOS should carefully consider the associated 
risks, especially if they are pregnant or planning to become pregnant. (See 
Table 3) 
Lifestyle Modifications 
Unlike drug therapy, there are no adverse side-effects associated with 
lifestyle modifications in the management of PCOS 
[49]
. Lifestyle modifications 
should be the first line of treatment prescribed to women with PCOS since is no 
evidence to suggest that drug therapy is any more effective. Lifestyle 
modifications include weight loss, dietary treatments, and exercise. 
Caloric Restriction to Achieve Weight Loss 
Mild to moderate weight loss dramatically reduces the symptoms of 
PCOS.  Weight loss of only 2-7% of initial bodyweight leads to improved 
ovulation and a reduction in androgen levels 
[43]
. An important feature of 
weight loss is that it leads to an improvement in insulin sensitivity.  This leads 
to a restoration in menstrual cycles, ovulation, and fertility and an improvement 
in androgen levels 
[54]
. 
The main goal of weight loss should be to reduce visceral adiposity 
which is associated with insulin resistance and the metabolic syndrome. In one 
study, 13 obese-women with PCOS were placed on a hypocaloric diet plan. 
Their mean weight loss was 12.4 kg with a reduction in truncal-abdominal 
skin-folds of 28% indicating that much of their weight loss was around the 
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abdomen. This resulted in an improvement in insulin sensitivity of 132% and 
an increase in SHBG of 35% 
[31]
. 
Diet- Macronutrient Modifications 
One proposed diet is the consumption of carbohydrates low on the 
glycemic index. Most women with PCOS experience compensatory 
hyperinsulinemia following carbohydrate ingestion. Consuming foods low on 
the glycemic index (GI) would help reduce this. In a randomized, prospective 
study, ninety-six women with PCOS were assigned to follow a reduced- 
energy, low-fat, low-saturated fat diet which was moderate-to-high in fibre.  
These women were then randomly assigned to consume foods which were 
either lower moderate-to-high on the glycemic index. They followed this diet 
until they had achieved 7% of weight loss or for 12 months. 
To investigate which is more important, weight loss or carbohydrate 
intake, a randomized, 12-week study was done to evaluate the difference 
between a hypo caloric diet and a low CHO diet. Improvements were observed 
for both groups in BMI, waist circumference, and menstrual function. 
However, there was no statistical significance between groups.  This indicates 
that weight loss and carbohydrate intake is two separate but important 
components in the treatment of PCOS 
[55]
. 
The effect of a high-protein diet can also be observed independent or 
carbohydrate consumption. In a 6-month prospective trial, subjects consumed 
either a high protein or standard protein diet. Women on the high protein diet 
experienced greater weight loss (4.4 kg), body fat loss (4.3 kg), and a greater 
reduction in waist circumference. When adjusted for weight loss, women on 
the high protein diet had greater improvements in glucose metabolism 
[30]
. 
Diet- Micronutrient Modification 
The focus of most dietary treatments for PCOS focuses on 
macronutrient content. However, micronutrient content may also play an 
important role.  Vitamin D is one of the micronutrients believed to impact 
PCOS. Through previous animal and human studies, it is known that vitamin D 
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deficiency is associated with impaired insulin secretion and glucose clearance 
[38]
. 
Vitamin D supplementation may also help improve insulin resistance. 
Across-sectional study was done to evaluate vitamin D levels in over 
500women with PCOS.  Anthropometric, metabolic, and endocrine measures 
were taken for each of these women as well as an oral glucose tolerance test. A 
negative correlation was found between the degree of insulin resistance and 
25(OH)D levels. A positive correlation was found between 25(OH)D levels and 
insulin sensitivity 
[47]
. In contrast, in a randomized, placebo-controlled, double-
blind trial of 50 women with PCOS, there was no statistical significance 
between groups in fasting serum insulin and insulin resistance when prescribed 
either a vitamin D supplement or a placebo 
[35]
. Further studies need to be done 
before a conclusion can be made about the relationship between vitamin D 
deficiency and insulin resistance in women with PCOS. 
Calcium and vitamin D are not the only micronutrients under 
investigation for their relationship with PCOS. In previous studies, Vitamin 
B12 and folate supplementation have improved insulin resistance in women 
with metabolic syndrome. A cross-sectional study was done to look for a 
similar relationship with PCOS women. Vitamin B12 levels were found to be 
significantly lower in obese women with PCOS compared to controls.  Women 
with PCOS who were insulin resistant also had lower B12 levels when 
compared to PCOS controls who were not insulin resistant 
[57]
. A prospective 
study with vitamin B12 supplementation should be done to further investigate 
the relationship between insulin resistance and vitamin B12.  Similar to 
Vitamin D, no conclusions can currently be drawn about the relationship 
between vitamin B12 and insulin resistance.  However, after speaking with a 
health care provider, it may be acceptable to take a Vitamin D and B12 
supplement as a precautionary measure.(See Table VII) 
Exercise 
A final component of lifestyle modifications in the treatment of PCOS 
is the inclusion of exercise. Although weight loss can be achieved through diet 
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alone, this will result primarily in muscle loss rather than fat loss as desired.   
Also, weight loss through exercise is better sustained better than weight loss 
through diet alone 
[24]
. With exercise, the goal should be to lose abdominal fats 
in cevisceral fat is closely related to insulin resistance and the development of 
metabolic syndrome. A similar randomized, prospective trial was done with 
overweight/obese women with PCOS.  These women were assigned to a 
dietary plan, a workout plan, or both.  Menstrual regularity improved in 69% of 
the women with are turn in ovulation for 34%. There was no statistical 
difference between groups. Resumption in ovulation most often occurred 
among women who experienced higher serum levels of insulin-like growth 
factor-binding protein 1 following intervention.  This supports a link between 
insulin sensitivity and reproductive function 
[43]
. In a similar trial, participants 
were assigned to diet alone, diet and aerobic exercise, or diet and aerobic-
resistance exercise. Again, little variation was observed between groups with 
the exception of fat-free mass which decreased the most with aerobic exercise 
and the least with aerobic-resistance exercise 
[58]
. This indicates that the type of 
exercise may also be an important factor. 
Combination Therapy 
Although lifestyle modifications and drug therapy are effective alone, 
combination therapies can also be effective in the treatment of PCOS. 
Metformin is one form of treatment which is often used in combination with 
other therapies. In a 6-month trial, girls were prescribed to a high-CHO and 
low-PRO diet alone and in combination with metformin. While on metformin, 
10 of the 11girls resumed menstruation, 9 girls lost weight, and total plasma 
cholesterol and testosterone levels fell for all 
[59]
. 
Metformin can also be used in conjunction with other drug therapies 
such as anti- androgenic drugs. In a prospective, placebo-controlled trial, PCOS 
women were prescribed to a hypocaloric diet and either metformin, flutamide, 
both metformin and flutamide, or a placebo for 12 months. The effects of 
flutamide and metformin were observed independently of each other 
suggesting that it is possible to benefit from each without adverse reactions 
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between the two drugs. Flutamide intake led to a decrease in visceral 
subcutaneous fat and a lower hirsutism score. Metformin led to an increase in 
menstruation, insulin sensitivity, and LDL levels. When taken together, 
subjects experienced all of these benefits 
[60]
. 
Further research needs to be done to further evaluate the effectiveness 
of various combinations of therapy in treating PCOS.  The major challenge 
with combination therapy is that as more components are measured, it becomes 
difficult to control for confounding variables. However, with continued 
research, it is possible to analyze the effectiveness of different forms of 
combination therapy.(SeeTableIX) 
Although there are a large number of studies investigating different 
treatments for polycystic ovary syndrome, there remains plenty of room for 
continued research. This is especially true in the area of combined therapies. At 
this time, studies suggests that through lifestyle modifications alone, women 
with PCOS can improve menstrual regularity, androgen and lipid profiles, and 
the clinical signs of PCOS associated with androgen excess. If lifestyle 
modifications can improve upon all of these areas, there is no need to include 
drug therapy in the treatment of PCOS.  Until there is evidence to suggest that 
drug therapy or combination therapy are significantly more effective than 
lifestyle modifications alone, it is safer to avoid them. At this time, therapy 
should focus on improving upon insulin sensitivity through weight loss, diet, 
and exercise. 
3.3. Pharmacological activity methods 
Letrozole method 
A control group received 2% of CMC (carboxymethylcellulose). Other 
groups for 28 days were once, daily administered, letrozole at the concentration 
of 1mg/kg. Vaginal smears were collected daily from all groups and studied for 
estrous cycle. During 28 days of administration of letrozole, the changes in 
estrous cycle were observed. 
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Estradial method 
The reproductive cycles of the rats were synchronized by the following 
method. 100μg estradiol dissolved in 2 ml olive oil was injected 
subcutaneously. All rats after a 24 hr period, received intramuscular injections 
of 50 μg progesterone dissolved in olive oil. After few hours, vaginal smears 
were obtained by vaginal lavage to monitor ovulation and oestrous cycle.  
Vaginal smears were prepared by washing vaginal opening with 0.9% 
w/v of sodium chloride with a glass dropper and placed in a clean glass slide 
and viewed under light microscope at 40X magnification. Examination of 
vaginal smears showed that all the animals were in the estrus stage. All the 
animals were weighed daily after drug administration for 10 days. 
OGTT 
Women  with  polycystic  ovarian  syndrome  (PCOS)  are  at  increased  
risk  for developing glucose intolerance leading to type 2 diabetes mellitus 
(DM). Hence, it was necessary to evaluate the efficacy of Ashuwathi 
chooranam on glucose homeostasis.  Thereby, Oral glucose tolerance test 
(OGTT) was performed in all groups of animals. PCOS rats exhibited high 
glucose tolerance compared to normal control rats (**p<0.01, ***p<0.001) at 
all the time points of OGTT profile.  
Ashuwathi chooranam treated PCOS rats in different doses (100mg, 
200mg) demonstrated significantly reduced glucose intolerance. Glucose 
homeostasis is governed by insulin action. Thereby, we measured serum insulin 
level in all group of animals wherein serum insulin levels of untreated PCOS 
rats were increased signiﬁcantly (***p<0.001). Treatment of AC caused a 
decrease in insulin level. 
 
ANTIOXIDANT ACTIVITY 
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Ashuwathi chooranam contains substantial amounts of antioxidants 
including phytosterols, saponins, flavonoids, tannins and it has been suggested 
that antioxidant action may be an important property of plant medicines used in 
treatment of  various  diseases.  Ashuwathi chooranam contain good scavenge 
property wherein it able to scavenge the free radicals, DPPH. Administration of 
the ethanolic extract of Ashuwathi chooranam on tissue antioxidants have been 
attributed to reduction in blood glucose level in diabetic rats, which helps to 
prevents excessive formation of free radicals through various biochemical 
pathways and also reduces the potential glycation of the enzymes. 
3.4. PHARMACEUTICAL REVIEW 
CHOORANAM 
Definition 
Chooranam is a fine powder s of drugs. The “Chooranam” may be 
applied to the powders of a single drug or a mixture of two or more drugs, 
which are powdered separately prior to their being mixed to homogeneity.  
Method of preparation 
Equipment required 
1. The drug enumerated in the recipe in clean and well dried state. 
2. A mortar and pestle. 
3. A fine sieve or fine cloth of close mesh. 
Process of preparation 
The drugs which are to be used in the preparations should be taken from 
recently collected material. Drugs which are aged by prolonged storages or 
changed in colour, taste and scent, and those that are insects infested or attacked 
by fungi should be positively rejected. 
However drugs like Embelia fruits, Senna, Long Pepper, Jaggery and 
cows ghee are preferred from fairly aged stock, provided they are not infested 
with pests, deteriorated or spoiled or developed racidity. 
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In general the aromatic drugs are slightly fried in order to enhance their 
aroma and milling properties. Any extraneous material, organic or inorganic, 
should be removed from the drugs by close inspection. 
The chooranam should be so fine to be called amorphous and should 
never be damp. The fineness of the sieve should be 100 mesh or still finer. 
Purification of the prepared chooranam 
“஡ாநணன்ந சூ஧஠த்஡ின் சுத்஡ிக்ககல௃ 
஡ப்தாக஡ச஧க் நகல்னாஞ் சூ஧஠ித்து 
஢ாநணன்ந ஬ா஬ின் தானாற்தினசந்து 
஢ன஥ாண சட்டி஦ிகன தானன஬ிட்டு 
஬ாநணன்ந சுத்஡ சனம்தா஡ி஬ிட்டு 
஬ப஥ாக க஥ற்சனீன ககாடுகட்டிப் 
தாநணன்ந சூ஧஠த்ன஡ப் திட்டுகதால்ன஬து 
த஡நாக஡ ந஬ந்ந஡டுக்ச் சித்஡ி஦க஥ !"  
- அகத்஡ி஦ர் ன஬த்஡ி஦ இ஧த்஡ிணச் சுபேக்கம் 
The prepared chooranam is mixed with the milk in pot half quantity 
milk and half quantity water is taken. The mouth of the pot is covered with a 
thin cloth material. Above this cloth the mixed chooranam is placed. The pot is 
placed over the stove and heated. 
ஆ஥ப்தா ஧஬ிப௅னர்த்஡ிப் நதாடி஡ான் நசய்து 
அப்தகண ச஥ணாய்ச் சர்க்கன஧ன஦ச் கசர்த்து 
஢ா஥ப்தா நகாண்டு ஬஧க஡ா஭ம் கதாச்சு 
஢ன்நாக்ச் சுத்஡ி நசய்஦ாச் சூ஧஠ந்஡ான் 
஡ா஥ப்தா க஧ாகத்ன஡ ந஬ல்னா ஡ப்தா 
஡ப஥ாண ஬ி஦஡ிந஦ல்னாம் தாரிக்கும் தார் 
க஬஥ப்தாசுத்஡ிநசய்துநகாண்டா஦ணால் 
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ந஬கு சுறுக்காய் ஡பீே஥ா஬ி஦ா஡ி ககல௃ 
- அகத்஡ி஦ர் ன஬த்஡ி஦ இ஧த்஡ிணச் சுபேக்கம் 
Then the chooranam is placed in the sunlight and powdered. Equal 
amount of sugar is added and taken internally. All type of diseases gets cured.  
If the drug is taken without purification the disease does not cure. If 
taken after purification the disease cures easily. 
Storage  
  The prepared chooranam should be allowed to cool by spreading and 
mixing, prior to packing.  
  They should be stored in tightly stoppered glass, polythene or tin 
containers, or in polythene or cellophane bags and sealed. These bags should in 
turn be enclosed in cardboard boxes. 
  The chooranam to facilitate easy handling and to assure exact dosage 
administration, could be pressed into tablets, could be packed in bottles or tubes 
made either of glass or plastic or packed in strip of metal foil or plastic sheets. 
  In industry the tablets are made, counted & packed by electronic 
devices. 
Then chooranam is said to retain its potency for 2 months and then 
gradually deteriorate. However if properly packed & stored they keep good for 
a year.  
According to AYUSH guidelines shelf life of chooranam is one year. 
Based on the AYUSH guidelines, the analytical specifications of Ashuwathi 
Chooranam were performed and standardized as follows. 
       Table  No.3. ANALYTICAL  SPECIFICATIONS  OF CURNA/CHOORNAM 
S.NO Test 
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3.5. Lateral research 
1. 
 
2. 
3. 
4. 
5. 
6. 
7. 
 
8. 
 
9. 
 
 
 
 
10. 
 
 
 
11. 
 
 
 
 
12. 
 
 
13 
Description 
Macroscopic, Microscopic 
Loss on drying at 1050 C 
Total – ash 
Acid – insoluble ash 
Water-soluble extractive 
Alcohol – soluble extractive 
Particle size (80-100 mesh for Churna; 40-60 
mesh  for churna) 
Identifications, TLC/HPTLC-with marker (wherever 
possible) 
Test for heavy/Toxic metals 
Lead 
Cadmium 
Mercury 
Arsenic 
Microbial contamination 
Total bacterial count 
Total fungal count 
Test for specific Pathogen 
E. coli 
Salmonella spp. 
S.aureus 
Pseudomonas aeruginosa 
Pesticide residue 
Organochlorine pesticides 
Organophosphorus pesticides 
Pyrethroids 
Test for Aflatoxins (B1,B2,G1,G2) 
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Withania somnifera 
Investigation the effect of an aqueous extract of  Withania somnifera on 
insulin sensitivity in non-insulin dependent diabetes mellitus (NIDDM)  rats. 
NIDDM was induced by single intraperitoneal injection streptozoin 
(100mg/kg) to 2 days old rat pups. Withania somnifera  (200 and 400 mg/kg) 
was administered orally once a day for 5 weeks after the animals were 
confirmed diabetic (i.e. 75 days after streptozocin injection). A group of citrate 
control rats (group I) were also maintained that has received citrate buffer on 
the second day of their birth. A significant increase in blood glucose, 
glycosylated haemoglobin (HbA1c) and serum insulin levels were observed in 
the NIDDM control rats. Treatment with Withania somnifera reduced the 
elevated levels of blood glucose, HbA1c and insulin in the NIDDM rats. An 
oral glucose tolerance test was also performed in the same group, in which it 
was found a significant improvement in glucose tolerance in the rats treated 
with Withania somnifera 
[61]
. 
Glycyrrhiza glabra 
Phytoestrogens are plant constituents that possess either estrogenic 
activity. Although their activities are weak as compared with human 
endogenous estrogens, the consumption of phytoestrogens may have clinically 
significant consequences. A number of botanicals, or the compounds contained 
therein, have been identified as putative estrogenic agents, but consensus in the 
biochemical community has been hampered by conflicting data from various in 
vitro and in vivo models of estrogenic activity. Here they attempt to sort out 
discrepancies between various experimental models and establish whether 
certain herbs possess estrogenic activity 
[62]
. 
Myristica fragrans 
In different parts of the World, medicinal plants have demonstrated a lot 
of health benefits to mankind and remain an important source for the discovery 
of new bio-active compounds. The relative ovary weight is significantly 
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reduced when female rats exposed to nutmeg. The serum LH level significantly 
following the exposure to nutmeg and black seed 
[63]
. 
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4. MATERIALS AND METHODS 
 
 
4.1. PREPARATION O F THE TRIAL DRUG: 
ASHUWATHI CHOORANAM 
 
Selection of the drug 
 
The herbal formulation Ashuwathi chooranam was taken  The preparation drug 
Ashuwathi chooranam was taken as a drug for Soothaga vayu, has been selected from 
the Siddha literature “AGATHIYAR VAITHYA KAAVIYAM 1500” first part 
published by Tamarai noolagam, Edition 2001, p.no 293. 
 
Ingredients of Ashuwathi chooranam: 
 
Amukkura  - Withania somnifera  
Chukku   - Zingiber officinale (dried ginger) 
Milagu   - Piper nigram 
Thippili   - Piper longum 
Jaadhikaai   - Myristica fragrans 
Jaadhipathiri  - Myristica fragrans          
Adhimadhuram - Glycirriza glabra 
Krambu  - Syzygium aromaticum 
Kadugurohini  - Picrorhiza scrophulariiflora 
Krosaniomam   - Hyoscymus niger 
 
Collection of the drug: 
 
The ingredients of the drug were collected from around Chennai district in 
Tamilnadu. 
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Identification and Authendification of the Drug: 
  
The test drug was identified and authenticated by Gunapadam Experts, P.G 
Gunapadam branch, GSMC, Arumbakkam, Chennai-106. Sample of the ingredients 
kept in PG Gunapadam department for future reference. GSMCC/PGGM/0004-
0013/14-17. 
All the raw materials here were purified individually as per the Siddha literature 
Preparation of the Trial Drug  Ashuwathi chooranam: 
 
Purification of the Chooranam: 
 
The drugs that are purified by removing the sand, dust particles, and roasted are 
Withania somnifera, Piper nigram, Myristica fragrans, Picrorhiza scrophulariiflora, 
Hyoscymus niger;Zingiber officinale (dried ginger)-the outer skin were removed, the 
other drug was roasted slightly Piper longum, Myristica fragrans, Glycirriza glabra, 
Syzygium aromaticum -the flower buds were removed and fried slightly
 [64]
. 
 
PREPARATION OF THE DRUG: 
 
Ingredients: 
 
Amukkura(Withania somnifera)  -35gms 
Chukku(Zingiber officinale(dried ginger) -35gms 
Milagu(Piper nigrum)   -35gms 
Thippili(Piper longum)   -35gms 
Jaadhikaai(Myristica fragrans)  -35gms 
Jaadhipathiri(Myristica fragrans)  -35gms         
Adhimadhuram(Glycirriza glabra)  -35gms 
Krambu(Syzygium aromaticum)  -35gms 
Kadugurohini(Picrorhiza scrophulariiflora) -35gms 
Krosaniomam(Hyoscymus niger)  -15.3gms 
Sugar (Saccarum officinarum)  -127.5gms 
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Procedure: 
 
Take the equal quantities of all drugs winter cherry, chukka, milagu tippili, 
jadhikai, jadhipathiri, adhimadhuram, krambu, kadugurogini and krosaniomam were 
and roasted and grounded into a fine powder. The powder was sieved through a clean 
white cloth to get a uniform particle size of Chooranam. 
The Ashuwathi chooranam was purified by pittaviyal method (steam cooking in 
milk) as per Siddha classical literature. For this process cow’s milk and water were 
taken in equal ratio and half-filled in mud pot. A clean dry cloth was tied firmly around 
the mouth of the pot with a depression. Chooranam was placed over the depression on 
the tied cloth. Another mud pot of similar size was kept over the mouth of the mud pot. 
The gap between mud and pot was tied with a wet cloth to avoid evaporation. The mud 
pot was kept on fire and boiled until the cow’s milk reduced to the lower pot. Then the 
chooranam was taken, dried, powdered finely
 [65]
. 
 
Storage of the drug: 
       
The test drug was stored in a clean, dry, air tight glass container. 
 
Dose: 2 to 3gm, twice daily after food 
 
Adjuvant: Perungayam (Ferula asafoetida) and thippili (Piper longum) 
 
Route of administration: Enteral route  
 
Indications: Soothag vaayu (PCOS)          
 
ANALYTICAL STUDY AS PER SIDDHA LITERATURE 
  
4.2. STANDARDIZATION OF THE DRUG: 
 
Standardization of the this drug comes under the following categories 
 
4.2.1. ORGANOLEPTIC EVALUATION 
The organoleptic characters of the sample were evaluated which include evaluation of   
the formulation by its colour, odour, taste, texture etc. 
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Colour 
A sample of chooranam was taken in watch glasses and placed against white 
back ground in white tube light. The tablets were observed for its colour by naked 
eye. 
Odour 
Chooranam smelled separately. The time intermission between two smelling 
was kept 2 minutes to nullify the effect of previous smelling. 
Taste 
A sample of about chooranam was tasted and the taste was reported 
[66]
. 
 PHYSICO-CHEMICAL ANALYSIS

 CHEMICAL ANALYSIS

 PHYTO-CHEMICAL ANALYSIS
 
4.2.2 PHYSICO-CHEMICAL ANALYSIS 
Testing Physical characterization of  
Physico‐chemical studies like total ash, water soluble ash, acid Insoluble ash, 
water and alcohol soluble extract, loss on drying at 105°C and pH were done at, 
Central Research Institute, Chennai. 
Sample: Colour examination:  
Ashuwathi chooranam was taken into watch glasses and positioned against white 
back ground in white tube light. Its colour was observed by naked eye and wrote in 
results. 
Odour examination:  
2 gm of Ashuwathi chooranam were smelled individually. The time interval 
among two smelling was kept two minutes to overturn the effect of previous smelling. 
Odour of Ashuwathi chooranam was noted in results table.  
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Solubility Test 
A pinch of sample (AC) was taken in a dry test tube and to it 2 ml of the solvent 
was added and shaken well for about a minute and the results are observed. The test 
was done for  solvents like distilled water, Ethanol, Petroleum ether, Propylene glycol, 
Toluene, Benzene, Chloroform, Ethyl alcohol, Xylene, Carbon tetra chloride  and the 
results are observed individually. 
Determination of Total Ash 
About 2 to 3 g of the ground drug (AC) was accurately weighed in a tarred 
platinum or silica dish and incinerated at a temperature not exceeding 450ºC until it 
was free from carbon, cooled and weighed. The percentage of ash with reference to the 
air-dried drug was calculated. 
Determination of Water Soluble Ash 
Total ash was heated up to 600
0
C with 25 ml of distilled water for 10 minutes and 
the residue was ignited in the furnace to get a constant weight. 
Determination of Acid Insoluble Ash: 
The ash obtained was boiled for 5 minutes with 25 ml of dilute hydrochloric acid 
and insoluble matter was collected in a ash-less filter paper, washed with hot water and 
put up in flames to constant weight. The percentage of acid-insoluble ash with 
reference to the air dried drug was analyzed.  
Determination of Alcohol Soluble Extractive: 
The air dried drug was finely grounded, added with 100 ml of ethanol of specified 
strength in a closed flask for twenty-four hours, shaken frequently during the course of 
six hours and allowed to stand for eighteen hours. Then the mixture was filtered rapidly 
taking precautions against loss of solvent, 25 ml of the filtrate was evaporated to 
dryness in a tarred flat bottomed shallow dish, and dried at 105º to constant weight. 
The percentage of alcohol-soluble extractive with reference to the air-dried drug was 
estimated. 
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Determination of Water Soluble Extractive 
The above procedure was repeated but instead of ethanol, chloroform with water 
was used. 
Determination of Moisture Content (Loss on Drying) 
This procedure was done to determine the amount of volatile matter in the drug. A 
sample of about 10 gram of the drug (AC) was placed in a tarred evaporating dish after 
accurately weighting without preliminary drying. The dish was dried at a temperature 
of 105
0
 for about 5 hours and again weighed. The drying and weighing procedure was 
repeated again and again until the difference between two successive weights was not 
more than 0.25%. A constant weight was achieved only when the successive weight 
difference was not more than 0.01% after drying for 30 min and cooling for 30 min. 
pH value 
 pH value of the sample (AC) was determined potentiometric ally by a glass 
electrode and a suitable pH meter and noted down. 
Specific gravity estimation by density bottle method 
Procedure 
 The density bottle was dried in an oven at 105
0
c, weighed (M1), sample was 
added and the bottle was weighed again (M2). Then distilled water was added to the 
sample, shaken gently and the mass of the bottle with the contents was weighed again 
(M3).  
 The mass of the bottle only with distilled water was taken as M4 and the specific 
gravity was calculated according to the formula, 
  
     
(     ) (     )
           
   The results obtained from the above procedure were noted 
Macroscopic Appearance of Sample:  
1 g of Ashuwathi chooranam  was taken and the colour, texture, grain size and other 
morphology were viewed by naked eye under sunlight.  
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SOPHISTICATED INSTRUMENTAL ANALYSIS 
 
4.2.3. PHYTO CHEMICAL ANALYSIS
 
Phytochemicals are chemical compounds that are naturally present in plants. 
Phytochemical screening of the plant gives a vast idea about the chemical constituents 
present in the drug.  
The AC sample was subjected to the following phytochemical screening based on 
the method illustrated in Prashant Tiwari et al., 2011 and Harborne, 1973. 
Preparation of the extract 
5g of AC sample was taken in a 250 ml clean beaker and 50 ml of distilled water 
was added, boiled well and allowed to cool and filtered in a 100 ml volumetric flask 
and made up to 100 ml with distilled water. 
Test for Alkaloids 
A small portion of AC extract was stirred separately with few drops of dilute 
hydrochloric acid and filtered and tested carefully with various alkaloidal reagents like 
Mayer’s reagent, and observed for the appearance of coloured precipitates and noted 
down.  
Test for Carbohydrates and Reducing Sugars 
A small quantity of the AC was dissolved in 5ml of distilled water and filtered. The 
filtrate was subjected to test for carbohydrates & glycosides. 
a) Molisch’s test 
To the 1 ml of AC filtrate 2-3 drops of 1% alcoholic alpha naphthol & 2ml 
concentrated Sulphuric acid was added along the sides of test tube and observed for the 
presence of violet ring at the junction of 2 layers.  
b) Benedict’s test 
To 1ml of the AC filtrate Benedict’s reagent was added and heated gently and 
observed for the appearance of orange red precipitate. 
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Test for Glycosides: 
To the AC extract dilute. HCl was added and it was subjected to test for glycosides. 
a) Modified Borntrager’s test 
To the hydrolysate extract, 1 ml of Ferric chloride solution was added and dipped in 
boiling water for about 5 min.  
The cooled mixture was extracted with equal volume of benzene.  
The benzene layer was again separated and treated with ammonia solution and 
observed for the appearance of rose pink colour in the ammoniacal layer. 
b) Legal’s test 
The hydrolysate extract was treated with sodium nitropruside in pyridine and 
sodium hydroxide and observed for the presence of pink to blood red colour.  
Test for Saponins 
0.5 ml of the AC extract was shaken with 5 ml of distilled water and observed for 
the appearance of copious lather. 
Test for Tannins 
Gelatin test 
To the AC extract, 1% gelatin solution containing sodium chloride was added and 
waited till the appearance the white precipitate. 
Test for Phenolic compounds 
To 0.5 ml of AC extract, 1 ml of alcoholic ferric chloride solution was added and 
observed for the appearance of bluish green or bluish black colour.  
Test for Phytosterol 
Ferric chloride – acetic acid test 
To 1 ml of AC extract 1 ml of chloroform, 2 ml of ferric chloride acetic acid reagent 
was added followed by 1 ml of concentrated. Sulphuric acid is added and waited for the 
appearance for reddish pink colour. 
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Test for Diterpenes 
Copper acetate test 
To 1 ml of AC extract water was added and 3-4 drops of Copper acetate solution 
was added again to see the appearance of emerald green colour. 
Test for Triterpenes 
Salkowiski’s test 
To 1 ml of AC extract 1 ml of chloroform followed by 1 ml of concentrated 
Sulphuric acid was added, shaken and allowed to stand for the appearance of golden 
yellow colour. 
Test for Flavonoids 
a) Alkaline reagent test 
To 1 ml of AC extract, 1 ml of 10% sodium hydroxide solution was added to 
observe for dark yellow colour. 
b) Lead acetate test 
To 1 ml of AC extract, 3-4 drops of 10% lead acetate solution was added and waited 
for the appearance of yellow precipitate. 
c) Ferric chloride test 
To 1 ml of AC extract, 3-4 drops of ferric chloride solution was added and observed 
for the appearance of dark green colour. 
d) Shinoda test 
With 1ml of the AC extract, magnesium turnings of few mg, few drops of 
Concentrated  Hydrochloric acid was added. 
The extract was boiled for 5 minutes in a boiling water bath and observed for the 
appearance of red colour. 
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Test for Proteins and Free Amino Acids: 
a) Xanthoproteic test 
To 1 ml of AC extract, 3-4 drops of concentrated Nitric acid was added and 
observed for the formation of yellow precipitate. 
b) Million’s test 
To 0.5 ml of AC extract, 2.5 ml of Million’s reagent was added, warmed and waited 
for the appearance of white precipitate.  
c) Biuret test 
To 0.5 ml of AC extract, 2.5 ml of diluted Biuret reagent was added and observed 
for the appearance of purple colour or brick red precipitate.   
Test for Quinones 
Sodium hydroxide test 
To 0.5 ml of AC extract, 1 ml of 10% sodium hydroxide was added to observe for 
the   appearance of blue or green or red colour 
[67]
. 
TLC/ HPTLC finger print studies  
 
HPTLC finger printing was carried out as per the reference. 
 
Preparation of spray reagent-vanillin-sulphuric acid reagent 
Vanillin (1g) was dissolved in ice cold ethanol (95ml).  Add to 5ml of cooled 
concentrated Sulphuric acid. Ice was added and stirred well. The solution was stored in 
refrigerator.   
Chromatographic conditions  
 
Instrument : CAMAG (Switzerland). 
 
Sample Applicator: Camag Linomat - IV applicator with N2 gas flow. 
 
Photo documentation System: Digi store - 2 documentation system with Win Cat 
& video scan software. 
Scanner: Camag HPTLC scanner - 3 (030618), Win Cats - IV. Development 
 
Chamber: Camag HPTLC 10X10, 10 X 20 twin trough linear development chamber. 
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Quantity applied: 5, 10 µl for extracts and 5 µl for standards 
 
Stationary phase : Aluminium plate pre-coated with silica gel 60(E. Merck) 
 
Plate thickness  : 0.2 mm. 
 
Mobile Phase: For Chloroform extract - Toluene: Ethyl acetate (9:1) and ethanol 
extract - Toluene: Ethyl acetate (1:1).  
Scanning wavelength : 254 nm 
Laboratory condition : 26 ± 5
o
C and 53 % relative humidity 
 
The plate was developed up to a height of 8 cm, air dried, spots were observed 
under the UV light at 254 and 366 nm. Finally the plates were derivatized using 
Vanillin -Sulphuric acid reagent heated at 105° till colour spots appeared 
[68]
. 
 
4.2.4. CHEMICAL ANALYSIS: 
 
Preliminary Basic and Acidic radical studies: 
 
Preparation of extract: 
 
5g of sample was taken in a 250 ml of clean beaker and 50 ml of distilled water was 
added to it. Then it was boiled well for about 10 min. Then it is allowed to cool and 
filtered in a 100 ml volumetric flask and made up to 100 ml with distilled water. This 
preparation is used for the qualitative analysis of acidic/ basic radicals and biochemical 
constituents in it. 
 Preliminary Basic and Acid Radical studies  
 
Preparation of extract 
5gm of was weighed accurately and placed in a 250ml clean beaker and added with 
50ml of distilled water. Then it was boiled well for about 20 minutes. Then it was 
cooled and filtered in a 1000ml volumetric flask and made up to 100ml distilled water. 
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Table: 4. Test for basic radicals 
PROCEDURE OBSERVATION INFERENCE 
Test for Potassium: A pinch of 
sample is treated with 2ml of sodium 
nitrate solution and then treated with 
2ml of cobalt nitrate in 30% of glacial 
acetic acid. 
Formation of Yellow 
colour Precipitate 
Presence  of 
Potassium 
Test for Calcium: Taken2 ml of 
extract in a clean test tube. Then 
acetic acid and potassium chromate 
solution were added 
No Yellow precipitate Presence  of 
Calcium 
Test For Magnesium: 2ml of extract 
was taken in a clean test tube, few 
drops of Magnason reagentwas added 
in drops. 
Formation of Blue  
colour precipitate 
Presence  of 
Magnesium 
Test For Ammonium: 2mlof extract 
was taken in a test tube and added 
few ml of Nessler's reagent. 
Appearance of Brown 
colour 
 
Presence of 
Ammonium 
Test For Sodium: 2 pinches of drug 
was mixed with HCl and made it into 
paste.  And introduced into the blue 
flame of Bunsen burner. 
Appearance of  intense 
Yellow colour 
Presence of 
Sodium 
Test for Iron (Ferrous):  2ml of 
extract was taken in a clean dried test 
tube and conc. HNO3 and ammonium 
thiocyanate were added. 
Appearance of Blood red 
colour 
Presence of 
Ferrous iron 
Test For Zinc: 2 ml of the extract 
was taken in a test tube and 
Potassium ferro cyanide solution was 
added.  
 
Formation of White 
colour precipitate 
Presence  of 
Zinc 
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PROCEDURE OBSERVATION INFERENCE 
Test For Aluminium: To the 2m1of 
the extract was taken in a test tube 
sodium hydroxide drops were added 
to it. 
White precipitate 
obtained 
Presence of 
Aluminium 
Test For Lead: 2 ml of extract was 
taken in a test tube and added with 
2ml of potassium iodide solution 
Formation of yellow 
colour precipitate 
Presence of 
Lead 
Test for Copper: To a small portion 
of a extract dilute hydrochloric acid 
was added and then hydrogen 
sulphide gas is passed through the 
solution. 
Black precipitate Presence of 
Copper 
 
Test For Mercury: 2m1 of the 
extract was taken in a test tube and 
treated With 2ml of sodium 
hydroxide solution. 
Formation of 
Yellow precipitate 
 
Presence of 
Mercury 
Test for Arsenic:       
2m1 of the extract was taken in a test 
tube and treated with 2ml of sodium 
hydroxide solution. 
Formation of 
 brownish red 
 precipitate 
Presence of 
Arsenic 
 
Results were noted and tabulated in Table No: 9 
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Table: 5. Test for acidic radical 
PROCEDURE OBSERVATION INFERENCE 
Test for Sulphate: 2 ml of the extract 
was taken in clean, dry test tube and 5 
% barium chloride solution was added 
to it. 
Formation of white 
     precipitate 
Presence of 
Sulphate 
Test for Chloride: The extract was 
taken in a test tube and then treated 
with Silver nitrate solution. 
 Formation of White    
precipitate 
Presence of 
Cholride 
Test for Phosphate: The extract was 
taken in a test tube and treated with 
ammonium molybdate and conc. 
HNO3. 
Formation of Yellow 
precipitate 
Presence of 
Phoshate 
Test for Carbonate: The substance 
was taken in a clean dry test tube and 
then treated with Conc. HCl. 
Formation of 
Effervescence 
Presence of 
Carbonate 
Test for fluoride &oxalate: 2ml of 
extract was taken in a test tube and 
added with 2ml of dil.acetic acid, 2ml 
calcium chloride solution and then 
heated. 
Formation of cloudy 
appearance 
Presence of 
Fluoride & 
 Oxalate 
Test For Nitrate: 1gm of the drug 
was heated with copper turnings and 
concentrated H2SO4 and observed the 
test tube vertically down. 
Characteristic changes Presence of 
 Nitrate 
 
The results were tabulated in Table No: 9 
The bio-chemical analysis was done to identify the acid and basic radicals present in 
the AC 
[69] 
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4.2.5. Availability of bacterial load: 
 
Enumeration of bacteria by plate count – agar plating technique 
The plate count technique is one of the most routinely used procedures because of 
the enumeration of viable cells by this method.  
Principle:  
 This method is based on the principle that when material containing bacteria are 
cultured, every viable bacterium develops into a visible colony on a nutrient agar 
medium. The number of colonies therefore is the same as the number of organisms 
contained in the sample. 
Dilution:  
 A small amount of the measured volumes are mixed with a large volume of 
sterile water or saline called the diluent or dilution blank. Dilutions are usually made in 
multiples of ten. A single dilution is calculated as follows: 
               
   Dilution =                Volume of the sample 
                          Total volume of the sample and the diluent 
Requirements: 
 Sample or Bacterial suspension 
 9 ml dilution blanks (7) 
 Sterile petri dishes (12) 
 Sterile 1 ml pipettes(7) 
 Nutrient agar medium (200 ml) 
 Colony counter 
Procedure: 
1. Label the dilution blanks as 10-1, 10-2, 10-3, 10-4, 10-5, 10-6, 10-7. 
2. Prepare the initial dilution by adding 1 ml of the AC into a 9 ml dilution blank 
labelled 10
-1
 thus diluting the original sample 10 times. 
3. Mix the contents by rolling the tube back and forth between hands to obtain 
uniform distribution of organisms. 
4. From the first dilution transfer 1 ml of the suspension while in motion, to the 
dilution blank 10
-2
 with a sterile and fresh 1 ml pipette diluting the original 
specimen to 100 times. 
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5. From the 10-2 suspension, transfer 1 ml of suspension to 10-3 dilution blank with 
a fresh sterile pipette, thus diluting the original sample to 1000 times. 
6. Repeat this procedure till the original sample has been diluted 10,000,000 times 
using every time a fresh sterile pipette. 
7. From the appropriate dilutions transfer 1ml of suspension while in motion, with 
the respective pipettes, to sterile petri dishes. Three petri dishes are to be used 
for each dilution. 
8. Add approximately 15 ml of the nutrient medium, melted and cooled to 450c, to 
each petri dish containing the diluted sample. Mix the contents of each dish by 
rotating gently to distribute the cells throughout the medium. 
9. Allow the plates to solidity. 
10. Incubate these plates in an inverted position for 24-48 hours at 370c [70]. 
Observation: 
Observe all the plates for the appearance of bacterial colonies. Count the 
number of colonies in the plates. 
Calculate the number of bacteria per ml of the original suspension as follows: 
                Number of colonies (average of 3 replates) 
Organisms per millimeter =  
       Amount of plated × dilution 
 
4.2.6. SOPHASTICATED INSTRUMENTAL ANALYSIS: 
 
FT-IR (Fourier Transform Infra-Red) 
 
Model   : Spectrum one: FT-IR Spectrometer 
Scan Range   :  MIR 450-4000 cm-1 
Resolution   :  1.0 cm-1  
Sample required :  50 mg, solid or liquid. 
Fourier transform infrared spectroscopy (FTIR) is a technique which is used to 
obtain an infrared spectrum of absorption, emission, photoconductivity or Raman 
scattering of a solid, liquid or gas. An FTIR spectrometer simultaneously collects 
spectral data in a wide spectral range. Fourier Transform Infrared Spectroscopy (FTIR) 
identifies chemical bonds in a molecule by producing an infrared absorption spectrum. 
The spectra produce a profile of the sample, a distinctive molecular fingerprint that can 
MATERIALS AND METHODS 
 
OVULATION INDUCING ACTIVITY OF ASHUWATHI CHOORANAM                                         93  
 
be used to screen and scan samples for many different components. FTIR is an 
effective analytical instrument for detecting functional groups and characterizing 
covalent bonding information. 
 
In infrared spectroscopy, IR radiation is passed through a sample. Some of the 
infrared radiation is absorbed by the sample and some of it is passed through 
(transmitted). The resulting spectrum represents the molecular absorption and 
transmission, creating a molecular fingerprint of the sample. Like a fingerprint no two 
unique molecular structures produce the same infrared spectrum. This makes infrared 
spectroscopy useful for several types of analysis. 
 
Applications: 
 
          Ashuwathi chooranam was a herbal drug, FT-IR study was selected to identify 
the unknown materials of the test drug and determine the amount of components in the 
sample 
[70]
. 
 
Scanning Electron Microscopy (SEM)  
 
  SEM provides detailed high resolution images of the sample by rastering a 
focussed electron beam across the surface and detecting secondary or backscattered 
electron signal.  
 
 SEM provides images with magnifications up to ~X 50,000 allowing sub-micron-
scale features to be seen i.e. well beyond the range of optical microscopes. It gives 
rapid, high resolution imaging with identification of elements present and  
 
 Scanning Electron Microscopy uses a focused beam of high-energy electrons to 
generate a variety of signals at the surface of solid specimens. In most SEM 
microscopy applications, data is collected over a selected area of the surface of the 
sample and a two-dimensional image is generated that displays spatial variations in 
properties including chemical characterization, texture and orientation of materials. 
The SEM is also capable of performing analyses of selected point locations on the 
sample. This approach is especially useful in qualitatively or semi-quantitatively 
determining chemical compositions, crystalline structure and crystal orientations
[71]
. 
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ICPOES (Inductively Coupled Plasma Optic Emission Spectrometry) 
Manufacturer: Perkin Elmer 
Model:  Optima 5300 DV ICP-OES Inductively Coupled Plasma Spectrometer (ICP) 
Principle: 
An aqueous sample was converted to aerosols via a nebulizer. The aerosols are 
transported to the inductively coupled plasma which was a high temperature zone 
(8,000– 10,000ºC). The analysts are heated (excited) too different (atomic and/or ionic) 
states and produce characteristic optical emissions (lights). These releases are separated 
based on their respective wavelengths and their strengths are measured (spectrometry). 
The intensities are proportional to the concentrations of analyses in the aqueous 
sample. The quantification was an external multipoint linear standardization by 
comparing the emission intensity of an unknown sample with that of a standard sample. 
Multi-element calibration standard solutions are prepared from single- and multi 
element primary standard solutions. With respect to other kinds of analysis where 
chemical speciation was relevant (such as the concentration of ferrous iron or ferric 
iron), only total essential concentration was analysed by ICP-OES. 
Application: 
The analysis of major and minor elements in solution samples. 
Objectives: 
 Determine elemental concentrations of different metals. 
 Learn principles and operation of the ICP-OES instrument 
 Develop and put on a method for the ICP-OES sample analysis 
 Enhance the instrumental conditions for the analysis of different elements 
 probes the outer electronic structure of atoms. 
Mechanism:  
In plasma emission spectroscopy (OES), a sample solution was presented into the 
core of inductively coupled argon plasma (ICP), which generates temperature of 
approximately 8000°C. At this temperature all elements become thermally excited and 
emit light at their characteristic wavelengths. This light was collected by the 
spectrometer and passes through a diffraction grating that serves to resolve the light 
into a spectrum of its essential wavelengths. Within the spectrometer, this deflected 
light was then collected by wavelength and amplified to yield an strength of  
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measurement that can be converted to an elemental concentration by comparison with 
standardization values 
The Inductively coupled plasma optical emission spectrometric (ICP-OES) analysis 
was done in SAIF, IIT MADRAS, and Chennai-36 using Perkin Elmer Optima 5300 
DV. 
Sample preparation: 
Inductively Coupled Plasma Spectroscopy techniques are the so-called "wet" 
sampling methods whereby samples are introduced in liquid form for analysis. 
100 mg AC was occupied in a clean, dry test tube. To this, 3 ml Nitric acid was 
added and mixed well and allowed for few minutes untill the reactions were completed. 
And then, 25 ml of Refined water, was added to prepare digested solution. The 
digested sample solution was shifted into plastic containers and labeled properly. It was 
completed in Bio-chemistry lab, Govt. Siddha Medical College, Chennai-106 
[72]
. 
X-Ray Powder Diffraction Method(X-RD) 
Definition 
X-ray powder diffraction is most widely used for the identification of unknown 
crystalline materials (e.g. minerals, inorganic compounds). Determination of unknown 
solids is important to studies in geology, environmental science, material science and 
biology. 
Applications: 
 Characterization of crystalline materials  
 Identification of fine-grained minerals such as clays and mixed layer clays that 
are difficult to determine optically 
 Determination of unit cell dimensions 
 With specialized techniques, XRD can be used to: 
 Determine crystal structures using Rietveld refinement 
 Determine of modal amounts of minerals (quantitative analysis) 
 Characterize thin films samples by: 
a. determining lattice mismatch between film and substrate and to 
inferring stress and strain 
b. determining dislocation density and quality of the film by rocking curve 
measurements 
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c. measuring super lattices in multilayered epitaxial structures 
d. determining the thickness, roughness and density of the film using 
glancing incidence X-ray reflectivity measurements 
e. Make textural measurements, such as the orientation of grains, in a 
polycrystalline sample. 
Strengths and Limitations of X-ray Powder Diffraction 
Strengths 
 Powerful and rapid (< 20 min) technique for identification of an unknown 
mineral 
 In most cases, it provides an unambiguous mineral determination 
 Minimal sample preparation is required 
 XRD units are widely available 
 Data interpretation is relatively straight forward. 
Limitations 
 Homogeneous and single phase material is best for identification of unknown 
 Must have access to a standard reference file of inorganic compounds 
 Requires tenths of a gram of material which must be ground into a powder 
 For mixed materials, detection limit is ~ 2% of sample 
 For unit cell determinations, indexing of patterns for non-isometric crystal 
systems is complicated. 
Sample Collection and Preparation 
Determination of an unknown requires: the material, an instrument for grinding, and a 
sample holder. 
 Obtain a few tenths of a gram (or more) of the material, as pure as possible 
 Grind the sample to a fine powder, typically in a fluid to minimize inducing    
     extra strain (surface energy) that can offset peak positions, and to randomize     
     orientation.  
 Powder less than ~10 μm(or 200-mesh) in size is preferred place into a sample    
     holder or onto the sample surface 
[73]
. 
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4.3 TOXICOLOGICAL STUDIES 
 
4.3.1 ACUTE ORAL TOXICITY – OECD GUIDELINES - 423  
 
Introduction:  
 The acute toxic class method was a stepwise procedure with the use of 3 
animals of a single sex per step. Depending on the mortality and/or the moribund status 
of the animals, on average 2-4 steps may be necessary to allow judgment on the acute 
toxicity of the test substance. Morbid animals or animals obviously in pain or showing 
signs of severe and enduring distress shall be humanely killed, and are considered in 
the interpretation of the test  results  in  the  same  way  as  animals  that  died  on  test.  
The method allows for the determination of an LD50 value only when at least two 
doses result in mortality higher than 0% and lower than 100%. 
 Acute toxicity study was carried out as per OECD guideline (Organization for 
Economic Co - operation and Development, Guideline-423. 
 The experimental protocol was approved by the institutional ethical committee 
(IAEC) under CPCSEA [Approval no: IAEC/XLIV/27/CLBMCP/2014]  
Animal: Healthy wistar albino female rats weighing 200–220 gms. 
Principle:  
It was the principle of the test that based on a stepwise procedure with the use 
of a minimum  number  of  animals  per  step,  sufficient  information  was  obtained  
on  the  acute toxicity  of  the  test  substance  to  enable  its  classification.  The 
substance was administered orally to a group of experimental animals at one of the 
defined doses.  The substance was tested using a stepwise procedure, each step using 
three animals of a single sex. Absence or presence of compound-related mortality of 
the animals dosed at one step will determine the next step, i.e.; − no further testing was 
needed − dosing of three additional animals with the same dose − dosing of three 
additional animals at the next higher or the next lower dose level. The method will 
enable a judgment with respect to classifying the test substance to one of a series of 
toxicity classes.   
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Studies carried out at three female rats under fasting condition, signs of toxicity 
were observed for every one hour for first 24 hours and every day for about 14 days 
from the beginning of the study 
[74]
. 
Methodology   
Selection of animal species:  
The preferred rodent species is rat, although other rodent species may be used.  
A healthy young adult animal of commonly used laboratory strain Swiss albino rat was 
obtained from Animal house of king’s institute, Guindy, Chennai. Females should be 
nulliparous and non-pregnant.  Each animal at the commencement of its dosing should 
be between 8 and 12 weeks old and its weight should fall in an interval within±20 % of 
the mean weight of the animals. The studies were conducted in the animal house of 
C.L. Baid Metha college of Pharmacy, Duraipakkam, Chennai. 
 
Housing and feeding conditions:   
  The temperature in the experimental animal room should be 22ºC (+3ºC). 
Although  the  relative  humidity  should  be  at  least  30%  and  preferably  not  
exceed  70% other than during room cleaning the aim should be 50-60%. Lighting 
should be artificial, the sequence being 12 hours light, 12 hours dark. For feeding, 
conventional laboratory diets may be used with an unlimited supply of drinking water. 
Animals may be grouped and tagged by dose, but the number of animals per cage must 
not interfere with clear observations of each animal.   
Preparation of animals:   
  The animals are randomly selected, marked to permit individual identification, 
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization to 
the laboratory conditions. 
 Experiment procedure: 
 
Administration of doses 
 AC was prepared as per the classical Siddha literature was suspended in 2% CMC 
with uniform mixing and was administered to the groups of Wistar albino rats. It was 
given in a single oral dose by gavage using a feeding needle. Animals were fasted prior 
to dosing. Following the period of fasting, the animals were weighed and then the test 
substance was administered. After the substance has been administered, food was 
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withheld for a further 3-4 hours. The principle of laboratory animal care was followed. 
Observations were made and recorded systematically and continuously observed as per 
the guideline after substance administration.  
  The visual observations included skin changes, mobility, aggressively, 
sensitivity to sound and pain, as well as respiratory movements. They were deprived of 
food, but not water 16–18 hours prior to the administration of the test suspension. 
Finally, the number of survivors was noted after 24 hours and these animals were then 
maintained for a further 14 days and observations made daily. The toxicological effect 
was assessed on the basis of mortality.  
Number of animals and dose levels 
 Since this AC has been under practice for long time and likely to be non-toxic, 
a limit test at one dose level of 2000 mg/kg body weight will be carried out with 6 
animals (3 animals per step). 
Duration of Study:  48 hours 
Evaluation           :   14 Days 
Limit test 
 The limit test was primarily used in situations where the experimenter has 
information indicating that the test material is likely to be nontoxic, i.e., having toxicity 
only above regulatory limit doses. A limit test at one dose level of 2000 mg/kg body 
weight was carried out with three animals per step. The test substance-related mortality 
was not produced in animals, so further testing at the next lower level need not be 
carried out.  
Observations 
 The animals were observed individually after dosing at least once during the 
first 30mins and periodically during the first 24 hours. 
 Special attention: First 1-4 hours after administration of drug, and  
 It was observed daily thereafter for a total of 14 days, except when they needed 
to be removed from the study and killed humanely for animal welfare reasons or are 
found dead. 
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a. Mortality 
Animals will be observed intensively at 0.5, 2.0, 4.0, 6.0, 12.0, 24.0 and 48.0 
hours following drug administration on day 1 of the experiment and daily twice 
thereafter for 14 days.   
b. Body weight 
Body weights will be recorded at day: ‐1, day 1, 2, 7 and 14 of the study 
c. Cage-side observation 
These include changes in skin and fur, eyes and mucous membranes and also 
respiratory, circulatory, autonomic and central nervous systems, somatomotor activity 
and behaviour patterns. Attention should be directed to observations of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma. 
d. Gross necropsy 
  All animals (including those which die during the test period are removed from 
the study) will be subjected to gross necropsy. Gross necropsy includes examination of 
the external surface of the body, all orifices, cranial, thoracic and abdominal cavities 
and their contents, brain, eye, thymus, lungs, heart, spleen, liver, kidneys, adrenals, 
testes and uterus of all animals 
Histopathology 
Microscopic examination will be carried out  in organs to show the evidence of 
any toxicity in gross pathology. 
Data and reporting 
All the data were summarised in tabular form showing the animals used, 
number of animals displaying signs of toxicity, the number animals found dead during 
the test or killed for humane reasons, a description and the time course of toxic effects 
and reversibility, and necroscopic findings. 
Test substance and Vehicle  
  In order to ensure the uniformity in drug distribution in the medium the 
suspension was made by mixing AC with 2% CMC solution and it was found suitable 
for dose accuracy.  
Justification for choice of vehicle 
The vehicle selected as per the standard guideline was pharmacologically inert 
and easy to employ for new drug development and evaluation technique 
[75]
. 
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4.3.2. Repeated dose 28 days oral toxicity study of  Ashuwathi chooranam  on rats 
– (OECD-407 guidelines) 
Justification for Dose Selection 
The results of acute toxicity studies in Wistar albino rats indicated that AC was 
non-toxic and no behavioural changes was observed up to the dose level of 2000 mg/kg 
body weight. On the basis of body surface area ratio between rat and human, the doses 
selected for the study were100mg/kg, 200 mg/kg and 400 mg/kg body weight. The oral 
route was selected for use because oral route was considered to be a proposed 
therapeutic route. 
Preparation and administration of dose 
AC at three doses respectively was suspended in 2 ml of 2% CMC in distilled 
water. It was administered to animals at the dose levels of 100, 200 and 400 mg/kg. 
The test substance suspensions were freshly prepared every day for 28 days. The 
control animals were administered vehicle only. Administration was by oral (gavage), 
once daily for 28 consecutive days. 
METHODOLOGY 
Randomization, Numbering and Grouping of Animals 
 Ten rats (Five Male and Five Female) were in each group randomly divided 
into four groups for dosing up to 28 days. Animals were allowed acclimatization period 
of 7 days to laboratory conditions prior to the initiation of treatment. Each animal was 
fur marked with picric acid. The females were nulliparous and non-pregnant. 
OBSERVATIONS 
Experimental animals were kept under observation throughout the course of 
study for the following:  
Body Weight: 
 Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study and at termination to calculate relative organ weights. From the data, 
group mean body weights and percentage body weight gain were calculated.  
Clinical signs: 
  All animals were observed daily for clinical signs. The time of onset, intensity 
and duration of these symptoms, if any, were recorded. 
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Mortality: All animals were observed twice daily for mortality during entire course of     
study. 
Functional Observations: 
At the end of the 4
th
 week exposure, ‘sensory reactivity’ to graded stimuli of 
different types (auditory, visual and proprioceptive stimuli), ‘motor reactivity’ and 
‘grip strength’ were assessed. 
Laboratory Investigations:  
Following laboratory investigations were carried out on day 29 in animal’s 
fasted over-night. Blood samples were collected from orbital sinus using sodium 
heparin (200IU/ml) for Blood chemistry and potassium EDTA (1.5 mg/ml) for 
Haematology as anticoagulant. Blood samples were centrifuged at 3000 rpm. for 10 
minutes. On 28th day of the experiment, 24 hour urine samples were collected by 
placing the animals in the metabolic cage with free access to tap water but no feed was 
given.  
 The urine was free from fecal contamination. Toluene was used as a 
preservative while collecting the sample. The sediments present in the urine were 
removed by centrifugation and the collected urine was used for biochemical 
estimations. On 29th day, the animals were fasted for approximately 18 hour, then 
slightly anesthetized with ether and blood samples were collected from the retro-orbital 
plexus into two tubes: one with EDTA for immediate analysis of haematological 
parameters, the other without any anticoagulant and was centrifuged at 4000 rpm at 4 
°C for 10 minutes to obtain the serum. Serum was stored at 20 °C until analyzed for 
biochemical parameters. 
Haematological Investigations: 
Blood samples of control and experimental rats was analyzed for hemoglobin 
content, total red blood corpuscles (RBC), white blood corpuscles (WBC) count and 
packed cell volume (PCV).  
Biochemical Investigations:  
Serum was used for the estimation of biochemical parameters. Samples of 
control and experimental rats were analyzed for protein, bilirubin, urea, BUN, 
creatinine, triglyceride, cholesterol and glucose levels was carried using standard 
methods. Activities of glutamate oxaloacetate transaminase/ Aspartate 
aminotransferase (GOT/AST), glutamate pyruvate transaminase/ Alanine amino 
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transferase (GPT/ALT) and alkaline phosphatase were estimated as per the colorimetric 
procedure.  
Urine analysis: Urine samples were collected on end of treatment for estimation of 
normal parameters. The estimations were performed using appropriate methodology.  
Necropsy: 
All the animals were sacrificed on day 29. Necropsy of all animals was carried 
out and the weights of the organs including liver, kidneys, spleen, brain, heart, and 
lungs were recorded. The relative organ weight of each animal was then calculated as 
follows; 
     Absolute organ weight (g) 
Relative organ weight = __________________________________×100 
    Body weight of animal on sacrifice day (g) 
 
Histopathology: 
Histopathological investigation of the vital organs was done. The organ pieces 
(3-5µm thick) of the highest dose level of 400 mg/kg were preserved and were fixed in 
10% formalin for 24 hours and washed in running water for 24 hours. Samples were 
dehydrated in an auto technicon and then cleared in benzene to remove absolute 
alcohol.  Embedding was done by passing the cleared samples through three cups 
containing molten paraffin at 50°C and then in a cubical block of paraffin made by the 
“L” moulds. It was followed by microtome and the slides were stained with 
Haematoxylin-eosin. The organs included heart, kidneys, liver, ovary, pancreas, brain, 
spleen and stomach, of the animals were preserved they were subjected to 
histopathological examination. 
 
Statistical analysis: 
Findings such as clinical signs of intoxication, body weight changes, food 
consumption, and haematology and blood chemistry were subjected to One-way 
ANOVA followed by Dunnet’s multi comparison test using a computer software 
programme GRAPH PAD INSTAT-3 version 
[76]
. 
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4.4. PHARMACOLOGICAL STUDIES 
4.4.1. Ovulation inducing activity in female Wistar albino rat model  
Method 
After that 2ml of blood was collected by retro orbital puncture. Blood samples 
were centrifuged for 15 minutes at 4000 rpm and the separated serum samples were 
frozen at -20°C and kept for later estimation of LH, FSH and Estradiol by ELISA 
method 
[77]
. 
The study tried to evaluate the effect of this exercise type on reproductive 
dysfunction in rats with polycystic ovarian syndrome.  
Materials and Methods: Female white albino rats were allocated into three groups: 
 Group I: Control rats  
 Group II: Letrozole induced polycystic ovarian syndrome rats (PCO) 
where letrozole was given orally and daily in a dose of 1 mg/kg dissolved in 0.9% 
NaCl solution for 21 days.  
 Group III: Polycystic ovarian syndrome rats subjected to Ashuwathi 
chooranam (PCO+AC) of the lower limbs for three weeks after the induction of 
polycystic ovarian syndrome. After 6 weeks from the beginning of the study, final 
body weight, body mass and Lee indices were determined. Plasma levels of LH, free 
testosterone, estradiol, progesterone, prolactin, fasting glucose and fasting insulin 
were measured.  
4.4.2. OGTT 
 Women  with  polycystic  ovarian  syndrome  (PCOS)  are  at  increased  risk  
for developing glucose intolerance leading to type 2 diabetes mellitus (DM) 
[97]
. 
Hence, it was necessary to evaluate the efficacy of Ashuwathi chooranam on 
glucose homeostasis. Thereby, Oral glucose tolerance test (OGTT) was performed 
in all groups of animals. PCOS rats exhibited high glucose tolerance compared to 
normal control rats (**p<0.01, ***p<0.001) at all the time points of OGTT profile. 
AC formulation treated PCOS rats in different doses (5 mg, 10 mg) demonstrated 
significantly reduced glucose intolerance and improved cellular glucose uptake 
upon increasing time period of dose (30 days) of OGTT profile. 
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 Glucose homeostasis is governed by insulin action. Thereby, we measured 
serum insulin level in all group of animals wherein serum insulin levels of untreated 
PCOS rats were increased signiﬁcantly (***p<0.001).  Treatment of fresh AC 
caused a decrease in insulin level as compared to PCOS group (p<0.001)
 [78]
. 
 
4.4.3. Hormonal assay  
Experimental design 
 Group I Normal Control animals 1ml/kg of CMC solution.  
 Group II rats were administered  AC 100mg/kg for 10days,  
 Group III rats were administered AC 200mg/kg for 10 days  
 Group IV received Clomiphene 10mg/kg and served as standard. All the drugs 
were given orally. 
 Group V Letrozole induced PCOS animals 
Biochemical assay  
The method employed was Micro well Enzyme Linked Immunosorbent Assay 
(ELISA) using analytical grade reagents.  
Estimation of serum luteinizing hormone (LH)  
The method employed was Micro well immunoassay (ELISA) using analytical 
grade reagents. 0.050ml of the serum was pipetted into the assigned wells. 0.001ml of 
LH-Enzyme reagent was added to all the wells. The micro plate was swirled for 20-30 
seconds and covered; this mixture was allowed to incubate for 60 minutes at room 
temperature. After which, the contents were discarded by decantation. 350µl of wash 
buffer was added and decanted for 3 times. 100µl of working substrate solution was 
added to all the wells and was allowed to incubate for fifteen minutes. 50µl of stop 
solution was added to all the wells and gently mixed for 20 seconds. The optical 
density was read at 450nm in a micro plate reader within 30mins. The mean 
absorbance values for each set of standards, controls, and test samples were calculated 
and a standard curve was constructed by plotting a mean absorbance obtained from 
each of the reference standard against its concentration from the standard curve.  
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Estimation of serum follicle stimulating hormone (FSH)  
 The method employed was Micro well immunoassay (ELISA) using analytical 
grade reagents. 0.050ml of the serum was pipetted into the assigned wells. 0.001ml of 
FSH-Enzyme reagent was added to all the wells. The micro plate was swirled for 20-30 
seconds and covered; this mixture was allowed to incubate for 60 minutes at room 
temperature. After which, the contents were discarded by decantation. 350µl of wash 
buffer was added and decanted for 3 times. 100µl of working substrate solution was 
added to all the wells and was allowed to incubate for fifteen minutes. 50µl of stop 
solution was added to all the wells and gently mixed for 20 seconds. The optical 
density was read at 450nm in a micro plate reader within 30mins.The mean absorbance 
values for each set of standards, controls, and test samples were calculated and a 
standard curve was constructed by plotting a mean absorbance obtained from each of 
the reference standard against its concentration from the standard curve. 
Determination of serum progesterone levels  
 The method employed was Micro well immunoassay (ELISA) using analytical 
grade reagents. 0.025ml of the serum was pipetted into the assigned wells. 0.050ml of 
progesterone Enzyme reagent was added to all the wells. The micro plate was swirled 
for 20 seconds to mix, 0.050ml progesterone biotin reagent was added to all the wells, 
the mixture was swirled for 20 seconds to mix and covered, this mixture was allowed 
to incubate for 60 minutes at room temperature. After which, the contents were 
discarded by decantation. 350µl of wash buffer was added and decanted for 3 times. 
100µl of working substrate solution was added to all the wells and was allowed to 
incubate for twenty minutes. 50µl of stop solution was added to all the wells and gently 
mixed for 20 seconds. The optical density was read at 450nm in a micro plate reader 
within 30mins. The mean absorbance values for each set of standards, controls, and test 
samples were calculated and a standard curve was constructed by plotting a mean 
absorbance obtained from each of the reference standard against its concentration from 
the standard curve.  
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Determination of serum Estradiol levels  
The method employed was Micro well immunoassay (ELISA) using analytical 
grade reagents. 0.025ml of the serum reference was pipetted into the assigned wells. 
0.050ml of Estradiol Biotin reagent was added to all the wells. The micro plate was 
swirled for 20 seconds to mix, the mixture was incubated at room temperature for 
30mins,0.050ml Estradiol enzyme reagent was added to all the wells , the mixture was 
swirled for 20 seconds to mix and covered, this mixture was allowed to incubate for 90 
minutes at room temperature. After which, the contents were discarded by decantation. 
350µl of wash buffer was added and decanted for 3 times. 100µl of working substrate 
solution was added to all the wells and was allowed to incubate for twenty minutes. 
50µl of stop solution was added to all the wells and gently mixed for 20 seconds. The 
optical density was read at 450nm in a micro plate reader within 30mins. The mean 
absorbance values for each set of standards, controls, and test samples were calculated 
and a standard curve was constructed by plotting a mean absorbance obtained from 
each of the reference standard against its concentration from the standard curve 
[79]
. 
4.4.4 Antioxidant activity:  
Free radical scavenging activity:  
DPPH ASSAY (2, 2-diphenyl -1-picrylhydrazyl) 
The radical scavenging activity of AC extracts was determined by using DPPH 
assay according to Chang et al. [2001]. The decrease in the absorption of the DPPH 
solution after the addition of an antioxidant was measured at 517 nm. Ascorbic acid 
(10mg/ml DMSO) was used as reference. 
Principle 
1,1-diphenyl-2-picryl hydrazyl was a stable free radical with red colour which turns 
yellow when scavenged. The DPPH assay uses this character to show free radical 
scavenging activity. The scavenging reaction between (DPPH) and an antioxidant (H-
A) can be written as,  
                                    DPPH + [H-A] →DPPH-H + (A) 
MATERIALS AND METHODS 
 
OVULATION INDUCING ACTIVITY OF ASHUWATHI CHOORANAM                                         108  
 
Antioxidants react with DPPH and reduce it to DPPH-H and as consequence the 
absorbance decreases. The degree of discoloration indicates the scavenging potential of 
the antioxidant compounds or extracts in terms of hydrogen donating ability. 
Reagent preparation 
0.1mm DPPH solution was prepared by dissolving 4mg of DPPH in 100ml of 
ethanol.  
Procedure 
 Different volumes (2.5µl - 40µl) of plant extracts were made up to a final 
volume of 40µl with DMSO and 2.96ml DPPH (0.1mM) solution was added. The 
reaction mixture incubated in dark condition at room temperature for 20 minutes. After 
20 minutes, the absorbance of the mixture was read at 517nm. 3ml of DPPH was taken 
as control 
[80]
. 
Calculation 
                                 % inhibition =  
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5. RESULTS AND DISCUSSION 
 
The present study reveals that the polyherbal formulation “Ashuwathi 
chooranam” from the classical siddha literature had the potential for curing 
“Soothaga vayu” which in Modern is termed as PCOS. The convenience of the 
chooranam is safe and effective. To validate the trial drug, it is subjected to various 
scientific analysis such as literary review, physico-chemical analysis and elemental 
analysis, toxicity studies and pharmacological studies for promoting ovulation 
activity, evaluation of the hormone level FSH, LH, progesterone, estradiol and 
antioxidant activity for spontaneously curing Poly Cystic Ovarian Syndrome. 
 
Discussion of review of literature: 
 
In the review of literature the medicinal plants were identified as being used in 
Siddha System of Medicine from ancient period. The Siddha aspect of the herbs 
describes the habit, habitat, description of the plant, actions of it, phytoconstituents 
present in the plant, traditional and medicinal uses, preparations from the herbs such 
as decoction, chooranam, legium, oils (both internal and external) that are used for 
various diseases. Many of the herbs used here causes normal menstrual flow, 
regularization of menstrual cycle, induces ovulation. 
 
Discussion of pharmacological review: 
 
 The pharmacological aspect of the drug shows the presence availability of 
various animal models for PCOS. 
 The  current   pharmacological   methods   available  for  carrying  out   the 
ovulation inducing activities were explained clearly and the suitable animal 
for carrying out the activities were discussed to be Wistar strain of albino 
rats than other animals because of the parallelism with the human. 
 They are also more sensitive compared to other animals and hence they were 
chosen for the study. 
 The exact ovulogenic activity could never be better studied by analyzing the 
pharmacological activities like ovulation inducing activity, antioxidant 
activity and estimation of female hormones. 
RESULTS AND DISCUSSION 
 
 
 
 
110 OVULATION INDUCING ACTIVITY OF ASHUWATHI CHOORANAM 
 
 
 
 
 
 Since  the  three  activities  could  clearly  explain  the  whether  the  drug 
effectively induce  ovulation  and  maintains  the  level  of  hormones  which 
gives the knowledge about the activities. 
 
Discussion of the pharmaceutical review: 
 
 
 This review explained the preparation of Chooranam in detail including the 
purification of raw drugs, methods of manufacturing Chooranam. 
 The ingredients are cleaned, wiped with a clean cloth so as to remove the 
sand and other impurities. 
 The aromatic substances are roasted which may result in certain chemical 
changes and increase in antioxidants. Then the drugs are powdered well 
purified, as per Siddha literature. 
 The powdered drugs were filtered through the white cloth so as to reduce the 
size of the particle in turn which enhances the bio-availability. 
 The shelf life of the drug is improved by proper purification methods and 
preservation. 
 
Discussion of materials and methods: 
 
 The preparation of the drug was done carefully so as to achieve the highest 
potency. 
 The drugs were ground well and filtered through a clean white cloth to get 
fine particles of size which in turn increases the bioavailability of the drug. 
 The drug along with the Asafotida powder and thippili juice enhances the 
capability of the drug. 
 
Standardization of the drug 
 
 
The standardization of the drugs was achieved through various procedures like 
analyzing the organoleptic characters, physico-chemical characters, elements present 
in the drug and the results and discussion of standardization parameters is 
Physical characterization 
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Table No. 6. Organoleptic characters of Ashuwathi Chooranam 
 
 
 
S.No. Parameter Results 
1 Colour Green 
2 Odour Characteristic odour 
3 State of Matter Amorphous 
4 Consistency Fine 
5 Taste Bitter 
6 Solubility  
 I Distilled water Soluble 
 Ii Benzene Soluble 
 Iii Choroform Soluble 
 Iv Carbon tetrachloride Soluble 
 V Xylene Soluble 
 Vi Petroleum ether Soluble 
 vii Propylene glycol Not Soluble 
 
 
Interpretation 
 
 
The organoleptic characters of the drugs, like colour, odour, pH, volatile matter, 
characteristic odour. The amorphous nature of the drug and its fine texture also an 
important factor for drug absorption. 
 
Table No. 7. Physicochemical analysis of   Ashuwathi chooranam 
 
S.No. Parameter Mean 
1. Loss on drying at 105ºC 8.81% 
2. Total ash 2.64% 
3. Water soluble ash 1.35% 
4. Acid insoluble ash 0.185 
5. Water soluble extractive 46.37% 
6. Alcohol soluble extractive 46.92% 
7. pH 3.53 
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Interpretation: 
 
pH 
 
The pH is used as a measure of whether the body is maintaining a normal Acid- 
Base balance. A favorable ph is essential to the functioning of enzymes and other 
biochemical systems. 
In acidic medium, lots of protons are present. Therefore, greater amount of 
acidic drug is unionized. Thus in acidic medium acidic drugs are present in more in 
unionized form, which increases its absorption. That is why acidic drugs are better 
absorbed from stomach. 
 
Total Ash 
 
The ash content is a measure of the total amount of minerals present, whereas 
the mineral content is a measure of the amount of specific inorganic components 
such as Ca, Na, K, Cl. The total ash value of AC is 2.64%, which determines the 
presence of inorganic content. 
 
Acid insoluble ash 
 
 
The acid insoluble ash value of the drug denotes the amount of siliceous matter 
(dust, sand etc.,) present in that drug. The quality of the drug is better if the acid 
insoluble ash value is low. Here, acid insoluble ash value of AC is 0.185%. Hence, it 
represents the superior quality of the AC. 
 
Water soluble ash 
 
 
Water soluble ash, is a part of total ash value, which denotes the colloidal or 
crystalline nature of the drug. Here, the water soluble ash value of AC is 1.35%, 
which represents easy facilitation of diffusion and osmosis mechanism. 
 
Disintegration time 
 
 
According to Ayush guidelines, the disintegration time does not exist more than 
 
45  min.  The  disintegration  time  of  AC  is  25  min.  This  implies  a  reasonable 
disintegration time, thereby a better absorbability and solubility is achieved. 
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Loss on Drying (LOD) 
 
 
It indicates the amount of volatile substance and moisture present in the drug. 
This also indicates the stability and shelf life of the drug. The loss on drying 
percentage of AC is 8.81. 
Being a Chooranam, the moisture content is high. So the stability and shelf life of 
 
AC is about three months. 
 
 
PHYTOCHEMICAL ANALYSIS 
 
 
Table: 8. Results of phytochemical analysis of Ashuwathi chooranam 
 
 
Phytochemicals Test Result 
1. Alkaloids Mayer’s test + 
2. Carbohydrates Molisch’s test + 
3.Glycosides Modified Borntrager’s test + 
4. Tannins Gelatin test + 
5. Phenols Alcoholic Ferric chloride test + 
6. Phytosterols Ferric chloride acetic acid test + 
7. Flavanoids Alkaline reagent test + 
8. Proteins and 
 
Amino Acids 
 
Xanthoproteic test 
 
+ 
 
 
 
 
Interpretation 
 
 
From the above results the following Phytochemicals are present alkaloids, 
carbohydrates, glycosides, Phytosterols, proteins and amino acids. 
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Carbohydrates: 
 
 
Complex carbohydrates coat on the surfaces of cells and have the potential to 
carry the information necessary foe cell-cell recognition. Sugar specific receptors are 
also present on cells, and can interact with sugars on opposing cells which causes 
adhesion of two cells via carbohydrate and is appears to be important in many 
intracellular activities including infection by bacteria and viruses, communication 
among cells of lower eukaryotes, specific binding of sperm to egg; and recirculation 
of lymphocytes, among others. 
 
Phytosterols: 
 
 
Phytosterols are the plant streols are structurally similar to cholesterol that act in 
the intestine to lower cholesterol absorption and their hydrogenated forms, stanols, 
have attracted much attention because of their benefits in reducing LDL cholesterol 
levels,  with  vegetable  oil  processing  being  the  major  source  in  several  food 
products. 
 
Proteins and aminoacids: 
 
 
Lifestyle contributors to disease include not only calorie excess but also the 
dietary intake of specific nutrients. Advanced glycated end-products (AGEs) is a 
class of nutrients incriminated in the pathogenesis of diet-related diseases. Cooking 
or processing at high temperatures such as broiling, grilling, frying and roasting is 
the  major  source  of  AGEs.  The  AGEs  promote  oxidative  stress  and  insulin 
resistance in peripheral tissues. PCOS women have increased serum AGEs levels, 
and these have been positively correlated with serum androgen levels. By activating 
protein kinase C, AGEs may impair insulin action, thereby perpetuating insulin 
resistance in PCOS. 
 
HPTLC (High Performance Thin Layer Chromatography) 
 
 
Sample Name: Ashuwathi  Chooranam 
 
Stationary Phase - Silica Gel 60 F254 
RESULTS AND DISCUSSION 
 
 
 
 
115 OVULATION INDUCING ACTIVITY OF ASHUWATHI CHOORANAM 
 
 
 
 
 
 
 
 
 
 
 
Mobile Phase – Toluene: Ethyl acetate: Acetic acid (5: 1.5: 0.15 v/v/v) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
λ = 254 nm λ  = 366 nm λ  = 575 nm 
(Derivatized) 
Color Rf 
value(s) 
Color Rf 
value(s) 
Color Rf value(s) 
Color Rf 
value(s) 
Color Rf 
value(s) 
Color Rf value(s) 
Grey 0.14 Blue 0.07 Blue 0.24 
Grey 0.22 Red 0.14 Brown 0.36 
Grey 0.27 violet 0.18 Brown 0.39 
Grey 0.34 Blue 0.22 Yello 
w 
0.51 
Bright 
blue 
0.40 yellow 0.25 Brown 0.52 
Grey 0.53 Red 0.29 Black 0.65 
Black 0.60 Red 0.35 Violet 0.75 
Grey 0.70 Blue 0.38 Black 0.89 
Blue 0.72 Green 0.44   
Black 0.77 Blue 0.46   
Black 0.85 Blue 0.57   
Black 0.92 Light 
blue 
0.62   
  Bright 
blue 
0.72   
  Red 0.88   
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HPTLC Chromatogram @ 254 nm: 
 
 
 
 
 
 
 
 
Peak Table @ 254 nm: 
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3D Chromatogram @ 254 nm: 
 
 
 
A qualitative finger printing of Ashuwathi chooranam has been performed by 
HPTLC method, which provides qualitative insights into the bioactive Constituents 
present in the drug. HPTLC shows separation of components present in the 
Chloroform extract of Ashuwathi chooranam. 
 
The present study revealed that Ashuwathi chooranam showed best results in 
Toluene: Ethyl Acetate: Acetic Acid 5: 1.5: 0.15  solvent system. After scanning and 
visualizing the plates in absorbance mode at 254nm, 366 nm and 575 nm and visible 
light range. 
 
TLC plate showed different colour phyto constituents of chloroform extract of 
Ashuwathi chooranam. The bands revealed presence of bright blue, greenish blue, 
violet, and dark pink, showing the presence of steroids, terpenoids, alkaloids, 
flavonoids, tannins, lignans and saponins. 
 
The results from HPTLC finger print scanned at wavelength 366 nm for 
chloroform extract of Ashuwathi chooranam. There are eleven polyvalent 
phytoconstituents and corresponding ascending order of Rf. values start from 0.07 to 
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0.88  in  which  highest  concentrations  of  the  phytoconstituents  was  found  to  be 
 
15.19% and 14.61 % with its corresponding Rf. value were found to be 0.32 and 
 
0.55 respectively. 
 
 
Chemical analysis of Ashuwathi chooranam 
 
 
Table: 9. Results of basic and acidic radical studies 
 
 
Parameter Result 
Test for Calcium +ve 
Test for Potassium +ve 
Test For Magnesium +ve 
Test For Sodium +ve 
Test for Phosphate +ve 
 
 
Results 
 
 
The  result  of  Acidic-Basic  radical  analysis  shows  that  the  trial  drug  has 
 
Sulphate, Chloride, Phosphate, Calcium, Sodium and Potassium. 
 
 
Calcium: 
 
 
Calcium is necessary for the maturation of oocyte as well as in the resumption 
and progression of follicular development, menstrual regularity. Polycystic ovarian 
syndrome  (PCOS)  is  characterized  by the hyperandrogenic chronic  anovulation, 
theca cell hyperplasia, and arrested follicular development. The calcium 
dysregulation  contribute  to  the  development  of  follicular  arrest  in  women  with 
PCOS. 
 
Magnesium: 
 
 
Many women with PCOS are on the birth control pill, which also depletes 
magnesium and have sugar and simple carb carvings. To process excessive sugar in 
our diets requires a great deal of magnesium, and a refined diet that is based mostly 
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on white flour, meat and dairy (all of which have no magnesium). High glucose 
levels make the body flush magnesium from its system. So it must be added by 
eating magnesium rich foods. 
 
Anti- microbial load 
 
The antibacterial and antifungal activity of Ashuwathi Chooranam was tested. 
The maximum inhibition zone was observed for the E.coli, S. typhi and Candida 
albicans 7-9mm at the concentration range of 25-100µg/ml. 
 
Instrumental analysis 
 
Fourier Transform InfraRed spectroscopy (FTIR) 
 
Ashuwathi chooranam 
 
100.0 
 
 
 
 
 
 
 
2657 
1000 
 
 
 
1648 
779 
 
%T                                                                                                                                                                                                                                                                                668 
 
1341 
 
 
1466  
1306 
816 
 
2884 
 
2 
 
 
3380                  2972 
 
1380 
 
 
1161 
1129 
 
 
 
 
952 
 
0. 
000.0           3600             3200             2800             2400             2000             1800             1600             1400             1200             1000              800                600         450.0 
cm-1 
 
 
FTIR ANALYSIS - Ashuwathi chooranam 
 
Test 
 
REF 4000 85 1300 50 700 65 
 
3380 4 2972 3 2932 26 2884 29 2657 74 1648 57.5 1466 39 1380 23 
 
1341 46 1306 37 1161 20 1129 17 1000 83 952 12 816 39 779 63 
 
END: 16 PEAK(S) FOUND 
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Table No. 10. FTIR interpretation 
 
 
Absorbtion peak 
cm-1 
Stretch Functional 
Group 
779 C-Cl Stretch 
C-H “oop” 
Alkyl halides 
Aromatics 
816 C-Cl Stretch 
C-H “oop” 
Alkyl halides 
Aromatics 
952 =C-H bend Alkenes 
1648 N-H bend 1ºamine 
2657 C=N Nitriles 
3380 N-H stretch 1º, 2ºamines, 
amides, alcohol 
 
 
Interpretation 
 
 
The trial drug was subjected to FTIR analysis to know the functional groups of 
the bio molecules, to elucidate the structure and to confirm the active molecules 
responsible  for  the  therapeutic  effect  of  the  drug.  It  helps  to  understand  the 
formation of complexes with the phytoconstituents during the processing of herbal 
medicines. The study revealed the presence of functional groups alkyl halides, 
aromatics, alkenes, 1º amine, nitriles. 
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SCANNING ELECTRON MICROSCOPE (SEM) 
 
 
 
 
 
 
Fig. No. 5 & Fig. No.6:  SEM reveals the nano size (100nm-800nm) particle of 
the sample. 
 
Interpretation: 
 
 
Nano particles are defined as particulate dispersion or solid particles with a size 
in the range of 100-800nm in diameter. 
 
They are easily 
 
 
    Absorbable 
 
    Non-antigenic in nature 
 
    Biodegradable 
 
    Biocompatible 
 
 Selective/Targeted/Controlled delivery of drugs to specific site of action in the 
body even across the blood brain barrier 
 Use  to  extend  time  window  of  bioavailability  and  to  protect  drug  from 
enzymatic and chemical decomposition 
    Result in reduced peripheral side effect of drugs [81]. 
 
 
SEM analysis of the test drug  Ashuwathi chooranam revealed the presence of nano 
particles of size 100-800 nm.  The particles of size nano and near nano size show 
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that the drug may easily enter the cells at the molecular level to treat the disease 
rapidly and increase the therapeutic effect. 
 
Electron Microscopes are scientific instruments that use a beam of highly 
energetic electrons to examine objects on a very fine scale. This examination can 
yield information about the topography (surface features of an object) morphology 
(shape and size of the particles making up the objects) composition (the elements 
and compounds that the object is composed of the relative amounts of them) and 
crystallographic information (how the atoms are arranged in the object). 
Nanoparticles have valuable properties that can be used to improve drug 
delivery. Where larger particles would have been unfurnished from the body, cells 
take   up   these   nanoparticles   because   of   their   size.   Complex   drug   delivery 
mechanisms are being developed, together with the ability to get drugs through cell 
membranes  and  into  cell cytoplasm.  Effectiveness  is  important  because  many 
diseases depend upon processes within the cell and can only be impeded by drugs 
that make their way into the cell. 
 
X-ray Diffraction Method (XRD) 
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Ashuwathi Chooranam 
(wt:0.14715g) 
 
Element symbol 
wavelength (nm) 
Al396.152  
BDL 
As 188.979  
BDL 
Ca 315.807 mg/L  
51.160 
Cd 228.802  
BDL 
Cu 327  
BDL 
Hg 253.652  
BDL 
K766.491 mg/L  
43.114 
Mg285.213 mg/L  
01.334 
Na 589.592  
15.310 
Ni231.604  
BDL 
Pb220.353  
BDL 
P213.617  
224.301 
Zn206.200 mg/L  
01.218 
 
 
 
 
Interpretation 
 
 
The structure, the size and shape of the particles are highly dependent on the route of 
synthesis and high lights the efficacy of the drug. The micro particles may enhance 
bio absorption of the drug. 
 
The major diffraction peaks are identified after XRD analysis of AC concluded that 
range 48-75nm in association with organic molecules probably plays an important 
role in making it biocompatible and nontoxic at therapeutic doses.  Other elements 
present in AC act as additional supplement and possibly helps in increasing the 
efficacy of the formulation. 
 
ICP-OES (Inductively Coupled Plasma Optical Emission Spectrometry) 
Table No. 11. ICP-OES Interpretation 
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Interpretation 
 
 
Potassium 
 
A composition and method for stimulating gonadodtropin hormone production 
and maintaining intracellular mineral balance in the reproductive organs of mammals. 
The composition consists of a mineral mixture containing effective amounts of 
manganese, iron and zinc as amino acid chelates in appropriate ratios. Preferable the 
composition also contains effective amounts of one or more minerals selected from the 
group consisting of copper, magnesium and potassium all of which are present at least 
in part as amino acid chelates or complexes. When magnesium and potassium are 
present at least some of these are present in inorganic form. Vitamins, other minerals 
such as calcium and phosphorus, and fillers may also be utilized. 
 
The composition is orally administered to female mammals to both induce 
estrus and bring about a stronger and more noticeable estrus 
[82]
. 
 
Phosphorus, Calcium and Zinc 
 
Calcium (Ca) plays an important role in gonadotropic regulation of ovarian 
steroidogenesis. Marginal deficiency of phosphorus cause disturbance in the pituitary- 
ovarian-axis including ovulation. Zinc (Zn) deficiency may reduce GnRH secretion that 
eventually leads to arrest of ovulation. It also suggests that Ca is involved in the 
disruption of cumulus cell cohesiveness by regulating the number of gap junctions 
between the cells, which contributes to the process of ovulation 
[83]
. 
 
 
TOXICITY STUDIES 
 
 
Preparation for Acute Toxicity Studies 
 
 
Rats were deprived of food overnight (but not water 16-18 h) prior to administration of 
the, Ashuwathi Chooranam. 
 
The principles of laboratory animal care were followed and the Institutional Animal 
 
Ethical Committee approved the use of the animals and the study design 
 
 
IAEC approved  Number: 1248/AC/09/CPCSEA-9/DEC-2013/12 
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Test Substance                      : Ashuwathi Chooranam 
 
 
Animal Source                      : Kings institute, Chennai. 
 
 
Animals                                 : Wistar Albino Rats (Female-3+3) 
 
 
Age                                         : >6 weeks Body Weight on 
Day 0         :180-300 gm. Acclimatization                     : 
Seven days prior to dosing. 
Veterinary examination       : Prior and at the end of the acclimatization period. 
 
 
Identification of animals      : By cage number, animal number and individual 
marking by using Picric acid. 
 
Numberofanimals                 : 3 Female/group, 
 
 
Routeofadministration         :  Oral 
 
 
Diet                                        :  Pellet  feed  supplied  by  Sai  meera  foods,  Pvt  Ltd, 
Bangalore 
 
Water                                     : Aqua guard portable water in polypropylene bottles. 
 
 
Housing & Environment     : The animals were housed in Polypropylene cages 
provided with bedding of husk. 
 
Housing temperature           : between 22ºC + 3ºC. 
 
 
Relative humidity                 : between 30% and 70%, 
Air changes                           : 10 to 15 per hour and 
Dark and light cycle             : 12:12 hours. 
Duration of the study           : 14 Days 
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Administration of Doses: 
 
 
Ashuwathi Chooranam was suspended in water and administered to the groups 
of wistar albino rats in a single oral dose by gavage using a feeding needle. The 
control group received an equal volume of the vehicle. Animals were fasted 12 
hours prior to dosing. Following the period of fasting, the animals were weighed and 
then the test substance was administered. Three Female animals are used for each 
group. The dose level of 5, 50, 250 and 500 mg/kg body weight was administered 
stepwise. After the substance has been administered, food was withheld for a further 
3-4 hours. The principle of laboratory animal care was followed. Observations were 
made and recorded systematically and continuously as per the guideline after 
substance administration. The visual observations included skin changes, mobility, 
aggressively,  sensitivity  to  sound  and  pain,  as  well  as  respiratory  movements. 
Finally, the number of survivors was noted after 24 hrs and these animals were then 
monitored for a further 14 days and observations made daily. The toxicological 
effect was assessed on the basis of mortality. 
Observations: 
 
Animals are observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during 
the first 4 hours, and daily thereafter, for a total of 14 days, except where they need 
to be removed from the study and humanely killed for animal welfare reasons or are 
found dead. It should be determined by the toxic reactions, time of onset and length 
of recovery period, and may thus be extended when considered necessary. The times 
at which signs of toxicity appear and disappear are important, especially if there is a 
tendency for toxic signs to be delayed. All observations are systematically recorded 
with individual records being maintained for each animal. 
 
 
Observations include changes in skin and fur, eyes and mucous membranes, and 
also respiratory, circulatory, autonomic and central nervous systems, and 
somatomotor activity and behavior pattern. Attention was directed to observations of 
tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma. The principles 
and criteria summarized in the Humane Endpoints Guidance Document taken into 
consideration. Animals found in a moribund condition and animals showing severe 
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pain or enduring signs of severe distress was humanly killed. When animals are 
killed for human reasons or found dead, the time of death was recorded. 
 
 
Acute oral toxicity study of Ashuwathi Chooranam 
 
 
Table 12: Dose finding experiment and its behavioural Signs of acute oral Toxicity 
 
 
SL CONTROL Observation SL TEST GROUP Observation 
1 Body weight Normal 1 Body weight Normally 
increased 
2 Assessments of 
posture 
Normal 2 Assessments of 
posture 
Normal 
3 Signs of 
Convulsion 
Limb paralysis 
Normal 3 Signs of 
Convulsion 
Limb paralysis 
Absence of sign 
(-) 
4 Body tone Normal 4 Body tone Normal 
5 Lacrimation Normal 5 Lacrimation Absence 
6 Salivation Normal 6 Salivation Absence 
7 Change in skin 
color 
No significant 
color change 
7 Change in skin 
color 
No significant 
color change 
8 Piloerection Normal 8 Piloerection Normal 
9 Defecation Normal 9 Defecation Normal 
10 Sensitivity 
response 
Normal 10 Sensitivity 
response 
Normal 
11 Locomotion Normal 11 Locomotion Normal 
12 Muscle gripness Normal 12 Muscle gripness Normal 
13 Rearing Mild 13 Rearing Mild 
14 Urination Normal 14 Urination Normal 
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Behaviour: 
 
The animals will be observed closely for behaviour in the first four hours which 
includes abnormal gait, aggressiveness, exophthalmos, ptosis, akinesia, catalepsy, 
convolusion, excitation, head twitches, lacrimation, loss of corneal reflex, loss of 
traction, piloerection  reactivity of touch, salivation, scratching, sedation, chewing, 
head movements, sniffing, straub, tremor and writhes, diarrhoea, leathery, sleep and 
coma. 
 
Body Weight: 
 
 
Individual weight of animals was determined before the test substance was 
administered and weights will be recorded at day 1, 7, and 14 of the study. Weight 
changes were calculated and recorded. At the end of the test, surviving animals were 
weighed and humanly killed. 
 
Food and water Consumption: 
 
 
Food and water consumed per animal was calculated for control and the treated 
dose groups. 
 
Mortality: 
 
Animals were observed for mortality throughout the entire period. 
 
 
Results: 
 
All data were summarized in tabular form, (Table-1-4) showing for each test 
group  the  number  of  animals  used,  the  number  of  animals  displaying  signs  of 
toxicity, the number of animals found dead during the test ,description of toxic 
symptoms,, weight changes, food and water intake. 
No of animals in each group: 3 
 
Table No.13. Observational study Results 
 
 
No Dose 
mg/kg 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
11 
 
12 
 
13 
 
14 
 
15 
 
16 
 
17 
 
18 
 
19 
 
20 
1. Control + - - + - + - - - - - - - - - - - - - - 
 
2. 
500 
mg/kg 
 
+ 
 
- 
 
- 
 
+ 
 
- 
 
+ 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
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1..Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch 
Response  7.  Decreased  Motor  Activity  8.  Tremors  9.  Convulsions  10.  Muscle 
Spasm   11.   Catatonia   12.   Muscle   relaxant   13.   Hypnosis   14.   Analgesia 
15.Lacrimation 16. Exophthalmos 17. Diarrhea 18. Writhing 19. Respiration 20. 
 
Mortality. 
 
(+ Present, -  Absent) 
 
 
Table No. 14. Body weight Observation 
 
 
 
DOSE DAYS 
1 7 14 
CONTROL 186.6± 2.75 189.2± 3.87 194.2 ± 7.62 
500 mg/kg 182.5± 4.08 184.2± 2.16 187.4 ± 2.67 
 
 
N.S- Not Significant, **(p > 0.01),  *(p >0.05), n = 10 values 
 
are mean ± S.D (One way ANOVA followed by Dunnett’s test) 
 
 
 
Table No. 15. Water intake (ml/day) of Wistar albino rats group exposed to 
 
(Ashuwathi Chooranam): 
 
 
 
DOSE DAYS 
1 6 14 
CONTROL 28.5 ± 2.74 30.0± 9.13 32.4± 3.13 
500 mg/kg 30.4±2.33 36.6±1.11 38.9± 2.19 
 
 
N.S- Not Significant, **(p > 0.01),  *(p >0.05), n = 10 values are mean ± S.D 
 
(One way ANOVA followed by Dunnett’s test) 
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Table No. 16. Food intake (gm/day) of Wistar albino rats group exposed to 
Ashuwathi Chooranam 
 
 
 
DOSE DAYS 
1 7 14 
CONTROL 23.56±3.36 28.60±2.42 31.61±5.46 
500 mg/kg 22.42±1.64 29.31±1.22 32.22±3.24 
 
 
N.S- Not Significant, **(p > 0.01),  *(p >0.05), n = 10 values are mean ± S.D 
 
(One way ANOVA followed by Dunnett’s test) 
 
 
 
Subacute Oral Toxicity Study Of Ashuwathi Chooranam 
 
28-Days Repeated Dose Oral Toxicity Study Of Ashuwathi Chooranam 
 
 
Test Substance                 : Ashuwathi Chooranam 
 
 
Animal Source                 : King institute, Chennai. 
 
 
Animals                             : Wistar Albino Rats (Male -24, and Female-24) 
 
 
Age                                    : >6 weeks Body Weight                     
: 180-300 gm. Acclimatization                : Seven 
days prior to dose. 
Veterinary examination  : Prior and at the end of the acclimatization period. 
 
 
Identification of animals : By cage number, animal number   and    individual 
marking by using Picric acid 
Diet                                      :  Pellet  feed  supplied  by  Saimeera  foods  Pvt  Ltd, 
Bangalore 
Water                                 : Aqua guard portable water in polypropylene bottles. 
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Housing & Environment  : The animals were housed in Polypropylene cages 
provided with bedding of husk. 
Housing temperature      : between 22ºC ±3ºC. 
Relative humidity            : between 30% and 70%, 
Air changes                      : 10 to 15 per hour 
Dark and light cycle        : 12:12 hours. 
 
 
Duration of the study      : 28 Days. 
 
 
 
 
Groups No of Rats 
Group I Vehicle control 12(6male,6 female) 
Group II Ashuwathi Chooranam 50 mg/kg 12 (6male,6 female) 
Group   III  Ashuwathi   Chooranam   250 
 
mg/kg 
 
12 (6male,6female) 
Group  IV  Ashuwathi  Chooranam  500 
 
mg/kg 
 
12(6male,6female) 
 
 
Methodology 
 
 
Randomization, Numbering and Grouping of Animals: 
 
 
48 Wistar Albino Rats (24M + 24F) were selected and divided into 4 groups. 
Each group consists of 12 animals (Male -6, and Female-6). First group treated as a 
control and other three groups were treated with test drug (low, mid, high) for 28 
days.  Animals  were  allowed  acclimatization  period  of  7  days  to  laboratory 
conditions prior to the initiation of treatment. Each animal was marked with picric 
acid. The females were nulliparous and non-pregnant. 
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Justification for Dose Selection: 
 
 
As per OECD guideline three dose levels were selected for the study. They are 
low dose (50 mg/kg), mid dose (250 mg/kg), high dose (500 mg/kg). X is calculated 
by multiplying the therapeutic dose of human (3000mg/kg) and the body surface 
area of the rat (0.018). i.e., X dose is 50 mg/kg/animal, 5X mid dose is 250 mg/kg, 
10 X high dose is 500 mg/kg. 
 
 
Preparation and Administration of Dose: 
 
 
Ashuwathi Chooranam suspended in with water, it was administered to animals 
at the dose levels of 50, 250 and 500 mg/kg. The test substance suspensions were 
freshly prepared every two days once for 28 days. The control animals were 
administered vehicle only. The drug was administered orally by using oral gavage 
once daily for 28 consecutive days. 
 
Observations: 
 
 
Experimental animals were kept under observation throughout the course of 
study for the following: 
 
Body Weight: 
 
 
Weight of each rat was recorded on day 0, at weekly intervals throughout the course 
of study. 
 
Food and water Consumption: 
 
 
Food and water consumed per animal was calculated for control and the treated dose 
groups. 
 
Clinical signs: 
 
 
All animals were observed daily for clinical signs. The time of onset, intensity and 
duration of these symptoms, if any, were recorded. 
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Mortality: 
 
 
All animals were observed twice daily for mortality during entire course of study. 
 
 
Necropsy: 
 
 
All the animals were sacrificed by excessive anesthesia on day 29. Necropsy of all 
animals was carried out. 
 
Laboratory Investigations: 
 
 
Following laboratory investigations were carried out on day 29 in animal’s fasted 
over-night. Blood samples were collected from orbital sinus using sodium heparin 
(200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for Hematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. 
 
Hematological Investigations: 
 
 
Hematological parameters were determined using Haematology analyzer. 
 
 
Biochemical Investigations: 
 
 
Biochemical parameters were determined using auto-analyzer. 
 
 
 
Histopathology: 
 
 
Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose group 
than the low,  then the  mid  dose group  will  also  be examined.  Organs  will  be 
collected from all animals and preserved in 10% buffered neutral formalin for 24 h 
and washed in running water for 24 h.  The organ sliced 5 or 6µm sections and were 
dehydrated in an auto technicon and then cleared in benzene to remove absolute 
alcohol. Embedding was done by passing the cleared samples through three cups 
containing molten paraffin at 50°C and then in a cubical block of paraffin made by 
the “L” moulds. It was followed by microtome and the slides were stained with 
Haematoxylin-eosin red. 
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Statistical analysis: 
 
 
Findings   such   as   body   weight   changes,   water   and   food   consumption, 
hematology and blood chemistry were subjected to One-way ANOVA followed by 
dunnett’s test using a computer software programme – Graph pad version 5.0. All 
data were summarized in tabular form. 
 
 
Table: 17. Body weight of Wistar albino rats group exposed to Ashuwathi 
 
Chooranam 
 
Dose DAYS 
1 7 14 21 28 
Control 165.6± 2.76 166.4 ± 3.42 167.7 ± 3.26 169.2 ± 3.73 170.7 ± 1.31 
Low Dose 170.2 ± 2.12 172.7 ± 3.64 174.4± 1.51 175.2 ± 1.66 176.42± 2.76 
Mid Dose 176.6± 1.64 177.3 ± 2.74 179.4 ± 8.12 182.1 ± 3.36 183.7 ± 3.12 
High Dose 187.4± 6.74 189.6 ± 3.72 192.6 ± 2.46 187 ± 6.81 191.92 ± 2.49 
 
NS- Not Significant, ** (p > 0.01),*(p >0.05), n = 10 values are mean ± S.D (One way 
 
ANOVA followed by Dunnett’s test) 
 
 
 
Table: 18.  Water intake (ml/day) of Wistar albino rats group exposed to Ashuwathi 
 
Chooranam 
 
Dose DAYS 
1 6 14 21 28 
Control 31.5 ± 8.95 32.0 ±6.23 28.5±6.23 29.12±8.19 31.5±3.96 
Low Dose 28.5±3.31 26.4±3.62 26.7±3.02 22.2±3.29 34.9±3.13 
Mid Dose 26.7±4.33 26.3±2.11 27.1±2.43 28.4±2.11 32.4±2.34 
High Dose 30.1±1.32 30.2±2.13 32.7±2.13 35.2±1.73 38.4±2.65 
N.S- Not Significant, ** (p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One way 
 
ANOVA followed by Dunnett’s test) 
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Table: 19.  Food intake (gm/day) of Wistar albino rats group exposed to 
 
Ashuwathi Chooranam 
 
Dose Days 
2 7 23 22 28 
Control 37.12 ±5.37 38.5±3.22 39.5±3.37 38.5±3.37 37.12±3.12 
Low Dose 43.7±2.98 45.3±1.22 45.1±1.18 45.4±2.12 45.6±2.42 
Mid Dose 47.2±3.75 47.2±3.60 47.2±4.25 47.4±2.68 49.2±2.44 
High Dose 46.2±2.34 46.2±2.64 49.6±2.66 48.2±3.20 48.0±3.62 
 
 
N.S- Not Significant, ** (p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One 
 
way ANOVA followed by Dunnett’s test 
 
 
 
Table: 20. Haematological parameters of Wistar albino rats group exposed to 
 
Ashuwathi Chooranam 
 
Category Control Low dose Mid dose High dose 
Haemoglobin(g/dl) 14.8±1.88 13.88±1.66 14.94±0.66 15.28±0.96 
Total WBC (×10
3
) 10.91±2.59 11.25±3.73 11.48±3.91 12.20±3.17 
Neutrophils(%) 32.65±1.06 33.23±2.14 35.61±1.36 35.40±2.20 
lymphocyte (%) 69.34±2.48 72.12±3.12 72.48±2.66 73.10±3.16 
Monocyte (%) 0.78±0.17 0.79±0.09 0.82±0.03 0.84±0.06 
Eosinohil(%) 0.64±0.09 0.68±0.02 0.70±0.06 0.72±0.04 
Platelets cells 
10
3
/µl 
687.17±8.76 702.71±8.16 725.18±9.0 726.16±9.74 
Total RBC 10
6
/µl 7.99±0.12 7.82±0.57 8.82±0.59 8.38±0.72 
PCV% 37.79±0.6 43.35±1.13 45.2±1.68 46.82±2.54 
MCHC g/dL 33.6±2.23 35.09±1.29 35.98±1.22 36.03±1.24 
MCV fL(µm
3
) 49.17±3.64 50.20±1.22 52.28±1.24 53.24±1.44 
 
 
N.S- Not Significant, ** (p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
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Table: 21. Biochemical Parameters of Wistar albino rats group exposed to 
 
Ashuwathi Chooranam 
 
Biochemical 
 
Parameters 
 
Control 
Low 
 
Dose 
Mid 
 
Dose 
High 
 
Dose 
 
High Dose 
Glucose (R) 
 
mg/dl 
 
76.45±13.4 
 
78.16±8.44 
 
78.26±11.20 
 
78.42±11.6 
 
78.42±11.6 
Total 
 
Cholesterol 
 
(mg/dl) 
 
 
115.26±1.83 
 
 
115.45±1.83 
 
 
116.42±1.78 
 
 
116.22±1.73 
 
 
116.22±1.73 
Triglycerideds 
 
(mg/dl) 
 
46.35±1.48 
 
46.32±1.48 
 
44.58±1.30 
 
45.66±1.33* 
 
45.66±1.33* 
LDL 72.81±2.13 71.24±2.14 72.8±2.14 71.64±4.32 71.64±4.32 
VLDL 15.2±2.44 15.42±4.64 15.44±6.64 15.64±4.36 15.64±4.36 
HDL 26.66±6.88 26.86±2.24 26.68±4.66 31.78±2.22 31.78±2.22 
T.Chol/HDL 4.42±2.44 4.16±3.14 4.34±8.44 4.46±2.22 4.46±2.22 
LDL/HDL 2.83±4.22 2.84±2.22 2.86±2.20 2.96±6.02 2.96±6.02 
Albumin(g/dl) 3.63±0.17 3.43±0.12 3.14±2.02 3.24±6.86 3.24±6.86 
 
NS- Not Significant, ** (p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
 
 
Table:  22.  Renal  function  test  of  of  Wistar  albino  rats  group  exposed  to 
Ashuwathi Chooranam 
 
 
 
PARAMETERS 
 
CONTROL 
LOW 
DOSE 
MID 
DOSE 
HIGH 
DOSE 
UREA (mg/dl) 13.35±0.99 14.31±0.16 13.06±1.08 13.48±1.12 
CREATININE(mg/dl) 0.28±0.08 0.36±0.06 0.52±0.04 0.66±0.02 
BUN(mg/dL) 15.02±0.10 16.10±0.60 16.22±0.44 18.10±2.12 
URIC ACID(mg/dl) 5.17±0.35 5.31±0.43 5.42±1.25 5.58±0.23 
 
NS- Not Significant, ** (p > 0.01), * (p >0.05) , n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
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Table: 23. Liver Function Test of of Wistar albino rats group exposed to 
 
Ashuwathi Chooranam 
 
 
 
PARAMETERS CONTROL LOW DOSE MID DOSE 
 
T.Biliribin(mg/dl) 
 
0.48±0.07 
 
0.53±0.06 
 
0.51±0.08 
 
SGOT/AST(U/L) 
 
79.95±1.39 
 
78.35±0.51 
 
76.01±1.53 
 
SGPT/ALT(U/L) 
 
31.23±1.28 
 
30.91±1.59 
 
28.34±1.48 
 
ALP(U/L) 
 
143.25±8.70 
 
142±16.17 
 
145.16±24.07 
 
T.PROTEIN(g/dL) 
 
5.32±0.38 
 
6.48±0.34 
 
7.01±0.23 
 
 
NS- Not Significant, ** (p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One 
 
way ANOVA followed by Dunnett’s test) 
 
 
PHARMACOLOGICAL STUDIES 
 
The study tried to evaluate the effect of this exercise type on reproductive 
dysfunction in rats with polycystic ovarian syndrome. 
 
Experimental design:  Female white albino rats were allocated into three groups: 
 
 
Group I: Control rats; Group II: Letrozole induced polycystic ovarian syndrome rats 
(PCO) where letrozole was given orally and daily in a dose of 1 mg/kg dissolved 
in  0.9%  NaCl  solution  for  21  days; Group  III: Clomiphene received group. IV. 
Polycystic ovarian  syndrome rats subjected to Ashuwathi  chooranam  (100mg) 
V.  Polycystic   ovarian   syndrome   rats   subjected   to   Ashuwathi   chooranam 
(200mg) orally for three weeks after the induction of polycystic ovarian syndrome. 
After 6 weeks from the beginning of the study, final body weight, body mass and 
Lee  indices  were  determined.  Plasma  levels  of  LH,  free testosterone,  estradiol, 
progesterone, prolactin, fasting glucose and fasting insulin were measured 
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Fig. No.7: Effect on Ovarian structure in letrozole induced PCOS rat model. 
Development of PCOS in Rat Model 
Rats treated with letrozole for induction of PCOS showed a significant 
increase  in body weight and altered estrus cyclicity as compared to control.  As 
shown in Figure .3.  PCO animals exhibited an increase in body weight and glucose 
tolerance as compared to control and histology of ovary revealed many peripheral 
small atretic cysts Figure 2. Whereas no histological abnormalities were observed in 
control rat. 
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Fig. No.8. Body weight of letrozole induced PCOS in wistar albino rats 
 
 
 
The results from the above experiments clearly demonstrate that Letrozole 
induced PCOS rats exhibited all the pathological characteristics similar to the 
clinical manifestations found in PCOS women. The main  aim of the  current 
chapter was to evaluate the efficacy of Ashuwathi chooranam in PCOS rodent 
model. Hence, dose and time dependent experiments were directed towards the 
understanding   the   most   effective   dose   and   minimum   time   required   for 
management of PCOS phenotype. 
 
 
Body weight 
 
Obesity is a major feature in women with polycystic ovary syndrome (PCOS), 
and  evidence  suggests  that  obesity   contributes  to  the  pathogenesis  of  PCOS 
(Nestler 2000). Generally, excess abdominal adipose tissue (AT) initiates metabolic 
and endocrine aberrations that are central in the progression of PCOS 
[84]
. PCOS rat 
model exhibited significant increase in body weight with abdominal fat as compared 
to normal rats. However, after treatment with Ashuwathi chooranam, body weight 
reduction was not seen. 
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Fig. No. 9. Dose and time dependent effect of Ashuwathi Chooranam 
on Body weight 
 
 
 
ORAL GLUCOSE TOLERANCE TEST (OGTT) 
 
 
Women with polycystic ovarian syndrome (PCOS) are at increased risk for 
developing glucose intolerance leading to type 2 diabetes mellitus (DM) (Salley et 
al. 2007). Hence, it was necessary to evaluate the efficacy of Ashuwathi chooranam 
on  glucose  homeostasis.     Thereby,  Oral  glucose  tolerance  test  (OGTT)  was 
performed in all groups of animals. PCOS rats exhibited high glucose tolerance 
compared to normal control rats (**p<0.01, ***p<0.001) at all the time points of 
OGTT profile. Ashuwathi chooranam treated PCOS rats in different doses (100mg, 
200mg)  demonstrated  significantly  reduced  glucose  intolerance  and  improved 
cellular glucose uptake upon increasing time period of dose (30 days) of OGTT 
profile. 
Glucose homeostasis is governed by insulin action. Thereby, we measured serum 
insulin level in all group of animals wherein serum insulin levels of untreated PCOS 
rats were increased signiﬁcantly (***p<0.001). Treatment of AC caused a decrease 
in insulin level as compared to PCOS group (p<0.001). 
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Dose and time dependent effect of Ashuwathi chooranam on Oral Glucose 
 
Tolerance Test (OGTT Test) 
 
 
 
Fig. No.10. Effect of Ashuwathi Chooranam on OGTT Test. 
Table No. 25. Ashuwathi chooranam on Insulin status 
 
 
 
 
 
 
 
 
 
 
 
N= 6 per group, All values are represented as Mean + SEM. 
+
p<0.05; 
++
p<0.01as compared to 
PCOS group. Normal insulin resistance:  < 3; Moderate Insulin resistance: Between 3 – 5; 
Severe Insulin resistance: > 5 
 
Estrus Cyclicity 
 
The primary clinical manifestations of polycystic ovary syndrome (PCOS) 
are irregular  menstrual  cycle  and  chronic  anovulation,  which  is  found  to  be 
associated with approximately 80% of PCOS women 
[85]
. Hence, estrus cyclicity in 
PCOS rats was monitored, wherein PCOS rats exhibited arrested estrus cyclicity 
in late diestrus phase of cycle as compared to control rats. After treatment of AC at 
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various doses (100mg) and various time periods of (30 days), estrus cyclicity was 
evaluated wherein 100mg for 30 days treated group of  animals exhibited  reversion 
to   normal  cycle  in   80%   of   PCOS   rats.    But   upon  increasing  the  doses  of 
Ashuwathi chooranam (200mg) all rats showed improved cyclicity and  reverted 
b a c k to normal cycle. 
 
Ovarian Histological study 
 
Normal ovarian function relies upon the selection of a follicle that become 
dominant with appropriate signal  FSH and  ovulates  with the help of LH surge 
during ovulation. This mechanism is disturbed in women with PCOS, resulting in 
multiple small cysts (or   follicles), most of which contain potentially viable oocytes 
but  within  dysfunctional  follicles  
[86]
.  PCOS  rat  model  in  current  study  also 
 
demonstrated peripheral empty follicular cysts as compared to control ovary with 
normal  growing  follicles.  In  dose  dependent  study,  100  mg  dose/30  days  of 
treatment exhibited normal growing follicles but some cysts were present in ovary. 
Ashuwathi chooranam at higher doses (100 mg and 200 mg) at 30 days of treatment, 
number of peripheral cysts significantly decreased and increased normal growing 
follicles with presence of corpus luteum was present; indicating normal ovulation 
due to functional ovary. 
 
 
4.4. Interpretation 
 
 
PCOS has many clinical manifestations, which includes oligomennorhea and 
hyper- androgenism, leading to metabolic dysfunction (Dickerson et al. 2010). Rat 
model created using letrozole exhibited an increase in ovarian androgens and thus 
leading to hyperandrogenism, which is a hallmark of PCOS. Also, significant weight 
gain was observed in letrozole treated PCO as compared to control rats, which could 
be attributed to deposition of abdominal fat 
[ 8 7 ] 
. The model created show similar 
characteristics of PCOS shown by 
[88] 
.   It has been well documented that PCOS is 
 
positively correlated with insulin resistance 
[85]
. Apart from, systemic level changes, 
ovarian steroidogenesis were also altered leading to high testosterone level in PCO 
phenotype 
[88]  
which could be correlated to ovarian structural changes as seen in 
present     study   
[85]
.     Thereby,     letrozole     induced     PCOS     rat     model 
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demonstrated increased body weight, arrested cyclicity and impaired glucose 
intolerance with hyperandrogenim that are key features of PCOS phenotype. 
Aim  of current  chapter was  to  understand the dose and  time required  by 
Ashuwathi chooranam for  the  management  of  PCOS  condition. Thereby, future 
studies were directed to evaluate minimum effective dose and time period for 30 
days Ashuwathi chooranam treatment which would manage PCOS phenotype and 
restore normal ovarian function. 
Thereby, experiments were carried out with various doses (100mg, 200mg,) at 
different time points (30 days) with Ashuwathi chooranam formulation. 
Dose and time dependent effect demonstrated that treatment irrespective of 
time and dose could cause Dose and time dependent effect demonstrated that 
treatment irrespective of time and dose could cause a reversion to normo-glycemic 
condition   from   hyperglycemic   condition   as   observed   in   PCO   phenotype. 
Ashuwathi  chooranam  (AC)  formulation  treatment  with  higher  dose  (100mg, 
200mg) for short period time (30 days of treatment). This could be attributed to the 
nutritionally rich phytosterols and phyto-phenols present in the plant 
[89]
, that helps 
to recover the syndrome and could be able to sensitize the insulin receptors for the 
glucose uptake. Also, it should be noted that Ashuwathi chooranam is rich in fibers 
that could increase transit time for diet to be get absorbed which could modulate 
glucose homeostasis in PCO phenotype. 
In this study, PCO rats demonstrated the formation of empty cysts with 
follicular fluid which  is  similar  to  ovarian  structural changes that  was  reported 
by  
[88]
.  PCOS  rats  treated  with  fresh  AC  and  formulation  exhibited  normal 
follicular growth which was evident  from normal estrus cyclicity as seen in higher 
doses (100mg, 200 mg) rats also exhibited reversion in ovarian structure. However, 
it should consider that with increasing dose, phyto-components content is increased. 
These phyto-components present in AC could be active components which would 
alter the steroidogenesis and expression of steroidogenic protein, which alters the 
PCO condition 
[90]
. However, at 30 days of treatment caused significant change with 
lower dose (100mg). The  reversion  of  estrus  cyclicity  upon  extracts  treatment 
could  be  attributed  to phytochemical components present in the AC that maintains 
steroid status, regaining back the fertility status. 
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The results of ovulation effect revealed the significant influence at the dose 
level of 25mg/kg and this marked effect was ensured with the histological evaluation 
of uterus of experimental rats also. Hence it may be concluded that the Ashuwathi 
Chooranam is an excellent traditional medicine in the treatment for anovulatory 
conditions like PCOS and the effect may be attributed to the elevation of the 
ovulation stimulatory hormones in animal models. 
Table: 26. Effect of Ashuwathi Chooranam on weight of uterus and ovary after 10 
days treatment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N = 6. Values are expressed as Mean ± SEM. 
ns
P>0.0, *p<0.05;**p<0.01;p***<0.001 
 
When compared to normal control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. No.11:  Effect of AC on weight of Uterus and ovary 
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Experimental design 
 
 
    Group  I  Normal  Control  animals  1ml/kg  of  CMC  (Carboxymethyl 
 
Cellulose) solution. 
 
 
    Group II rats were administered Ashuwathi Chooranam 100mg/kg for 
 
10days, 
 
 
    Group III rats were administered Ashuwathi Chooranam 200mg/kg for 
 
10 days 
 
 
    Group IV received Clomiphene 10mg/kg and served as standard. All the 
drugs were given orally. 
 
After that 2ml of blood was collected by retro orbital puncture. Blood samples were 
centrifuged for 15 minutes at 4000 rpm and the separated serum samples were frozen at - 
20°C and kept for later estimation of LH, FSH and Estradiol by ELISA method. 
 
 
4.4.2 Hormonal assay 
 
Biochemical assay 
 
 
The method employed was Micro well Enzyme Linked Immunosorbent Assay (ELISA) 
 
using analytical grade reagents. 
 
 
Estimation of serum luteinizing hormone (LH) 
 
 
The method employed was Micro well immunoassay (ELISA) using analytical 
grade reagents. 0.050ml of the serum was pipetted into the assigned wells. 0.001ml 
of LH-Enzyme reagent was added to all the wells. The microplate was swirled for 
20-30 seconds and covered with this mixture was allowed to incubate for 60 minutes 
at room temperature. After which, the contents were discarded by decantation. 350µl 
of wash buffer was added and decanted for 3 times. 100µl of working substrate 
solution was added to all the wells and was allowed to incubate for fifteen minutes. 
50µl of stop solution was added to all the wells and gently mixed for 20 seconds. 
The optical density was read at 450nm in a microplate reader within 30mins. The 
mean absorbance values for each set of standards, controls, and test samples were 
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calculated and a standard curve was constructed by plotting a mean absorbance 
obtained from each of the reference standard against its concentration from the 
standard curve. 
 
Estimation of serum follicle stimulating hormone (FSH) 
 
 
The method employed was Microwell immunoassay (ELISA) using analytical 
grade reagents. 0.050ml of the serum was pipetted into the assigned wells. 0.001ml 
of FSH-Enzyme reagent was added to all the wells. The microplate was swirled for 
20-30 seconds and covered this mixture was allowed to incubate for 60 minutes at 
room temperature. After which, the contents were discarded by decantation. 350µl 
of wash buffer was added and decanted for 3 times. 100µl of working substrate 
solution was added to all the wells and was allowed to incubate for fifteen minutes. 
50µl of stop solution was added to all the wells and gently mixed for 20 seconds. 
The optical density was read at 450nm in a microplate reader within 30mins.The 
mean absorbance values for each set of standards, controls, and test samples were 
calculated and a standard curve was constructed by plotting a mean absorbance 
obtained from each of the reference standard against its concentration from the 
standard curve. 
 
Determination of serum progesterone levels 
 
The method employed was Microwell immunoassay (ELISA) using analytical 
grade reagents. 0.025ml of the serum was pipetted into the assigned wells. 0.050ml 
of progesterone Enzyme reagent was added to all the wells. The microplate was 
swirled for 20 seconds to mix, 0.050ml progesterone biotin reagent was added to all 
the wells, the mixture was swirled for 20 seconds to mix and covered, this mixture 
was allowed to incubate for 60 minutes  at room temperature.  After which, the 
contents were discarded by decantation. 350µl of wash buffer was added and 
decanted for 3 times. 100µl of working substrate solution was added to all the wells 
and was allowed to incubate for twenty minutes. 50µl of stop solution was added to 
all the wells and gently mixed for 20 seconds. The optical density was read at 
450nm in a microplate reader within 30mins. The mean absorbance values for each 
set of standards, controls, and test samples were calculated and a standard curve was 
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constructed by plotting a mean absorbance obtained from each of the reference 
standard against its concentration from the standard curve. 
 
Determination of serum Estradiol levels 
 
 
The method employed was Microwell immunoassay (ELISA) using analytical 
grade reagents. 0.025ml of the serum reference was pipetted into the assigned wells. 
0.050ml of Estradiol Biotin reagent was added to all the wells. The microplate was 
swirled for 20 seconds to mix, the mixture was incubated at room temperature for 
30mins,0.050ml Estradiol enzyme reagent was added to all the wells , the mixture 
was swirled for 20 seconds to mix and covered, this mixture was allowed to incubate 
for 90 minutes at room temperature. 350µl of wash buffer was added and decanted 
for 3 times. 100µl of working substrate solution was added to all the wells and was 
allowed to incubate for twenty minutes. 50µl of stop solution was added to all the 
wells and gently mixed for 20 seconds. The optical density was read at 450nm in a 
microplate reader within 30mins. The mean absorbance values for each set of 
standards, controls, and  test samples were calculated and a standard curve was 
constructed by plotting a mean absorbance obtained from  each of the reference 
standard against its concentration from the standard curve. 
 
Table No. 27. Effect  of Ashuwathi Chooranam  on  Serum Concentration of 
reproductive hormones of female Wistar albino rat 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N  =  6.  Values  are  expressed  as  Mean±SEM.  *p<0.05;**p<0.01;  
+
p<0.05; 
 
++
p<0.01as compared to PCOS group. 
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Fig No. 12: Effect of Ashuwathi Chooranam on Serum Estrdiol and 
Progesterone in rats 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. No. 13: Effect of Ashuwathi Chooranam on Serum LH and FSH in rats 
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Fig. No. 14: Effect of Ashuwathi Chooranam on Serum Testosterone in rats 
 
 
 
ANTIOXIDANT ASSAY: 
DPPH ASSAY: 
[91]
 
DPPH(1,1-diphenyl-2-picrylhydrazyl)is characterised as a stable free radical 
 
by virtue of the delocalisation of the spare electron over the molecule as a whole, so 
that the molecules do not dimerise, as would be the case with most fo the free 
radicals. The delocalisational so gives rise to the deep violet colour, characterised by 
an absorption band in ethanol solution centered at about 520nm. When a solution of 
DPPH is mixed with that of a substance that can donate a hydrogen atom, then this 
gives rise to the reduced form 
[92] 
with the loss of this violet colour (although there 
 
would be expected to be a residual pale yellow colour from the picryl group still 
present). 
 
Representing the DPPH radical by Z• and the donor molecule by AH, the 
primary reaction is 
 
Z•+AH=ZH+A• 
 
 
Where ZH is the reduced form and A• is free radical produced in this first step. 
This latter radical will then undergo further reactions which control the overall 
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stoichiometry, that is, the number of molecules of DPPH reduced (decolourised) by 
one molecule of the reductant. 
 
 
Chemicals 
 
 
1.   1, 1 – diphenyl-2-picrylhydrazyl (DPPH) 
 
2.   Dimethylsilphoxide (DMSO) 
 
3.    BHT (standard)-1.6mg/ml in methanol 
 
4.   Samples desired concentration from 1 mg/ml–max of 5mg/ ml (in /DMSO) 
 
 
Procedure: 
 
Aliquot 3.7ml of absolute methanol in all test tubes and 3.8ml of absolute 
methanol was added to blank. 
 
Add 100µl of BHT to tube marked as standard 100µl of respective samples to 
all other tubes marked as tests. 200µl of DPPH reagent was added to all the test 
tubes including blank. Incubate all test tubes at room temperature in dark condition 
for 30minutes.The absorbance of all samples was read at 517nm. 
 
Table: 28. Procedure for DPPH Assay 
 
 
 
S.NO REAGENTS BLAN 
K 
STANDARD TEST 
1 Methanol 3.8ml 3.7ml 3.7ml 
2 BHT - 100µl - 
3 Sample - - 100µl 
4 DPPH 200µl 200µl 200µl 
Incubation at dark for30minutes 
O.D at 517 nm 
 
 
Calculation: 
 
 
 
 
 
% Antioxidant activity  =    100X 
(Absorbance at blank) - (Absorbance at test) 
(Absorbance at blank) 
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Table: 29. Antioxidant activity. 
 
 
Sample 
concentration 
(µg/ml) 
Absorbance  
Percentage of Inhibition 
Drug Standard Drug Standard 
Control 0.5461 0.324 - - 
1.25 0.4742 0.262 13.1661 19.14 
2.50 0.3863 0.198 29.2621 38.89 
5 0.2545 0.113 53.3969* 65.15 
10 0.1912 0.084 64.9881 74.08 
20 0.1001 0.041 81.6701 87.35 
 
*µg/ml: microgram per millilitre. Drug:   AC (1.25-20µg/µl). Standard: Ascorbic acid 
(10mg/ml DMSO) 
 
 
 
/  
 
Fig No. 15: DPPH ASSAY 
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6. CONCLUSION 
 
The present dissertation is to validate the safety and efficacy of the Siddha poly-
herbal formulation Ashuwathi chooranam for its naturally curing polycystic ovarian 
syndrome (Soothaga vaayu) in female Wistar albino rat based on the classical Siddha 
literature “Agathiyar vathiyta kaaviyam 1500”. 
The ingredients of the test drug are Amukkura (Withania somnifera),Chukku 
(Zingiber officinale (dried ginger), Milagu Piper nigram, Thippili (Piper longum), 
Jaadhikaai (Myristica fragrans), Jaadhipathiri (Myristica fragrans), Adhimadhuram 
(Glycirriza glabra), Krambu (Syzygium aromaticum), Kadugurohini (Picrorhiza 
scrophulariiflora), Krosaniomam,(Hyoscymus niger). The drugs were identified and 
authenticated by the experts of Gunapadam (Pharmacology), Government Siddha 
Medical College.   
The drugs were purified and processed as per literature. The fine particles in it 
enhance the curative potential with shelf life of three months.  
The trial drug Ashuwathi chooranam is indicated for Soothaga vayu, which is 
related to the modern terminology PCOS. To validate the traditional usage, the drug was 
subjected to literary review, Physico-chemical and elemental analysis, Acute and Sub-
acute toxicity study, Anti-microbial load and Pharmacological studies ovulogenic 
activity, estimation of hormones FSH, LH, Progesterone, Estrodial and antioxidant 
activity for its naturally curing property for Polycystic ovarian syndrome.  
The anti-microbial load shown effective control that at medium and high doses 
against Streptococcus mutans, Staphylococcus aureus, Escherchia coli, Klebsiella 
pneumoniae and Pseudomonas aeruginosa. 
FTIR revealed the presence of functional groups aliphatic bromo compounds, nitro 
group, ketones, carbonyl group, phenols and alcohols. Phenolic group of compounds 
exert antioxidant activity, they are responsible for chemo-preventive properties like anti 
carcinogenic, antimutagenic, anti-inflammatory activity, apoptosis inducing and 
regulates carcinogen metabolism.  
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SEM revealed the presence of particles of size in which 3µm, 10µm particles have 
valuable properties that can be used to improve drug delivery. Where larger particles 
would have been unfurnished from the body, cells take up these nanoparticles because of 
their size. 
In the pharmacological studies, Letrozole induced PCOS rats model treated with two 
different forms of Ashuwathi chooranam formulation in various doses (100 mg, 200  
m g ) and time (30 days) dependent manner suggested maximum effect that reduced 
PCO like phenotype such as decreased in peripheral cysts with growing follicles, 
decreased glucose intolerance. Present study also elucidated that Ashuwathi chooranam 
formulation exhibiting effect in PCO phenotype that indicates natural preservatives. 
Ashuwathi chooranam has a good efficacy for management of PCOS phenotype. 
Ashuwathi chooranam is  rich  in  various  phyto-components  that  were  analysed  
by  several qualitative and quantitative analyses.. Further, confirmation for the presence 
of Phytosterols like sterols, β- sitosterol etc along with steroid derivatives has been 
performed by TLC, HPTLC. 
The certain compounds in Ashuwathi chooranam suppresses the conversion of 
cholesterol to pregnenolone through inhibition of P450 cytochrome activity, thus 
reducing testosterone production. The modulation could be due to effect of 
phytosterols acting at all organ levels hyperinsulinemic condition leading to restoration 
of ovarian function in PCO rodent model. This proves phytosterols could be novel 
component which can be explored for management of PCOS. 
Through the elaborate study Ashuwathi chooranam had shown its sphere of action 
over the female reproductive system especially over the ovaries in the condition called 
PCOS. 
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7. SUMMARY 
Polycystic Ovary Syndrome (PCOS) is the most common endocrinopathy 
seen in women of reproductive age. Though it is a reproductive disorder, it is 
associated with characteristics of metabolic syndrome including insulin resistance. 
Current available mode of treatment is by use of insulin sensitizers like metformin 
and ovulating agents like clomiphene citrate    But, these drugs have been reported 
for their side effects upon prolonged usage. 
Hence, researchers in current era are exploring alternative therapy to manage 
the metabolic syndrome. In this context, many scientists have demonstrated the role 
of medicinal plants in the management of hyperglycemic condition. It has gained its 
popularity as anti- hyperglycemic plant, wherein its phytosterols and polyphenols 
have been studied extensively for the above efficacy.  Thereby, it would be of interest 
to biopropsect Ashuwathi chooranam for management of metabolic induced 
anovulatory disorder like PCOS.   In this context, current work has elucidated the 
potentiality of Ashuwathi chooranam (AC). 
To study the efficacy of AC, Polycystic ovarian syndrome (PCOS) rat 
model was developed with use of letrozole (0.5 mg/kg/body weight/21 days/orally) - 
a non- steroidal aromatase inhibitor  in estrus cycle. Thus, letrozole induced PCOS rat 
model demonstrated key features of PCOS phenotype. 
Further, PCOS rat model was treated with Ashuwathi Chooranam formulation 
in various dose doses (100 mg, 200mg) at different time points (30 day). After 
completion of experiment regime, various biochemical parameters were checked to 
evaluate the efficacy of Ashuwathi chooranam  
Apart from the phytochemical analysis, “Ex vivo” experiments were 
performed with partially purified fraction to evaluate direct effect of phyto-
components on ovarian steroidogenic enzymes activities using PCOS model. Further, 
the detailed chromatographic analysis- TLC, HPTLC, and HPLC of demonstrated the 
presence of various phytosterols. 
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In current study, treatment with both Ashuwathi chooranam (AC) formulation 
with higher dose (100mg, 200 mg) at longer period of time (30days) 
demonstrated more significant effect and it restored glucose sensitivity and normal 
insulin level. Along with the above changes, ovarian structure-function (in terms of 
hormone levels and presence of developing follicles) was seen upon the AC 
treatment.   This could be attributed to the nutritionally rich phytosterols and phyto- 
phenols present in the plant, that helps to sensitize the insulin receptors for the 
glucose uptake. 
Ashuwathi chooranam phyto-components independently could cause a 
modulation in PCO phenotype. All the treatments did not affect toxicity parameters, 
thus suggesting AC treatment was safe and it contributes its maximum efficacy on 
reproductive organs. 
Current   study demonstrated altered in utero environment like decrease in 
progesterone with increased testosterone levels may result in failure of implantation 
and prenatal defects, which is implicated in PCOS phenotype as justified by other 
studies.  
In context of above observed physiological modulations, it was of interest to 
elucidate detailed phytochemistry of AC and to isolate, identify the active component 
responsible for mentioned efficacies. In this regard, both qualitative and quantitative 
analysis confirmed the presence of phyto-components namely polysaccharides, 
alkaloids, polyphenols, sterols, flavonoids, etc., which is similar to data reported by.  
Several data has suggested that phytosterols and polyphenols can have a role in 
modulation of steroid status.  
Thus, this current analysis authenticates that Ashuwathi chooranam has 
impressive ovulogenic activity over PCOS (Soothaga vayu) in female, which 
exemplifies the intelligence of the Siddha literature to reach globally for the welfare 
of mankind.  
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8. FUTURE SCOPE 
Ashuwathi chooranam indicated for Soothaga Vayu as per Siddha literature is 
being proved that the drug has its role in the treatment of PCOS.  
With reference to the in vivo studies in female Wistar albino rat, clinical trials 
should be conducted in future to authenticate the traditional use of AC in menstrual 
irregularities and fertility issues in humans.  
SEM depicted the presence of nano particles, the active compound exhibiting the 
therapeutic efficacy should be analyzed. The composition of the compound in micro size 
and their percentage of presence in AC should be elucidated in future by Dynamic Light 
Screening and Nuclear Tracking Analysis. 
More recently, with the advance of gene technology many new animal models 
that can aid in illumination of PCOS pathophysiology have been established. 
This is first study where implication of Ashuwathi chooranam has shown the 
potential to manage PCOS, which could be considered as a novel component for 
future drug development and should be screened for rest of the pharmacological 
activities like ovulogenic activity, hormonal assays, antioxidant activity to rule the 
effective pathways so that the exact benefit and aim of the study would be fulfilled. 
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